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High rates of comorbidity have been reported between PTSD and musculoskeletal
pain (e.g., Asmundson & Hadjistavropolous, 2006; Asmundson et al., 1998). Comorbid
PTSD and chronic pain have been associated with elevated levels of affective distress,
greater perceptions of pain, interference in daily activities, and high rates of disability
(Otis et al., 2003; Sherman et al., 2000). Overall, comorbid conditions of PTSD and
chronic pain are associated with large personal costs for the individual and economic
costs for society.
The triple vulnerability model was originally proposed to account for anxiety
symptoms in general, and it was later applied to the specific development of PTSD
(Barlow, 2000; Barlow, 2002; Keane & Barlow, 2002). Otis and colleagues (2003)
further proposed that the triple vulnerability model may account for the relationship
between PTSD and chronic pain. According to the triple vulnerability model, individuals
must present with a generalized biological, generalized psychological, and a specific
psychological vulnerability for either of these conditions to develop (Keane & Barlow,
2002; Otis et al., 2003).

In the current study, aspects of the triple vulnerability model were examined
within the following groups of women: women who have PTSD without chronic pain (n
= 11), women who have musculoskeletal pain without PTSD (n = 10), women with both
PTSD and musculoskeletal pain (n = 10), and women without PTSD and chronic pain (n
= 15). Cortisol reactivity and anxious mood were assessed before and after the Trier
Social Stress Task (TSST). Participants also completed questionnaires to assess for other
potential indicators of the triple vulnerability model.
Results indicate that: 1) the roles of generalized biological, generalized
psychological, and specific psychological vulnerabilities toward developing PTSD were
supported; 2) limited findings supported the potential role of these vulnerabilities toward
developing chronic pain; however, results of these measures were not similar to that of
PTSD (e.g., family history of chronic pain); 3) it is not thought that PTSD and chronic
pain are associated with the same vulnerabilities; 4) having a diagnosis of PTSD and
chronic pain was associated with an increase in symptoms across many measures utilized
in the current study.
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Chapter 1
INTRODUCTION
Recently, there has been widespread interest among professionals in the
behavioral medicine and medical communities regarding the relationship of chronic pain
and anxiety. In particular, high comorbidity rates have been observed among individuals
with chronic pain and posttraumatic stress disorder (PTSD). Among individuals who are
seeking treatment for chronic pain, approximately 20% to 34% of these individuals are
also thought to report high levels of PTSD symptomatology or have an actual PTSD
diagnosis (Asmundson, Norton, Allerdings, Norton, & Larsen, 1998; Geisser, Roth,
Bachman, & Eckert, 1996). Within the fibromyalgia population in particular,
approximately 56% of individuals tend to report symptoms associated with PTSD, and
approximately 21% report actual comorbid diagnoses of fibromyalgia and PTSD (Amir et
al., 1997; Cohen et al., 2002; Sherman, Turk, & Okifuji, 2000). Thus, high levels of
PTSD symptomatology are reported within the chronic pain population.
In studies that assess for the frequency of pain symptomatology within PTSD
populations, even higher comorbidity rates have been found (Otis, Pincus, & Keane,
2006). Furthermore, physical symptoms of pain are thought to be the most commonly
reported symptoms within the PTSD population, even when different types of traumatic
events are taken into account (e.g., military combat, motor vehicle accident, or sexual
assault; Asmundson, Coons, Taylor, & Katz, 2002). Among community samples,
approximately 20% to 30% of individuals with PTSD are thought to develop different
forms of chronic musculoskeletal pain (i.e., general pain conditions that influence
muscles, ligaments, tendons, and bones), and such estimates are dramatically increased
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within military populations (Asmundson, & Hadjistavropolous, 2006). For example,
multiple regression analyses were used to assess for the effects of exposure to war-zone
environments on PTSD and health within 109 female Vietnam veterans (Wolfe, Schnurr,
Brown, and Furey, 1994). Results indicated that PTSD was the strongest predictor of
poor health outcomes (Wolfe et al., 1994). In addition, both PTSD and fibromyalgia
have been found to occur more frequently in female populations (Otis, Keane, & Kerns,
2003).
Comorbid conditions of PTSD and chronic pain are also associated with other
difficulties (e.g., perceived levels of pain, affective distress, interference in daily
activities, higher rates of disability; Otis et al., 2003). Within a sample of fibromyalgia
patients who were seeking treatment, those who also reported PTSD symptomatology
tended to report more significant amounts of pain, interference in their life, emotional
distress, and inactivity. In addition, more than 85% of this subsample with both
fibromyalgia and PTSD reported high levels of disability, as opposed to 50% of the
subsample that did not report PTSD symptomatology (Sherman et al., 2000). In a female
chronic pain population, comorbid reports of childhood sexual abuse were correlated with
increased chances of receiving a surgical procedure (Finestone et al., 2000). Overall,
comorbid conditions of PTSD and chronic pain are associated with higher pain intensity,
psychological distress, disability, and medical utilization.
With such high rates of comorbidity, and subsequent costs to the individual and
society, it is imperative to assess for potential mechanisms that account for such
relationships. Although several models have been proposed to account for the
relationship between chronic pain and PTSD, limited empirical research has been
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conducted to provide support for these models. Even though the theoretical
underpinnings for these models were based on empirical research to varying degrees,
many of the models were originally proposed to account for another population and then
later adapted to account for the relationship of PTSD and chronic pain (e.g., triple
vulnerability model). Thus, no studies to date have tested these theoretical models in
their entirety (Otis et al., 2003). Prior to discussing specific theories that account for the
high comorbidity rates between PTSD and chronic pain, the conceptual basis for
understanding both PTSD and chronic pain individually is presented.
Posttraumatic Stress Disorder: General Characteristics
Diagnostic Criteria
PTSD was first introduced as a formal psychiatric diagnosis in the third version of
the Diagnostic and Statistical Manual in 1980 (DSM-III; American Psychiatric
Association [APA], 1980). Since this time, the amount of literature that addresses
various aspects of PTSD has increased significantly (Khouzam, Ghafoori, & Hierholzer,
2005). Currently, PTSD is characterized by the experience of a traumatic event, and
associated feelings of intense helplessness and fear during the time of the event (DSMIV-TR; APA, 2000). Traumatic events are characterized by the direct and personal
exposure to an extremely distressing event, with subsequent responses involving personal
perceptions of extreme fear, helplessness, or horror. In addition, PTSD is characterized
by re-experiencing aspects of the traumatic event (e.g., flashbacks, nightmares regarding
the traumatic event), avoidance of stimuli that serve as reminders of the traumatic event
(e.g., people, places), arousal symptomatology (e.g., hypervigilance), and clinically
significant levels of distress and interference. In terms of duration, symptoms must
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persist for at least one month (APA, 2000). For many individuals, symptoms associated
with PTSD tend to diminish within three months of experiencing the traumatic event;
however, individuals who experience symptomatology for longer than three months tend
to report fairly stable and chronic symptoms in the absence of any intervention (Resick &
Calhoun, 2001).
Prevalence and Demographics
Rates of traumatic events are extremely high in the United States. Within the
general population, approximately 90% of individuals will experience a traumatic event
(e.g., car accidents, interpersonal violence, natural disaster, or a combat related event)
during their lifetime (Breslau et al., 1998). Furthermore, data from the National
Comorbidity Study (Kessler, Sonnega, Bromet, Hughes, & Nelson, 1995) revealed that
approximately 20.4% of females and 8.1% of males go on to develop PTSD following the
experience of a traumatic event. These researchers also found that approximately 7.8%
of the general population will develop PTSD within their lifetime (Kessler et al., 1995).
Within the Primary Care Anxiety Project (Bruce et al., 2001; Weisberg et al., 2002), a
multi-site longitudinal study looking at anxiety disorders, approximately 12% of 1500
primary care patients met criteria for PTSD. It is clear that many individuals who
experience a traumatic event will not go on to develop PTSD. Thus, the sole experience
of a traumatic event is not necessarily adequate to account for the development of PTSD
symptomatology. Other vulnerability factors must be present for the disorder to develop
(Brewin, Andrews, & Valentine, 2000).
Although prevalence rates of PTSD may vary slightly across different
populations, women have consistently been found to be twice as likely to develop PTSD
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than men (e.g., Kessler et al., 1995; Khouzam et al, 2005). Many hypotheses have been
proposed to account for these differential rates of PTSD. One hypothesis is that women
may be more likely to develop PTSD as a result of the nature of their traumatic event
(Schnurr, Friedman, & Bernardy, 2002). According to research on this topic, women
report experiencing greater frequencies of being raped, sexual molestation, and childhood
abuse (Schnurr et al., 2002). Within the National Comorbidity Study, men were more
likely to report witnessing someone being badly injured or killed, being involved in a fire,
flood, or natural disaster, being physically attacked, combat related experiences, or being
threatened with a weapon, held captive, or kidnapped. Conversely, women were more
likely to report being raped, sexually molested, neglected by their parents during
childhood, and being physically abused during childhood (Kessler et al., 1995). Such
qualitative differences in reports of traumatic events by men and women may influence
prevalence rates of PTSD.
Although most PTSD research focuses on younger individuals, rates of
interpersonal traumatic events are also reported within older populations of women. In a
study that surveyed 842 women who were 60 years of age or older, rates of abuse were
still highly prevalent (Fisher & Regan, 2006). In this sample, 47% of the women
reported experiencing one or more types of abuse since they were 55 years of age. In
particular, 45% of the women reported experiencing psychological/emotional abuse, 12%
were threatened by somebody, 4% were physically abused and 3% were sexually abused
(Fisher & Regan, 2006). These results lend support to the hypothesis that women may be
more likely to develop PTSD due to the interpersonal nature of many traumatic events
that they experience compared to men.
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Conversely, other researchers argue that women still experience higher rates of
PTSD after the type of trauma is taken into account (Wong & Yehuda, 2002). In
addition, the researchers reported that the higher rates of PTSD in women cannot be
accounted for by mere exposure to a traumatic event as men are just as likely to
experience a traumatic event as women. Gender differences in PTSD development were
found to be significantly greater if an individual’s trauma occurred before they were 15
years old (Wong & Yehuda, 2002). Consequently, the age at which an individual
experiences a traumatic event may play a large role in PTSD development.
Many other risk factors for PTSD have also been proposed and debated by
various researchers (e.g., Khouzam et. al, 2005; Resick & Calhoun, 2001; Tanriverdi,
Karaca, Unluhizarci, & Kelestimur, 2007; Wong & Yehuda, 2002). Resick and Calhoun
(2001) proposed that women may be at a greater risk in the development of PTSD
because of a biological predisposition in addition to the types of traumas that they
experience. In particular, the hypothalamic-pituitary-adrenal axis (HPA axis) has gained
increasing attention in accounting for PTSD symptomatology. In general, human
responses to stress can be largely accounted for by HPA axis functioning (Tanriverdi et
al., 2007). Other risk factors may include: lower educational attainment, pre-existing
psychopathology, early conduct problems, family history of psychopathology, severity of
initial reaction to the trauma, peritraumatic dissociation, poor social support, history of
stress or abuse, and early separation from parents (Khouzam et. al, 2005; Wong &
Yehuda, 2002). Overall, it is clear that biological, psychological, and social factors may
all play a role in PTSD development.
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As might be expected, PTSD is associated with a very high cost to society. Not
only are individuals with PTSD frequently seen within mental health care settings
(Khouzam et al., 2005), they are even more likely to seek medical care (Gillock, Zayfert,
Hegel, & Ferguson, 2005). According to a study by Gillock and colleagues (2005),
individuals with a diagnosis of PTSD, and those with subsyndromal PTSD symptoms,
tend to visit their primary care office more frequently over a 3-month period than
individuals without PTSD. In addition, PTSD is associated with more severe physical
symptoms and worse physical functioning with regards to bodily pain, role limitations,
and general health perceptions (Gillock et al., 2005; Zayfert, Dums, Ferguson, & Hegel,
2002). An increase in medical utilization and health related problems is thought to
partially result from biological changes and physical symptoms that develop out of
perpetual nervous system activation following the experience of a traumatic event
(Butterfield & Becker, 2002; Gillock et al., 2005; McFarlane, 2000; Yehuda, 2002).
Furthermore, prolonged stress and nervous system activation have been shown to reduce
immune system functioning in both humans and animals (Chiarmonte, 1997; Khouzam et
al., 2005). It is clear that the effects of PTSD are costly with regard to physical effects on
the body and health care utilization.
Chronic Pain: General Characteristics
Diagnostic Criteria
Pain is defined as the experience of unpleasant sensory and emotional symptoms
(Merskey, & Bogduk, 1994; Staud, 2004). Pain is typically conceptualized as being
either acute or chronic in nature. When pain is defined as acute, it is generally caused by
tissue damage (e.g., wound, broken limb) from an injury (Taylor, 2006). Given that the
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experience of pain can help alert the body to tissue damage; it is thought to play an
adaptive role in day to day functioning. Furthermore, the experience of pain helps to
motivate an individual to react in a way that may decrease the risk of potential damage
and to also recover from its effects (Wall, 1978). Subsequently, pain from this type of
tissue damage tends to abate as the body repairs the damage. However, pain that begins
as an acute episode does not always lessen with treatment and time (Taylor, 2006).
When pain persists for three or more months and becomes a chronic condition
(International Association for the Study of Pain, 1986), it is thought to lose its adaptive
functioning, and can create a significant amount of distress and impairment (APA, 2000).
Consequently, the experience of pain is often associated with interference, feelings of
little control over pain symptoms, depression, and anxiety (Lautenbacher, Spernal,
Schreiber, & Krieg, 1999; Maxwell, Gatchel, & Mayer, 1998; Plehn, Peterson, &
Williams, 1998). Pain behaviors may also be rewarded when individuals receive special
attention from their family or friends (Osterhaus, Lang, Linssen, & Passchier, 1997). It is
not surprising that pain is viewed as a very complex experience, with physiological,
psychological, social, and behavioral influences (Taylor, 2006).
Musculoskeletal pain entails widespread pain involving the muscles and skeleton.
According to the American College of Rheumatology (1990), widespread pain is defined
as pain that is experienced above and below the waist, on the right and left sides of the
body, or axial skeletal pain. Fibromyalgia, in particular, is characterized as the
experience of widespread pain with tenderness in 11 or more of the 18 specified tender
points (see Figure 1.1 for a diagram of tender point locations). Tender points are defined
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as the experience of severe tenderness upon palpation (American College of
Rheumatology, 1990).
Figure 1.1 Fibromyalgia tender point locations (Slavkin, 1997).

Although there are numerous forms of musculoskeletal pain, research has
demonstrated that similar mechanisms (to different magnitudes) play a role in both
fibromyalgia and other forms of chronic musculoskeletal pain (Bennett, 1998; Carli,
Suman, Biasi, Marcolongo, 2002; Granges & Littlejohn, 1993). It has been difficult to
detect laboratory or radiographic abnormalities that may be used in the assessment of
musculoskeletal pain. Overall, little is known about the etiology of musculoskeletal pain
conditions.
Researchers have hypothesized that the HPA axis may play a role in the
development of musculoskeletal pain conditions (e.g., fibromyalgia; Crofford et al.,
2004). High concentrations of Substance-P, a neurotransmitter associated with pain
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levels, have also been found to be associated with fibromyalgia diagnoses (Clauw &
Crofford, 2003; Russell et al., 1994). With respect to psychological factors, it has
frequently been reported that symptoms of musculoskeletal pain begin or worsen during
times of physical or emotional stress (Crofford et al., 2004). In addition, fibromyalgia is
frequently associated with childhood and lifetime experiences of physical, sexual, and
verbal abuse (e.g., Finestone et al., 2000; Goldberg & Goldstein, 2000). The lengthy and
stressful process that individuals may go through to be diagnosed with fibromyalgia often
leaves women feeling as though they are being judged as imagining their symptoms
(Asbring & Narvanen, 2002; Zavestoski et al., 2004). Thus, there may be a relationship
between stress, HPA activity, and symptoms of musculoskeletal pain.
Prevalence and Demographics
Pain is a leading cause of health care utilization in the United States that accounts
for more than 70 million (80%) visits to physicians every year (Koch, 1986). According
to The National Institute of Health, more than 50 million Americans experience various
forms of pain, leading to more than 100 billion dollars in health care costs (as cited in
Litcher-Kelly, Martino, Broderick, & Stone, 2007). Of these individuals who experience
pain, approximately 17% are experiencing chronic pain (Gureje, 1998). According to
epidemiological research, 4.9 million individuals are seeking treatment for their chronic
pain condition (Marketdata Enterprises, 1999). Furthermore, approximately 7% of the
general population report having experienced chronic pain within the last 12 months
(McWilliams, Cox, & Enns, 2003).
Musculoskeletal pain is one of the most frequent forms of chronic pain, and is
also one of the primary causes of disability in the United States (Davis, Zautra, & Reich,
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2001). Fibromyalgia, one of the common types of musculoskeletal pain, is estimated to
occur in approximately 2% of the population, and is about nine times more likely to
develop within the female population. Prevalence rates of fibromyalgia have also been
found to increase as individuals get older, with approximately 7% of women who are
between 60 and 79 years of age reporting symptoms of fibromyalgia (Wolfe, Ross,
Anderson, Russell, & Hebert, 1995). On average, individuals with fibromyalgia receive
services from an outpatient physician approximately 10 times per year, costing
approximately $2,200 for these visits (Wolfe et al., 1997). Furthermore, up to 25% of
individuals with fibromyalgia report being on disability (Wolfe, 1996), and symptoms
tend to persist with little change over long periods of time (Forseth, Forre, & Gran, 1999;
Norregaard, Bulow, Prescott, Jacobsen, & Danneskiold-Samsoe, 1993; Wigers, 1996).
Musculoskeletal pain and fibromyalgia, in particular, represent very frequent and
debilitating chronic pain conditions within the female population.
Pain Sensitivity
Pain sensitivity is often operationalized as tenderness to pain (e.g., Montoya,
Pauli, Batra, Wiedemann, 2005; Petzke Clauw, Ambrose, Khine, & Gracely). A
diagnosis of fibromyalgia is based upon the existence of tender points and their
sensitivity to touch (American College of Rheumatology, 1990); however, this sensitivity
to touch is not necessarily limited to these specific tender points, and pain sensitivity is
frequently reported throughout the whole body (Petzke et al., 2003; Scudds, Rollman,
Harth, & McCain, 1987; Wolfe et al., 1995).
Many factors have been proposed to alter levels of pain sensitivity within
fibromyalgia populations. Stress, in particular, has frequently been shown to perpetuate
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levels of pain within individuals with fibromyalgia (Van Houdenhove & Egle, 2004), and
people that have a diagnosis of chronic pain tend to report higher levels of environmental
stressors, general stress, and psychological distress than individuals without chronic pain
(Naidoo & Pillay, 1994). Furthermore, factors associated with stress (i.e., anxiety,
depression, irritability) may perpetuate pain related symptoms of fibromyalgia and
subsequent levels of disability (Winfield, 1999). Pain sensitivity may also be enhanced
as a result of hypervigilance to bodily sensations (Lorenz, Grasedyck, & Bromm, 1996;
McDermid, Rollman, & McCain, 1996; Chang, Mayer, Johnson, FitzGerald, & Naliboff,
2000); however, some researchers still argue that no differences in body vigilance reports
are demonstrated between individuals with fibromyalgia and individuals without the
diagnosis (e.g., Peters, Vlaeyen, & van Drunen, 2000). Higher levels of pain
catastrophizing have been found to be associated with lower pain thresholds and
tolerance for pain within fibromyalgia populations (Geisser, Casey, Brucksch, Ribbins,
Appleton, & Crofford, 2003). Similarly, hypervigilance to pain has been positively
correlated with pain intensity, negative affectivity, and catastrophizing about pain
conditions (Crombez, Eccleston, Van den Broeck, Goubert, & Van Houdenhove, 2004).
Overall, many psychological factors have been found to worsen pain sensitivity within
fibromyalgia populations.
Theoretical Models of Comorbid PTSD and Chronic Pain
Although there are high comorbidity rates between PTSD and chronic pain, few
factors have been identified to account for these high prevalence rates. To date, three
models have been proposed to account for the comorbidity of PTSD and chronic pain: the
mutual maintenance model (Sharp & Harvey, 2001), the shared vulnerability model
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(Asmundson et al., 2002), and the triple vulnerability model (Otis et al., 2006). Although
some aspects of these models have been supported in research, no studies have tested the
complete models (Otis et al., 2006). Given that the triple vulnerability model accounts
for biological, psychological, and social aspects of PTSD and chronic pain development,
the current study will test aspects of this model.
Mutual Maintenance Model
According to the mutual maintenance model (Sharp & Harvey, 2001), there are
seven components of both PTSD and chronic pain that may work together to mutually
maintain or worsen the symptoms of one another. Furthermore, these components
interact to further worsen an individual’s distress and disability from each condition.
First, attentional biases resulting from a PTSD diagnosis are thought to cue individuals in
to potentially threatening or painful stimuli. In both conditions, individuals may have an
unrealistically high expectation of confronting or experiencing threatening stimuli (Sharp
& Harvey, 2001). Conflicting research has been demonstrated regarding the role of
attentional biases in PTSD. When compared to individuals that did not develop PTSD
following a traumatic event, Vietnam veterans with PTSD did not take longer to process
threat related words (McNally, Amir, & Lipke, 1996). However, many other researchers
have demonstrated that individuals with PTSD do demonstrate attentional biases for
threat related words (e.g., Bryant & Harvey, 1997; Buckley, Blanchard, & Neill, 2000;
Foa, Feske, Murdock, Kozak, & McCarthy, 1991; Harvey, Bryant, & Rapee, 1996).
Research has also found that participants with PTSD tend to overestimate the probability
of re-experiencing a traumatic event (Warda & Bryant, 1998). Similarly, participants
with a chronic pain condition tend to overestimate the likelihood of pain symptomatology
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and re-injury (McCracken, Gross, Sorg, & Edmunds, 1993). Consequently, attentional
biases towards painful stimuli may serve to amplify pain symptomatology. Research
assessing response latencies among individuals with chronic pain have tended to be
slightly more conflicting with regard to the existence of attentional biases (Beck,
Freeman, Shipherd, Hamblen, & Lackner, 2001). Only one study (Beck et al., 2001)
assessed and provided support for the role of attentional biases within a population of
individuals with comorbid chronic pain and PTSD. However, the sample was limited to
individuals who had developed chronic pain following a motor vehicle accident. Overall,
preliminary research tends to support the role of attentional biases in PTSD, although
more conflicting results have been demonstrated in the chronic pain population.
Second, anxiety sensitivity is hypothesized to serve as a vulnerability factor for
both PTSD and chronic pain conditions (Sharp & Harvey, 2001). Anxiety sensitivity
refers to the fear of symptoms of arousal that may develop from misattributions regarding
the potential harmfulness of various sensations (Reiss & McNally, 1985). In particular,
individuals may be fearful of public displays of anxiety, cognitive dyscontrol, or bodily
sensations (Taylor, 2004). High levels of anxiety sensitivity may lead individuals to
misinterpret and catastrophize physiological symptoms that are associated with both
chronic pain and PTSD (Sharp & Harvey, 2001).
According to a previous hypothesis (Taylor, 2004), anxiety sensitivity may
increase following the experience of a traumatic event, and this increased level of anxiety
sensitivity may then heighten the experience of PTSD symptoms (Taylor, 2004). Not
only has anxiety sensitivity been found to intensify an individual’s emotional response to
various stimuli, but it has also been found to be associated with PTSD severity (Taylor,
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2004). In a study that assessed anxiety sensitivity in children and adolescents (ages 8 to
15) five years after the experience of an earth quake, anxiety sensitivity levels were found
to predict PTSD symptomatology (Kilic, Kilic, & Yilmaz, 2008). Overall, research
suggests that there may be a relationship between anxiety sensitivity and PTSD
symptoms.
Support for the role of anxiety sensitivity in pain perception has generally come
from non-clinical undergraduate populations (Stewart & Asmundson, 2006). In a study
that assessed for pain experiences within high and low anxiety sensitivity groups, 90
female undergraduate students were administered a cold pressor task. Results
demonstrated that no significant differences were reported between both groups with
respect to pain threshold, pain recovery, or pain tolerance following a cold pressor task.
Conversely, the high anxiety sensitivity group reported greater perceptions of pain and
fear of pain. Thus, the relationship between anxiety sensitivity and pain intensity is
thought to be mediated by fear (Uman, Stewart, Watt, & Johnson, 2006). Although
elevated anticipatory anxiety may not be specific to pain; individuals with high anxiety
sensitivity have been found to report greater anticipatory anxiety prior to the experience
of a painful stimulus (Conrod, 2006). Finally, a treatment study focusing on high and
low anxiety sensitivity groups provided evidence for the role of anxiety sensitivity in pain
related anxiety. Following a cognitive-behavioral treatment plan for anxiety sensitivity,
pain-related anxiety was found to lessen (Watt, Stewart, Lefaivre, & Uman, 2006).
Research on anxiety sensitivity and attentional biases has indicated that high
levels of anxiety sensitivity are associated with color naming interference for physical
threat words (Stewart, Conrod, Gignac, & Pihl, 1998). Conversely, other researchers
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have reported that neither high nor low levels of anxiety sensitivity are associated with
response latencies for physical threat words in the emotional Stroop task. It has been
hypothesized that they may have obtained null results because they did not include
participants that had experienced panic attacks, whereas Stewart and colleagues (1998)
did include participants who had experienced panic attacks (McNally, Hornig, Hoffman,
& Han, 1999). In another study, a physical threat subscore on the anxiety sensitivity
index was created and was examined for attentional biases within participants with high,
moderate, and low physical threat anxiety sensitivity. These researchers also utilized the
visual dot probe task instead of the modified Stroop task. Results indicated that high
levels of physical threat anxiety sensitivity were associated with attentional biases for
anxiety related words (Hunt, Keogh, & French, 2006).
Third, physiological symptoms of pain may serve as a reminder of the traumatic
event. One study reported that individuals who have experienced a traumatic event tend
to report experiencing increased symptoms of panic, and subsequently fear these panic
related symptoms (Falsetti & Resnick, 1997). In particular, they may fear experiencing
physiological symptoms such as increased heart rate and numbness and tingling
sensations (Falsetti & Resnick, 1997). Arousal responses may lead individuals to further
avoid activities that increase pain levels and that remind an individual of his or her
trauma (Sharp & Harvey, 2001). PTSD research has demonstrated that various reminders
of a traumatic event may initiate further arousal and PTSD symptomatology (Blanchard,
Kolb, Gerardi, Ryan, & Pallmeyer, 1986). Furthermore, the experience of a traumatic
event has been associated with the onset of chronic pain conditions (e.g., Finestone et al.,
2000; Goldberg & Goldstein, 2000).
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Fourth, such avoidance may initially lower feared symptomatology; however,
prolonged behavioral and cognitive avoidance may lead to additional physical and
anxiety symptomatology. Evidence for this claim has been supported in both the PTSD
and chronic pain literature (e.g., Harvey & Bryant, 1998; Sharp, 2001). One study
assessed for cognitive avoidance (i.e., suppression of trauma related memories) in
individuals with acute stress disorder (n = 24) and in a control group (n = 24). Results
suggested that attempts to suppress trauma-related thoughts in the acute stress disorder
group were associated with a greater increase in ratings of anxiety and more frequent
anxious thoughts than the control group (Harvey & Bryant, 1998). In chronic pain
populations, behavior avoidance of physical activities has been associated with decreases
in physical functioning and increased levels of disability (Waddell et al., 1993). Thus,
preliminary evidence has supported the role of behavioral and cognitive avoidance in the
perpetuation of PTSD and chronic pain symptomatology.
Fifth, individuals with either PTSD or chronic pain frequently experience
symptoms of depression as well. Symptoms of depression have been found to be highly
prevalent in samples that have comorbid conditions of PTSD and chronic pain (RoyByrne, Smith, Goldberg, Afari, & Buchwald, 2004). It is commonly known that fatigue
is a diagnostic symptom for major depressive disorder (APA, 2000). Greater symptoms
of fatigue have been associated with decreased participation in physical activities within a
fibromyalgia sample (Rutledge, Jones, & Jones, 2007). Thus, symptoms of fatigue and
lethargy from depression may result in decreased participation in various activities, which
may then help to maintain or worsen PTSD and pain symptomatology.
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Sixth, perception of pain may increase due to anxiety associated with PTSD,
further limiting participation in activities (i.e., activities involving physical exercise;
Sharp & Harvey, 2001). Although researchers have not assessed for increased pain
perceptions within PTSD samples, research has indicated that self-perceptions of pain are
increased by the experience of anxiety (e.g., Difede, Jaffe, Musngi, Perry, & Yurt, 1997).
Seventh, high levels of cognitive demands associated with both conditions (i.e.,
catastrophic cognitions and recurrent thoughts of trauma) may limit the use of adaptive
coping strategies (i.e., cognitive restructuring; Sharp & Harvey, 2001). Further
information regarding the use of various coping strategies in PTSD and chronic pain
populations will be provided below.
Given that many aspects of the mutual maintenance model are indirectly
supported in the PTSD and chronic pain literature, it may hold some promising results as
an explanatory model; however, there are some criticisms regarding various aspects of
the model. As mentioned earlier, the modified Stroop task has often been used in the
PTSD and chronic pain literature as a means of measuring attentional bias, although the
validity of the modified Stroop paradigm has been questioned. In particular, it is unclear
if this task is actually measuring attentional bias, or if it is measuring another form of
information processing (e.g., determining the meaning of words) or motor response (e.g.,
trying to determine an appropriate response). Although the extant research has generally
supported the role of the Stroop paradigm in measuring attentional biases, there is still a
possibility that this research may be eliciting a more generalized information processing
bias than the intended attentional bias construct (Roelofs, Peters, Zeegers, & Vlaeyen,
2002).
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With regard to the role of anxiety sensitivity, research has demonstrated that
anxiety sensitivity and pain catastrophizing may independently contribute to the
experience of chronic pain (Drahovzal, Stewart, & Sullivan, 2006). As such, the role that
anxiety sensitivity plays in the development of pain perceptions and symptomatology
may be more complex than originally thought (Stewart & Asmundson, 2006). Finally,
the role of biological functioning (e.g., HPA axis) in both the PTSD literature and chronic
pain literature has been highly supported (e.g., Crofford et al., 1994; Olff et al., 2006;
Rasmusson & Friedman, 2002; Wingenfeld et al., 2008; Yehuda, 2003); however, this
model does not take biological or genetic influences (e.g., inherited vulnerabilities) into
account. As a result, the mutual maintenance model may not be the best predictor model
for the relationship between PTSD and chronic pain.
Shared Vulnerability Model
Asmundson and colleagues (2002) derived the shared vulnerability theory from
the mutual maintenance model. In particular, the researchers hypothesized that anxiety
sensitivity acts as a shared vulnerability that leads to the development of both PTSD and
chronic pain. In particular, they proposed that individuals who report higher levels of
anxiety sensitivity may be more likely to develop these conditions given they are
experiencing heightened fear levels and avoidance. Furthermore, these individuals with
high anxiety sensitivity are thought to demonstrate a greater emotional response (i.e., fear
and anxiety) when encountering a traumatic experience or physical injury (Asmundson et
al., 2002). If these individuals are demonstrating a stronger emotional reaction, then they
may be more likely to develop PTSD (Taylor, 2004). If individuals with chronic pain
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subsequently respond to their pain with fear and avoidance, then their symptoms are
likely to worsen (Asmundson et al., 2002).
Although anxiety sensitivity may serve as a promising vulnerability factor for
PTSD and chronic pain, many criticisms of this model still exist. As mentioned earlier,
the role of anxiety sensitivity in PTSD and chronic pain may be mediated by unknown
cognitive processes that are not accounted for by pain catastrophizing; thus, the influence
of anxiety sensitivity may be more complex than originally thought (Stewart &
Asmudson, 2006). Furthermore, a study comparing undergraduates with high and low
anxiety sensitivity demonstrated that fear levels in relation to a cold pressor task were
found to mediate the relationship between anxiety sensitivity and pain instead of the other
way around (Uman et al., 2006). Finally, this model is similar to the mutual maintenance
model in that it does not account for many other factors that may also play an important
role (e.g., social, biological, coping styles). Support for the role of these additional
factors will be provided below. Consequently, it is thought that the triple vulnerability
model may better account for biological, psychological, and social variables in the
development of PTSD and chronic pain.
Triple Vulnerability Model
The triple vulnerability model was originally proposed by Barlow (2000, 2002) to
account for the development of anxiety disorders in general. According to the triple
vulnerability model, three separate vulnerabilities must be present to develop anxiety
disorders: 1) a generalized biological vulnerability, 2) a generalized psychological
vulnerability, and 3) a specific psychological vulnerability. Keane and Barlow (2002)
further proposed that the triple vulnerability model may apply to PTSD when an
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individual experiences a traumatic event (i.e., the true alarm), which develops into a
specific psychological vulnerability (i.e., the learned alarm). However, PTSD cannot
develop without an individual having a generalized biological vulnerability (e.g.,
inherited aspects of personality traits that lead individuals to react to environmental
stressors in a defensive manner) and a generalized psychological vulnerability (e.g., sense
of uncontrollability and perceived inability to cope) prior to the traumatic experience
(Keane & Barlow, 2002). Further information regarding each of these vulnerabilities will
be provided below.
Otis and colleagues (2003) proposed that the triple vulnerability model can
account for the development of both PTSD and chronic pain. According to this variation,
chronic pain may also develop in a similar manner to that of PTSD with respect to the
three vulnerabilities. A sense of uncontrollability may be present prior to the
development of learned alarms associated with both PTSD and chronic pain. PTSD and
chronic pain may serve as a reminder of each other, and may act to maintain and worsen
symptomatology of each condition. Thus, increased levels of responsivity (i.e., fear and
avoidance) following these learned alarms may develop. Feelings of uncontrollability
may then worsen, and disability may develop (Otis et al., 2003).
Generalized Biological Vulnerability
According to Barlow (2000, 2002), individuals who go on to develop anxiety
have inherited personality traits that serve as a vulnerability for anxiety disorders. Such
traits are thought to consist of being “high-strung,” “nervous,” or “emotional” (Barlow,
2002). Other researchers have also hypothesized that personality traits, such as negative
affectivity and neuroticism, could also be inherited vulnerability factors (Clark, Watson,
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& Mineka, 1994). Negative affectivity is conceptualized as a general predisposition
towards experiencing negative emotions, with subsequent influences on cognitions, selfconcept, and world views (Watson & Clark, 1984). Similarly, neuroticism was originally
conceptualized as a personality dimension that develops out of a lowered threshold for
limbic system activation. Subsequently, neuroticism was defined as a personality
tendency to experience “fight or flight emotions” (i.e., fear, anxiety, anger, and distress),
which leads to a greater experience of negative moods (Eysenck, 1967, 1981). It is
estimated that genetic components of neuroticism may account for about 50% of its
expression in individuals (Barlow, 2002; Eysenck, 1967).
Gershuny and Sher (1998) conducted a three year longitudinal study of 466 young
adults to determine the correlates of neuroticism and extraversion (e.g., level of
sociability; Eaves & Eysenck, 1975) on anxiety and depression scores. Results indicated
that low levels of extraversion and high levels of neuroticism predicted higher levels of
global anxiety in the third year of the study. Furthermore, their results suggested that
there may be similar personality variables (i.e., neuroticism and extraversion) that predict
the development of both anxiety and depression (Gershuny & Sher, 1998). Other
research has also supported the hypothesis that anxiety and depressive disorders may
have a similar genetic vulnerability, with respect to personality, and that environmental
stressors may account for specific differences in how the disorders are expressed
(Barlow, 2002).
It has been difficult to determine specific genetic contributions for PTSD. For
example, it is difficult to differentiate between a vulnerability to being exposed to
traumatic events versus a vulnerability to developing PTSD symptomatology. In a study
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with World War II veterans with a diagnosis of PTSD, researchers found that 66% of
participants had family members with PTSD as well (Davidson, Swartz, Storck,
Krishnan, & Hammett, 1985). In another study, individuals who survived the bush fires
in Australia were surveyed. Results support the hypothesis that individuals with a family
history of PTSD were more likely to develop PTSD than to not develop PTSD following
this traumatic event (McFarlane, 1988). However, twin studies have provided conflicting
evidence regarding the genetic contributions for PTSD. Many of the studies that have
been reviewed also have some significant methodological flaws, and offer only
correlational findings instead of demonstrating causation (Keane & Barlow, 2002).
Within the chronic pain population, it has also been hypothesized that
musculoskeletal pain conditions (e.g., fibromyalgia) are associated with increased
negative affectivity and decreased positive affectivity. In particular, individuals with
fibromyalgia were found to report minimal experiences of positive emotions. This
finding, however, was not a direct result of decreased social engagements (Zautra et al.,
2005). Several researchers have hypothesized that various emotions (e.g., negative
affectivity) may serve as a vulnerability and maintenance factor for fibromyalgia (e.g.,
Davis, Zautra, & Reich, 2001; Geisser et al., 2003; Staud et al., 2003; Zautra et al., 2005).
After a prolonged difficulty in maintaining emotional homeostasis during periods of high
stress, individuals with fibromyalgia are thought to perceive future events as stressful.
This perception of future events as stressful is thought to perpetuate the cycle of poor
maintenance of emotional homeostasis (Zautra et al., 2005). Overall, researchers seem to
agree that aspects of Barlow’s original conception of a generalized biological
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vulnerability (i.e., negative affectivity) may apply to musculoskeletal pain populations as
well.
Researchers have provided initial support for 10 psychiatric conditions (i.e.,
attention-deficit hyperactivity disorder, bulimia nervosa, dysthymic disorder, generalized
anxiety disorder, major depressive disorder, obsessive-compulsive disorder, PTSD, panic
disorder, premenstrual dysphoric disorder, and social phobia) and 4 medical conditions
(i.e., fibromyalgia, irritable bowel syndrome, migraine, and cataplexy) to be grouped
together as affective spectrum disorders (ASD; Hudson & Pope, 1989, 1990, 1994;
Hudson et al., 2004). In particular, these researchers hypothesized that that the
psychological disorders and the medical conditions might share a physiological
irregularity (i.e., difference in physiological functioning) that plays a role in their
etiology. Support for this conception comes from similar responsivity among individuals
with the different diagnoses to antidepressant medications (e.g., tricyclics, monoamine
oxidase inhibitors, and serotonin reuptake inhibitors). Furthermore, this unknown
physiological irregularity is thought to be based in heredity (Hudson & Pope, 1989, 1990,
1994; Hudson et al., 2004). In a study that assessed for heritable pathophysiological
features of fibromyalgia, data were collected from 533 relatives of individuals with
fibromyalgia and 272 relatives of individuals without fibromyalgia. Results of this study
supported the original hypothesis that there are higher familial rates of ASD in relatives
of individuals with fibromyalgia as compared to relatives of individuals without
fibromyalgia. Subsequently, the idea of a similar genetic heritable component among
several conditions (i.e., fibromyalgia and PTSD) was supported. However, the exact
nature of this physiological irregularity has not been identified.
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With regards to the biological inheritance of personality traits, Barlow (2002)
proposed these personality traits (i.e., nervous, emotional, neuroticism, negative
affectivity) may lead individuals who develop anxiety disorders to react differently to
various changes in their environment. The genetic contribution is viewed as being nonspecific and it represents a general tendency to be emotionally unstable. In this sense, an
individual is genetically predisposed to respond to environmental changes/stressors in a
defensive way with an alarm reaction. Since they are perpetually ready for danger, the
threshold needed to initiate the fight or flight response is thought to be lower. However,
this biological tendency is only viewed as being vulnerability for the individual if they
present with specific psychological variables as well (Barlow, 2002).
Similar to research on PTSD, researchers have begun to look at abnormal brain
processing of pain related information (Gracely, Petzke, Wolf, & Clauw; 2002; Yunus,
1992). In particular, it has been hypothesized that musculoskeletal pain conditions (e.g.,
fibromyalgia), may be initiated and maintained by the hyperexcitability of the central
nervous system (Desmeules et al., 2003). Subsequently, hyperexcitability of the central
nervous system, and the negative feedback loop of the HPA axis, have been associated
with a blunted cortisol reaction following the experience of stressful events (e.g.,
Crofford et al., 1994; Wingenfeld et al., 2008). Similar to Barlow’s (2000, 2002)
conception of a generalized biological vulnerability, this HPA responsivity is not thought
to be specific to just that of chronic pain (Abeles, Pillinger, Solitar, & Abeles, 2007).
Further information regarding the role of HPA axis activation within PTSD and
musculoskeletal pain populations will be provided below.
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Given that individuals with anxiety disorders and chronic musculoskeletal pain
conditions are thought to be in a perpetual state of hyperarousal, it is not surprising that
researchers would anticipate that psychophysiological changes at baseline and in
response to stressful stimuli within these populations would be different than individuals
who do not have this predisposition. Various psychophysiological measures have been
used in PTSD and chronic pain research to examine arousal: facial electromyography
(EMG; muscle contractions), heart rate (HR; activity associated with cardiac
functioning), skin conductance (SC; activity associated with the sweat glands), systolic
blood pressure (SBP; blood pressure in the circulatory system with contractions of the
heart), and diastolic blood pressure (DBP; blood pressure in the circulatory system when
the heart is resting)(e.g., Flor & Turk, 1989; Pole, 2007,). In general, baseline
assessments using such measures have tended to show inconsistent results with respect to
various psychophysiological measurements within PTSD samples (Pole, 2007).
However, inconsistent results may be due to methodological limitations (i.e., differing
target muscles for various diagnoses, varying length of adaptation phases, lack of rest
between experimental stimuli, failure to counterbalance stressors, poor sampling rates;
Flor & Turk, 1989; Pole, 2007).
Frontalis (muscle located on the forehead) or corrugator (muscle located at the
end of the eye brow) EMG responsivity is thought to relate to the display of negative
emotions, zygomaticus (muscle located along the cheek bone) EMG is thought to reflect
positive emotions, and orbicularis oculi (muscle located above the eyelid) EMG is
thought to reflect an individual’s startle reflex (Blumenthal et al., 2005; Lang, Bradley, &
Cuthbert, 1998). The sympathetic nervous system (that prepares the body to react to
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emergencies, heightened emotions, or strenuous activity) is thought to regulate SC, and
both the sympathetic nervous system and the parasympathetic nervous system (that
maintains or helps the body return to normal functioning following reactivity of the
sympathetic nervous system) are thought to play a role in HR functioning. Thus,
increases in HR might reflect activation of the sympathetic nervous system, a decrease in
functioning of the parasympathetic nervous system, or both (Bernston, Cacioppo, &
Quigley, 1993; Taylor, 2006). Subsequently, a stronger increase in HR instead of SC
might reflect a greater role of the parasympathetic nervous system. Finally, measures of
SBP and DBP could provide information regarding reactivity during either contraction or
relaxation of the heart (Pole, 2007).
Baseline psychophysiological measurements have been frequently reported within
the PTSD literature. In a study of Vietnam veterans, baseline physiological
measurements were taken while they were sitting in a reclining position. Results
demonstrated that there were no significant differences between the PTSD group and the
control group with respect to heart rate (HR), systolic blood pressure (SBP), and diastolic
blood pressure (DBP; Orr, Meyerhoff, Edwards, & Pitman, 1998). In a meta-analysis
(Prins, Kaloupek, & Keane, 1995), five out of 13 studies focusing on PTSD samples were
found to demonstrate higher baseline HR values for the PTSD group than for control
groups. Only one study was found to demonstrate significant baseline differences in skin
conductance levels (SC); however, this study actually demonstrated that the PTSD group
had lower SC levels than the control group. Statistical analyses comparing these studies
demonstrated that those with shorter baseline levels (5 minutes) tended to demonstrate
more variability within and between groups. It was thought that this increase in
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autonomic arousal may be more due to the shorter duration of the baseline period than to
group differences (Prins et al., 1995). However, it should also be noted that many of
these studies did not report including an adaptation phase in addition to the baseline
phase. Conversely, another meta-analysis (Buckley & Kaloupek, 2001) reported that
PTSD groups did tend to show higher resting baseline HR and DBP than those without
PTSD. It is possible that baseline elevation of HR in PTSD could be mediated by
decreased parasympathetic activity instead of increased sympathetic activity (Pole, 2007).
Within the chronic pain literature, elevated baseline psychophysiological
measurements have not been demonstrated on a consistent basis in individuals with
chronic headaches, chronic back pain, and temporomandibular pain disorders (Flor &
Turk, 1989). In contrast, other researchers have found elevated levels. For example, one
study assessed baseline levels of HR and SC in 30 patients with fibromyalgia and 30
healthy control patients. Following a 30 minute adaptation phase, baseline
psychophysiological measures were collected for 4 minutes while participants were asked
to sit quietly and as still as possible with their eyes open. Results demonstrated that the
fibromyalgia group had significantly higher HR at baseline than the healthy controls. No
significant differences were demonstrated with respect to SCL at baseline (Thieme et al.,
2006). Similarly, results from another study indicated significantly higher resting
baseline levels of HR, SBP, and DBP in a 10 minute resting baseline period in the low
back pain group compared to individuals in the control group; however, this study did not
include an adaptation period prior to recording resting baseline measures (Burns, 2006).
Similar to findings with PTSD samples, baseline elevation of HR in chronic pain could
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also potentially be mediated by decreased parasympathetic activity instead of increased
sympathetic activity (Pole, 2007).
In summary, a generalized biological vulnerability is thought to be characterized
by a genetic tendency to be emotionally unstable in response to environmental changes
and stressors. This emotional instability may be caused by personality traits (i.e.,
nervousness, emotionality, neuroticism, negative affectivity) that lead individuals to be
more responsive to environmental stimuli (Barlow, 2002). Research within the PTSD
and chronic pain literature has supported the hypothesis that these personality traits are
associated with aspects of both PTSD (e.g., Davidson et al., 1985; Gershuny and Sher,
1998) and chronic pain (e.g., Davis et al., 2001; Geisser et al., 2003; Staud et al., 2003;
Zautra et al., 2005). Furthermore, baseline levels of physiological hyperarousal and
physiological reactivity to environmental stressors have been demonstrated within both of
these populations (e.g. Crofford et al., 1994; Desmeules et al., 2003; Orr et al., 1998;
Prins et al., 1995; Wingenfeld et al., 2008). Thus, the current literature supports aspects
of the generalized vulnerability hypothesis; however, limited research has assessed for
these factors within a comorbid PTSD and chronic pain population.
Generalized Psychological Vulnerability
A generalized psychological vulnerability refers to a general sense of
uncontrollability and perceived inability to cope with unpredictable negative life events.
In particular, individuals may perceive past attempts at coping with various situations as
signs of failure. Conversely, individuals without this vulnerability are thought to develop
an “illusion of control,” and they are more likely to attribute deficiencies to transient
external causes (Barlow, 2002). With respect to chronic pain, individuals with chronic
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pain may first view their pain as being uncontrollable and unpredictable. When the pain
condition is viewed as being uncontrollable and unpredictable, decreased feelings of selfefficacy and increased negative affect may develop (Otis et al., 2003). According to
Barlow (2002), the ability to produce anxiety symptomatology specific to an individual’s
disorder within laboratory settings is essential to measuring this change in coping
strategies and feelings of uncontrollability.
Attributional Style. Attempts to assess for the role of control in humans were
initiated by Rotter (1954). He hypothesized that an individual’s “locus of control” might
be rated along a continuum with internal causality on one end and external causality on
the other. Thus, psychometric measures were developed that assessed for “locus of
control” and “attributional style” (Barlow, 2002). Seligman (1975) hypothesized that
individuals develop a sense of uncontrollability with respect to the environment when
they experience numerous negative life events. Consequently, they develop a sense of
learned helplessness, and stop attempting to cope with environmental stimuli.
Furthermore, the relationship between negative events that individuals experience and the
development of learned helplessness is thought to be moderated by an individual’s
attributional style. In particular, the experience of negative life events is likely to lead to
the development of learned helplessness when individuals make internal, global, and
stable attributions regarding the negative life events that they experience (Abramson,
Seligman, & Teasdale, 1978). Helplessness was then thought to play a role in the
development of anxiety, although hopelessness was thought to play a larger role in the
development of depression (Abramson, Metalsky, & Alloy, 1989).
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Limited research has assessed for the role of learned helplessness in PTSD and
within the chronic pain literature. It is thought that similar types of events are
experienced that lead to the development of both learned helplessness and PTSD, and that
both conditions may be associated with similar behavioral and physiological symptoms
(Mineka & Zinbarg, 1996). Animal research has also suggested that similarities may
exist (e.g., sense of uncontrollability) in the development and perpetuation of learned
helplessness and PTSD (Maier, 2001). With respect to attribution styles within the PTSD
literature, helpless attributional styles have been associated with reports of abuse during
childhood and the onset of PTSD in adulthood (e.g., Casella & Motta, 1990; Gibb, 2002).
Many clinicians who have worked with individuals with PTSD have tended to notice that
PTSD is associated with personal feelings of helplessness in which individuals reportedly
feel that resolution of additional stressful events after their trauma is uncontrollable
(McKeever, McWhirter, & Huff, 2006). Similarly, regression analyses have
demonstrated that learned helplessness predicted PTSD symptom severity (McKeever,
McWhirter, & Huff, 2006). Only one study was found that assessed for the role of
attributional style within the chronic pain literature. This study compared attribution
styles within a depressed and chronic pain sample, a chronic pain sample that was not
depressed, and a control group. No differences were demonstrated between the groups
with regards to attribution styles (Ingram, Atkinson, Slater, Saccuzzo, & Garfin, 1990).
Coping Strategies. Within the PTSD literature, coping strategies have generally
been categorized as cognitive or behavioral (De Ridder, 1997; Holahan & Moos, 1987).
Cognitive coping strategies involve altering thoughts regarding an event to decrease
feelings of distress and to assign meaning to the event. Examples of cognitive coping
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strategies include cognitive restructuring, wishful thinking, self-blame, and self-criticism.
Conversely, behavioral coping strategies involve observable actions that an individual
engages in to help alleviate distress following a traumatic event (e.g., withdrawing from
others, seeking social support, and problem-avoidance; Waldrop & Resick, 2004).
Research has consistently demonstrated that avoidant coping strategies (e.g., diverting
attention) are associated with PTSD severity following the experience of a traumatic
event. In a study that assessed coping strategies in a sample of 74 rape victims and 48
physical assault victims, an increased tendency to express emotions, use cognitive
restructuring, and seek social support over a three month period of time was positively
correlated with diminished PTSD symptomatology. Conversely, increased levels of
wishful thinking and social withdrawal were associated with the perpetuation of PTSD
symptomatology. Self-criticism was found to be positively associated with PTSD
symptomatology at both one and three months following a traumatic event. Thus, some
coping strategies have been shown to change over time following a traumatic event (e.g.,
cognitive restructuring, seeking social support, social withdrawal), while others may
remain more stable (e.g., self-criticism; Gutner, Rizvi, Monson, & Resick, 2006).
Since the 1990s, a plethora of research has focused on coping styles in the chronic
pain literature (DeGood & Tait, 2001). Research has demonstrated that passive coping
styles are positively correlated with increased severity of pain, disability associated with
pain conditions, and psychological distress. Conversely, active coping strategies (i.e.,
seeking social support) have been found to be positively correlated with increased levels
of positive affect and higher levels of activity (Snow-Turek, Norris, & Tan, 1996; Zautra
et al., 1995). Longitudinal research has demonstrated a similar trend within a
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musculoskeletal pain population (DeGood & Tait, 2001; Potter & Jones, 1992). Coping
flexibility refers to the number of coping strategies that an individual utilizes on a regular
basis to cope with their pain (DeGood & Tait, 2001). In a chronic pain sample that was
seeking treatment for their pain; higher levels of coping flexibility were found to predict
greater self-perception of control regarding the pain condition, and potentially greater use
of effective coping strategies. However, coping flexibility did not predict ratings of pain
severity (Haythornthwaite, Menefee, Heinberg, & Clark, 1998). Research that has
focused on diverting attention away from the pain condition has been correlated with
positive adjustment to pain; however, this relationship has often been found to be
moderated by additional variables (e.g., pain intensity; Affleck, Urrows, Tennen, &
Higgins, 1992; DeGood & Tait, 2001). Conflicting results have been found regarding the
use of reinterpreting pain, coping self-statements, and ignoring pain (DeGood & Tait,
2001). Coping strategies such as praying or hoping have been found to be associated
with poor adjustment to pain. Subsequently, it has been hypothesized that this
relationship may exist since individuals tend to use these strategies when their pain levels
have worsened already (Boothby et al., 1999). Finally, research has also reported that
participants with increased symptoms of pain from fibromyalgia tended to experience
more difficulty in coping with chronic pain, and that increased levels of illness
uncertainty was associated with increased difficulty in coping with pain when
participants pain levels were exacerbated; however, a direct relationship between illness
uncertainty and coping with chronic pain was not demonstrated (Johnson, Zautra, &
Davis, 2006). In general, coping strategies have been found to play an important role in
the prediction and maintenance of pain.
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Specific Psychological Vulnerability
Specific psychological vulnerabilities refer to factors that lead an individual to
view a specific object or events as their primary focus of anxiety. In this sense,
individuals are learning what it is that might be threatening to them, and they are focusing
their anxious apprehension on stimuli that they view as being dangerous (Barlow, 2002).
This perception may occur when a true alarm becomes a learned alarm following the
experience of a traumatic event. Symptoms of numbing (i.e., avoidance of feelings) with
respect to general responsiveness may reflect avoidance of these learned alarms. Events
and the way in which an individual tends to respond to these events are viewed as being
unpredictable, which then may perpetuate the experience of anxious apprehension.
However, the development of PTSD is thought to be moderated by social support
networks and the ability to cope (Keane & Barlow, 2002).
Initial support for the role of learning mechanisms in the development of PTSD
began in the 1970s when researchers were treating rape victims and Vietnam veterans
(Resick & Calhoun, 2001). Originally, Mowrer’s (1947) two-factor theory was proposed
to account for the role of classical and operant conditioning in the development of PTSD
symptomatology following a traumatic event (e.g., Holmes & St. Lawrence, 1983).
Classical conditioning is thought to account for elevated levels of distress and fear that
are associated with a traumatic event, and operant conditioning was thought to account
for PTSD avoidance and long term maintenance of fear. In particular, traumatic
memories are thought to serve as the new conditioned stimuli, whereas fear and anxiety
serve as the conditioned emotional responses. Such cues are then avoided, which
provides negative reinforcement with the temporary decrease of fear and anxiety (Keane
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& Barlow, 2002). Although this model offers some compelling arguments, it is thought
that it may not be comprehensive enough to account for all PTSD symptomatology (e.g.,
recurrent memories, high rates of generalization; Foa, Steketee, & Rothbaum, 1989;
Resick & Calhoun, 2001).
Classical and operant conditioning accounts have also been proposed in the
chronic pain literature. Researchers have found that fear of pain and re-injury is
associated with avoidance of activities that may lead to additional pain; however, this
avoidance is associated with even greater physical deconditioning (i.e., deterioration of
physical functioning) and maintenance of pain (Asmundson, Norton, & Norton, 1999).
Given that anticipatory anxiety regarding potentially pain inducing activities may be
reduced through avoidance, such behaviors are then negatively reinforced via operant
conditioning with the reduction of anticipatory anxiety (McCracken, Zayfert & Gross,
1993). According to the triple vulnerability model, activities and sensations that are
associated with additional pain may serve as the learned alarms, and individuals may try
to avoid such activities as a result of their anxious apprehension.
Summary
In summary, research has provided preliminary support for Barlow’s (2002)
conception of a generalized biological and generalized psychological vulnerability within
PTSD and chronic pain populations. These vulnerabilities are thought to be the same for
both PTSD and chronic pain (Otis et al., 2003). With respect to a generalized biological
vulnerability, both groups have demonstrated baseline levels of hyperarousal, and blunted
cortisol responses following experimental stressors (e.g., Crofford et al., 1994; Olff et al.,
2006; Rasmusson & Friedman, 2002; Wingenfeld et al., 2008; Yehuda, 2003). Although
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preliminary research supports the role of a negative attributional style as a generalized
psychological vulnerability for PTSD (e.g., Cassella & Motta, 1990; McKeener et al.,
2006; Mineka & Zinbarg, 1996); limited research has been conducted with either
condition. Furthermore, the role of negative coping strategies in the maintenance of both
conditions individually has been frequently reported (e.g., Gutner et al., 2006; SnowTurek et al., 1996; Zautra et al., 1995). Finally, evidence of learned alarms has been
reported in a number of PTSD and chronic pain related studies (e.g., Asmundson et al.,
1999; Holmes & St. Lawrence, 1983; McCracken et al., 1993). However, limited
research on all aspects of the triple vulnerability model has been conducted on a
comorbid PTSD and chronic pain population.
Stress and Cortisol
Hypothalamic-Pituitary-Adrenal Axis (HPA axis)
As mentioned earlier, HPA axis functioning has received increased attention in
efforts to account for PTSD and chronic pain symptomatology development and
maintenance. In particular, human responses to stress can be largely accounted for by the
HPA axis (Tanriverdi et al., 2007). Prior to discussing the specific relationship of the
HPA axis to PTSD and chronic pain, a conceptual basis for how the HPA axis functions
and why it is activated in response to stress is presented.
Hypothalamus and Corticotropin-Releasing Hormone. At a general level, the
hypothalamus is part of the diencephalon, which is part of a larger structure of the brain
known as the forebrain. The size of the hypothalamus is fairly small compared to other
areas of the brain, but it contains a significant number of nuclei that play many critical
roles. In particular, the hypothalamus has been found to help regulate hunger, thirst,
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bodily regulation of temperature, behavior associated with reproductive functioning, and
the pituitary gland (Breedlove, Rosenzweig, & Watson, 2007). The hypothalamus
subsequently controls the pituitary gland by producing either releasing hormones that
activate the anterior pituitary or inhibiting hormones that limit activation of the anterior
pituitary. Through its control over the pituitary gland, the hypothalamus subsequently
functions as a connector between the nervous system and the endocrine system. The
main releasing hormone that the hypothalamus secretes in relation to the HPA axis is
corticotrophin-releasing hormone (CRH). CRH is a protein hormone that is released by
the hypothalamus via its neurosecretory cells to subsequently increase the amount of
cortisol that is secreted (Tortora & Grabowski, 2001).
Anterior Pituitary and Adrenocorticotropic Hormone. The anterior pituitary is
located in the front lobe within the pituitary gland, and it has been found to create and
release the majority of the hormones within our bodies (Breedlove et al., 2007). As
mentioned earlier, stimulation of the anterior pituitary is caused by releasing hormones
from the hypothalamus. The pituitary stalk is made up of many axons and blood vessels
that allow for the communication of hormones between the hypothalamus and anterior
pituitary. The anterior pituitary then secretes adrenocorticotropic hormones (ACTH), a
tropic hormone that helps to regulate other endocrine glands. Since ACTH is a protein
hormone, it tends to respond to stimulation very quickly, and it subsequently initiates
activation of the adrenal cortex (Breedlove et al., 2007).
Adrenal Glands and Glucocorticoids. Within the adrenal glands, the adrenal
cortex has been found to control the metabolism of carbohydrates, sodium, and bodily
reactions to inflammation. Conversely, the adrenal medulla is thought to regulate
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emotional arousal. Upon stimulation of the adrenal cortex, various steroid hormones are
released that are known as adrenocorticoids. Of the adrenocorticoids, glucocorticoids
have been found to directly affect the metabolism of carbohydrates and subsequently
increase levels of glucose within the body. Cortisol, in particular, is a glucocorticoid
hormone that is released in response to stress.
Since hormonal systems are able to both create and evaluate levels of hormones
within our bodies, the secretion of these hormones tends to be regulated depending on
what the body needs. Therefore, in negative feedback systems, the resulting release of
hormones returns to suppress the secretion of additional hormones of that type. Through
the process of negative feedback in the HPA axis, glucocorticoids return to the
hypothalamus to inhibit the production of releasing hormones and ACTH (Breedlove et
al., 2007). In addition, Dehydroepiandrosterone (DHEA) is also released by the adrenal
cortex during the experience of stressful situations as a result of changing ACTH levels.
DHEA helps to return the body’s cortisol levels back to their baseline state. Thus, the
production of DHEA may help to protect individuals with PTSD from developing even
more detrimental problems with their health (Charney, 2004).
Cortisol. Cortisol, in particular, is one of the most prevalent glucocorticoids, and
its production has been found to result in numerous changes within the body. In general,
it is known that the negative feedback of cortisol to the hypothalamus subsequently
inhibits activation of the HPA axis. Cortisol also activates various energy sources within
the body to initiate an automatic fight or flight response (Charney, 2004). This process
takes place through the breakdown of proteins, conversion of amino acids and lactic acid
to glucose, and through the breakdown of triglycerides (Tortora & Grabowski, 2001).
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This activation of energy sources eventually results in fatigue, wear and tear on bodily
muscles, and steroid diabetes (Breedlove et al., 2007). Secondly, processes associated
with inflammation and immune responses are inhibited (Charney, 2004). Not only does
cortisol inhibit the production of white blood cells, it also inhibits the repair of potential
wounds and diseases (Breedlove et al., 2007). Next, the inhibition of growth and
reproductive systems in response to cortisol may lead to bone degeneration, inability to
ovulate, and loss of sexual interest (Breedlove et al., 2007; Charney, 2004). Increased
cortisol may also lead to increased arousal, hypervigilance, focused attention, and
memory formation associated with emotions. Finally, regulation of the hippocampus,
amygdala, and prefrontal cortex are also altered (Charney, 2004; Gold, Drevets, &
Charney, 2002). Consistently high levels of cortisol may also lead to the development of
hypertension, osteoporosis, immunosuppression conditions, insulin resistance,
dyslipidemia (i.e., increased levels of plasma cortisol that can lead to atherosclerosis),
dyscoagulation (i.e., change in blood clotting), atherosclerosis, and cardiovascular disease
(Charney, 2004; Karlamangla, Singer, McEwen, Rowe, & Seeman).
Fight or Flight Response
Although the fight or flight response is not directly part of HPA axis activation, it
is worth mentioning as it is initiated in response to increased cortisol levels within this
process. The fight or flight response has been found to be associated with numerous
additional changes in body functioning including: 1) dilated pupils, 2) increased heart
rate, heart contractions, and blood pressure, 3) dilated airways, 4) constriction of blood
vessels that are connected to nonessential organs, 5) greater blood flow to organs
associated with exercise or fighting against dangerous stimuli, 6) glycogen and glucose
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are broken down by the liver, and triglycerides are broken down by adipose cells, 7)
glucose is released by the liver to increase glucose levels in blood vessels, and 8) all other
processes involved in nonessential tasks are inhibited (e.g., digestive secretions). Thus,
an extensive array of bodily changes occurs during the experience of stressful events
(Tortora & Grabowski, 2001).
HPA Axis and the Menstrual Cycle
With respect to women, conflicting results have been found when assessing for
cortisol levels across the menstrual cycle. Some researchers have found that there are no
differences in cortisol levels across the menstrual cycle, whereas other researchers have
found higher levels of cortisol during the luteal phase (i.e., the time period just before
menstruation begins; Kajantie & Phillips, 2006; Rasmusson & Friedman, 2002). To date,
no studies have found higher levels of cortisol during the follicular phase of the menstrual
cycle (i.e., the time period just after menstruation ends). In addition, higher levels of
cortisol have been associated with higher levels of estrogen (Lindholm & Schultz-Moller,
1973). Therefore, it may be possible that lower levels of cortisol during the follicular
phase of the menstrual cycle may serve as an additional risk factor for the development of
PTSD. Conversely, women who experience a traumatic event during the luteal phase of
their menstrual cycle may be more likely to develop depressive symptomatology
(Rasmusson & Friedman, 2002; Yehuda, 2003).
Only one study was found that assessed cortisol responsivity to stressful
laboratory tasks (e.g., the Trier Social Stress Task [TSST]) across phases of the menstrual
cycle. In an initial attempt to look at menstrual cycle phase influences, Kirschbaum and
colleagues (1999) examined cortisol reactivity to the TSST in men and women. Cortisol
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reactivity was compared in a sample of men (n = 20), women in the follicular phase of
the menstrual cycle (n = 19), women in the luteal phase of the menstrual cycle (n = 21),
and women who were taking oral contraceptives (n = 21). Results indicated that women
in the follicular phase of the menstrual cycle had similar salivary cortisol level increases
following the TSST as women taking oral contraceptives. Conversely, women in the
luteal phase of their menstrual cycle had similar cortisol levels to men. Both women in
the luteal phase of their menstrual cycle and men demonstrated greater cortisol reactivity
to the TSST than women in the follicular phase of their menstrual cycle and women
taking oral contraceptives. No significant salivary cortisol level differences were
demonstrated at baseline between any of the groups. Within the group as a whole,
cortisol levels peaked at 10 minutes following the TSST, and ACTH levels peaked 1
minute following the TSST (Kirschbaum et al., 1999). Thus, women in all phases of the
menstrual cycles may demonstrate similar baseline levels of cortisol; however, their
cortisol reactivity following the experience of stressful events may vary. Overall, all
groups demonstrated significant cortisol responsivity following the TSST; however,
women in the luteal phase of their menstrual cycle and men demonstrated larger cortisol
increases than women in their follicular phase and women taking oral contraceptives.
HPA Axis and Aging
Research assessing for aging effects on HPA axis functioning has also resulted in
conflicting outcomes. Although researchers in one study found that older participants
may demonstrate greater cortisol responsivity to stressful situations (Gotthardt et al.,
1995), other researchers have found no differences in older versus younger populations in
men or women (Kudielka, Schmidt-Reinwald, Hellhammer, & Kirschbaum, 1999, 2000).
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In an analysis that compiled data from five independent studies to investigate the role of
age and gender on HPA axis functioning and reactivity following the TSST, all age
groups (i.e., elderly, adults, young adults, and children) were found to have significant
and similar cortisol reactivity to the TSST. Furthermore, post-hoc analyses indicated that
there were no age effects in cortisol and ACTH reactivity across the different subgroups
of women. Only studies that assessed for cortisol responsivity of premenopausal women
in the luteal phase of their menstrual cycle were included to avoid confounding effects of
the menstrual cycle. Postmenopausal women were not included if they were receiving
hormone replacement therapy. Conversely, younger men were found to have greater
ACTH reactivity than older men (Kudielka, Buske-Kirschbaum, Hellhammer, &
Kirschbaum, 2004). Overall, age effects in cortisol and ACTH reactivity were not
demonstrated when women in the luteal phase of their menstrual cycle were compared to
postmenopausal women.
HPA Axis and PTSD
In general, lower levels of cortisol and increased negative feedback inhibition
have been associated with hypersensitization of the HPA-axis following the experience of
stressful events. Hypersecretion of corticotrophin-releasing factor (CRF) has also been
reported, as well as a reduction of the corticotrophin response to CRF (Kaufman et al.,
1997; Rasmusson & Friedman, 2002). One hypothesis is that individuals with PTSD
have greater numbers of lymphocyte glucocorticoid receptors (which are needed for
cortisol to create a strong effect), and that they have greater suppression to cortisol
following secretion of dexamethasone (Rasmusson & Friedman, 2002; Stein, Yehuda, &
Koverola, 1997; Yehuda et al., 1995). However, conflicting results have been found
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regarding the relationship of HPA axis dysregulation and PTSD, and some researchers
argue that individuals with PTSD do not have lower levels of cortisol (Rasmusson &
Friedman, 2002). In a meta-analysis that cumulated the results of 37 studies assessing for
basal cortisol levels among participants with PTSD, inconsistent results were
demonstrated with regards to differences in basal cortisol levels between participants
with PTSD and those in a control group; however, lower levels of basal cortisol tended to
be demonstrated among participants with PTSD that were female and/or those that had
experienced physical or sexual abuse, The inability to consistently obtain low cortisol
levels in PTSD tends to suggest that other factors may also play a role in the relationship
of HPA-axis regulation and PTSD (e.g., chronic pain).
Similarly, cortisol levels have been known to vary due to many factors which may
make the assessment of cortisol somewhat complicated. For example, individuals tend to
have higher cortisol levels in the morning and late in the evening (Crofford et al., 2004;
Kudielka et al., 2004). Levels of cortisol may also vary throughout the menstrual cycle,
or with daily stressors (Rasmusson & Friedman, 2002; Yehuda, 2003). In addition, much
of the research that has assessed the relationship between PTSD and HPA-axis
functioning has been limited in that researchers have tended to focus primarily on male
combat veterans (Rasmusson & Friedman, 2002). In a recent review article (Wong
&Yehuda, 2002), 20 studies were found that focused on male combat veterans, whereas
only 7 focused on other populations (4 of which focused on women specifically). More
recently, researchers have been starting to focus more on some of these less researched
populations.
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Conflicting results have been found with several studies assessing cortisol levels
after the experience of a traumatic event. Several studies have found that low levels of
cortisol following traumatic events were associated with the development of a PTSD
diagnosis within one month of the event (Delahanty, Raimonde, & Spoonster, 2000;
Yehuda, Shalev, & McFarlane, 1998). Types of traumatic events in these studies included
motor vehicle accidents, natural disasters, and a mining accident. However, one study
found that the predictive power of lower cortisol levels immediately following the
traumatic event was not predictive of a PTSD diagnosis at a one year follow-up
(Anisman, Griffiths, Matheson, Ravindran, & Merali, 2001). For individuals who were
recently raped, low cortisol levels following the most recent event were associated with
the experience of prior events that were similar in nature (Resnick, Yehuda, Pitman, &
Foy, 1995). Research has consistently demonstrated that prior experiences of traumatic
events are indicative of greater risk for the development of PTSD (e.g., Yehuda, 2003).
A recent study examined cortisol levels in individuals varying in traumatic event
history. In a study looking at PTSD and urinary cortisol levels (Young & Breslau, 2004),
292 participants were assigned to one of three groups: participants that were exposed to a
traumatic event, participants with a current diagnosis of PTSD, and a control group.
Participants completed a 32 hour sleep study, while urinary cortisol samples were taken
every 8 hours (at 8:00 a.m. and 8 p.m.). No main effects were found for the type of
trauma that individuals experienced and their levels of cortisol. Similarly, no significant
differences were found between individuals who experienced a traumatic event early in
their life (prior to the age of 16) versus traumatic events later in life. No group
differences were found with respect to urinary cortisol in the PTSD and control groups.
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However, women with comorbid PTSD and major depressive disorder (MDD) had higher
levels of urinary cortisol than controls and participants with either diagnosis alone. This
trend was not demonstrated in male participants (Young & Breslau, 2004).
Another recent study examined cortisol levels and severity of PTSD symptoms.
Olff and colleagues (2006) assessed cortisol, DHEA and DHEA sulfate (DHEA-S) levels
and severity of PTSD symptoms. Given that many studies have found conflicting results
regarding the effects of a comorbid diagnosis of depression, the researchers investigated
the potential moderating role of major depressive disorder (MDD). Participants consisted
of 39 civilian outpatients with PTSD and 44 healthy controls. Types of traumatic events
ranged from sexual abuse, vehicle accidents, to the death of loved ones. Hormone levels
were assessed between 8:00 a.m. to 10:00 a.m. via blood samples following an overnight
fast. Results indicated that lower cortisol levels were associated with greater severity of
PTSD symptomatology. The authors proposed that variability in the cortisol and PTSD
literature may be due to severity of PTSD symptoms. The researchers also hypothesized
that HPA dysregulation may be more problematic in individuals with more severe levels
of PTSD (Olff et al., 2006). Similar to the findings of other researchers (e.g., Oquendo et
al., 2003; Yehuda, Halligan, Golier, Grossman, & Bierer, 2004), the current results
demonstrated that there were no significant effects in cortisol levels resulting from
comorbid MDD (Olff et al., 2006). After accounting for demographic variables (e.g.,
age, sex), no significant difference was found between ratios of cortisol to DHEA within
the different groups. Limitations of the study included the small sample size used in this
study, use of blood sampling at only one time point, and levels of insomnia (Olff et al.,
2006).
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Previous research suggests that there may be a relationship between childhood
experiences of sexual abuse and greater body weight (e.g., Lemieuz & Coe, 1995). One
study assessed for the relationship between childhood experiences of sexual abuse,
obesity in adulthood, and cortisol levels. Participants consisted of 28 women that were
placed into three groups: women with PTSD diagnoses that experienced sexual abuse as a
child (n = 11), women who did not have PTSD but still experienced sexual abuse as a
child (n = 8), and women in the control group with no prior experiences of sexual abuse
(n = 9). All participants completed three questionnaires assessing for severity of PTSD
symptoms, general health, and premenstrual symptoms. Urinary samples were averaged
over a 24-hour time period, and all urine samples were collected during the premenstrual
phase of their menstrual cycle (i.e., luteal phase). For participants who were being treated
with psychotropic medication, no significant differences were found with respect to
cortisol levels. Results indicated that cortisol levels were not significantly associated
with weight levels. Cortisol levels were found to be higher in women with PTSD who
had experienced sexual abuse as a child than women with PTSD who had not
experienced childhood sexual abuse and women in the control group. Interestingly,
women in the PTSD group with childhood experiences of abuse tended to be more
overweight and reported higher levels of premenstrual symptoms (Lemieux & Coe,
1995). One significant limitation of this study was that urinary cortisol levels were
averaged over a 24 hour time period, when research has demonstrated that cortisol levels
vary throughout the day (e.g., Crofford et al., 2004). Overall, childhood experiences of
sexual abuse were found to be associated with higher levels of cortisol than other forms
of PTSD.
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HPA Axis Effects Resulting from Age of Trauma. Yehuda and colleagues
(2001) have examined cortisol levels in individuals whose parents were Holocaust
survivors. Participants were 20 adult males and 31 adult females who were children of
Holocaust survivors. Forty-one control participants were also included who were of the
same age range. Ten participants were taking psychotropic medications; however, these
effects were not included in the analyses as they were not shown to provide significant
effects in previous studies (Yehuda et al., 1995; Yehuda et al., 2000). Participants
provided urine samples for 24 hours, and they were instructed to obtain these samples on
a day in which they were not likely to be stressed out. Thus, many participants remained
at home for the day. Results indicated that participants who reported emotional abuse
had lower averages of cortisol levels for the 24 hour period than individuals who did not
report emotional abuse. Conversely, self-report of childhood sexual abuse was associated
with higher averages of urinary cortisol for the 24 hour period. Children of Holocaust
survivors tended to report higher levels of childhood trauma than other individuals in
their demographic group. Higher levels of abuse among Holocaust survivors tended to be
associated with parental diagnoses of PTSD (Yehuda et al., 2001). Results of the current
study may be partially limited since many of the participants tended to stay home for the
day while others did not. Such variations in schedule could potentially alter cortisol
outcomes.
Recent research has also assessed for effects of early adverse experiences and the
frequency of stressful events in adulthood (Heim et al., 2002). Researchers wanted to
discover if early life experiences of trauma were more predictive of alterations in HPAaxis regulation, or if experiences of stressful events in adulthood accounted for more of
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the variance. In this study, 49 females were divided into four groups: a control group
with no history of early life stress (n = 12), women without a current diagnosis of MDD
who were abused as children (n = 14), women with a current diagnosis of MDD who
were also abused as children (n = 13), and women with a current diagnosis of MDD who
were not abused as children (n = 10). None of the women reported the use of
psychotropic medications and medications that could alter their hormone levels.
Participants were admitted as inpatients, and were instructed to remain in bed until the
experiment began. Participants were then brought to the experimental area via a wheel
chair to avoid exercise while walking. All women participated in a stress condition that
consisted of a speech and math task. Blood samples were taken prior, during, and after
the stress task. When compared to the control group, all three patient groups reported
experiencing greater numbers of stressful events in the previous month. Results indicated
that a history of abuse during childhood predicted greater ACTH responsivity, even when
controlling for stressful events in adulthood. In addition, ACTH responsivity was
increased even more when the women experienced traumatic events in adulthood as well.
Thus, trauma during adulthood was found to play an additional role in regulating ACTH
responsiveness to a stressful event beyond that of just childhood experiences of abuse.
Depressive symptoms were found to be associated with the highest levels of ACTH
concentrations, which contrasted to the results within the PTSD group without depression
(Heim et al., 2002).
HPA Axis Regulation as a Potential Risk Factor. Although many studies have
assessed HPA dysregulation following traumatic events, one study attempted to assess
the role of low cortisol levels as both a risk factor and/or as a result of maladaptive
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responses to stress such as that seen in PTSD in an animal model (Cohen et al., 2006). In
this study, adult male Lewis, Fischer 344, and Sprague-Dawley rats were exposed to a
stressful event when they were placed on used cat litter for 10 minutes. These rats differ
in their sensitivity to stimuli. Control rats were exposed to unused cat litter for 10
minutes as well. Some of the rats were injected with corticosterone (a glucocorticoid in
rodents) prior to being placed in the cat litter. Responses to the cat litter were categorized
as “extreme behavioral responses” (EBR) and “minimal behavioral responses” (MBR).
Rats participated in an elevated plus maze, acoustic startle response task, and the Morris
water maze. Blood samples from all rats were collected during times when the rats were
experiencing low levels of stress. At baseline, the Lewis rats demonstrated greater
anxiety responses (i.e., less time spent in open areas) than the Fischer 344 and SpragueDawley rats, although their cortisol levels were not significantly different. Results
indicated that rats who demonstrated a blunted HPA response following the stressful task
were more likely to demonstrate EBRs than those with regular HPA functioning.
Similarly, the rats that were exposed to corticosterone prior to the stressful task were less
likely to demonstrate EBRs. Thus, administration of corticosterone to the Lewis rats
significantly decreased the amount of EBRs that they demonstrated. Overall, results
suggest that susceptibility to PTSD may be decreased by administrating cortisol prior to
the experience of a traumatic event by reducing the likelihood of blunted HPA responses
to such events (Cohen et al., 2006).
HPA Axis Functioning Following Treatment for PTSD. A recent study
investigated cortisol levels in individuals who were treated for PTSD. Participants (n =
21), with varying types of traumatic events (e.g., assault, work accident, loss of loved
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ones, car accident, etc.) were included (Olff, de Vries, Güzelcan, Assies, and Gersons,
2007). All participants met criteria for PTSD, and all participants began the study with
low baseline levels of cortisol. Participants received a Brief Eclectic Psychotherapy
treatment that contained both aspects of cognitive behavior therapy (e.g.,
psychoeducation, imaginal exposure, writing assignments, and cognitive restructuring)
and psychodynamic elements (e.g., “giving meaning” to events and a farewell ritual
toward the end of therapy). Without taking depressive symptomatology into account, no
changes in cortisol levels were found following treatment. When controlling for severity
of depressive symptoms, cortisol levels were found to increase in individuals who were
“successfully treated.” Cortisol levels decreased further in individuals who were not
successfully treated. Since participants with depression tended to have higher baseline
levels of cortisol, cortisol levels following the treatment were found to be associated with
these baseline levels of depression. Cortisol levels following treatment were also found
to be associated with progress that participants made with respect to depressive
symptoms.
Various limitations of the study should be taken into consideration when looking
at these results. Typically, aspects of cognitive behavior therapy and psychodynamic
treatment are not viewed as being compatible with each other. As such, the type of
treatment given to participants could potentially be a limitation of the study. Other
limitations include the small sample size, no control group for comparison, and cortisol
was only assessed between 8:00 a.m. and 10:00 a.m. Treatment results were also only
significant when various aspects of treatment for depressive symptoms were taken into
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account (Olff et al., 2007). Regardless of the limitations, this study represents a first
attempt examining the effects of psychotherapy on HPA dysregulation in PTSD.
HPA Axis and Chronic Pain
Research has consistently associated the increased experience of fibromyalgia
symptoms, among other forms of chronic pain, with physical and emotional stress (e.g.,
Clauw & Chrousos, 1997; Turk, Okifuji, Starz, & Sinclair, 1996; Van Houdenhove &
Egle, 2004). Subsequently, several researchers have hypothesized the importance of the
role of the HPA axis in chronic pain patients (e.g., Crofford et al., 2004; Okifuji & Turk,
2002); however, few studies have assessed this relationship in chronic musculoskeletal
pain samples. Furthermore, no research studies were found that assessed for the
relationship between the HPA axis and perceptions of pain.
In a recent study, researchers examined HPA axis functioning in a sample of
individuals with chronic pelvic pain and in a sample with fibromyalgia (Wingenfeld et
al., 2008). Salivary-free cortisol levels were assessed following the Trier Social Stress
Test and in response to pharmacological ACTH stimulation where ACTH was injected
into participants. Results indicated that participants with fibromyalgia had lower total
cortisol levels following the TSST and ACTH stimulation as compared to controls.
Conversely, no significant differences were found between the chronic pelvic pain and
control groups (Wingenfeld et al., 2008). Similar results were reported in another study
that assessed for HPA functioning in participants with fibromyalgia (n = 12) and a
control group (n = 12). Results indicated that the fibromyalgia sample had a lower
cortisol response to CRH physiological stimulation. These results provide support for the
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hypothesis that HPA functioning is disrupted in individuals with fibromyalgia (Crofford
et al., 1994).
The basal circadian rhythm of HPA axis functioning has also been found to be
disrupted within a fibromyalgia sample. ACTH levels were found to be lower across a
24-hour time period within the fibromyalgia group when compared to a control group,
and cortisol levels were found to be slightly higher within the fibromyalgia group.
However, these results were only approaching significance. No experimental stressor
was used within this study. These results suggest that fibromyalgia may be associated
with decreased resiliency of HPA axis functioning. Thus, it may be more difficult for
individuals with fibromyalgia to return to baseline ACTH and cortisol levels following
activation of the HPA axis (Crofford et al., 2004). Results from these studies suggest that
fibromyalgia may be associated with decreased activation and resiliency of HPA axis
functioning.
Summary
From a review of the current literature, it is clear that hypothalamic-pituitaryadrenal axis (HPA) functioning has implications in the experience of PTSD and chronic
musculoskeletal pain conditions. What seems less clear is the potential role of HPA axis
functioning in the development and maintenance of PTSD and chronic pain, or if
alterations in HPA axis functioning play a direct role in the experience of traumatic
events and the onset of both conditions. Preliminary results in the study by Cohen and
colleagues (2006) seem to suggest that cortisol levels prior to the experience of traumatic
experiences may be a risk factor in the development of PTSD. However, Cohen and
colleagues (2006) study was conducted with rats, and the generalizability of the study
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data to humans is unknown. Unfortunately, it would be extremely time consuming,
expensive, and difficult to obtain preventative data with humans because that would
require longitudinal research to obtain information both before and after the experience of
traumatic events and comorbid diagnoses. A variety of designs will be needed in future
research to help clarify the role of HPA axis functioning in both conditions. To date, no
research studies have been found that assessed for the role of the HPA axis functioning in
a sample of both PTSD and chronic musculoskeletal pain participants.
Overview and Statement of Purpose
Not only have high rates of PTSD and musculoskeletal pain been reported in the
literature (e.g., Davis et al., 2001; Geisser et al., 1996; Kessler et al., 1995; Wolfe et al.,
1995), but research has also indicated that high comorbidity rates exist between these two
conditions (e.g., Asmundson & Hadjistavropolous, 2006; Asmundson et al., 1998). Both
conditions occur more frequently within female populations (e.g., Kessler et al., 1995;
Khouzam et al, 2005; Wolfe et al., 1995). Comorbid PTSD and chronic pain are also
associated with increased perceptions of pain, affective distress, interference in daily
activities, and high rates of disability (Otis et al., 2003; Sherman et al., 2000). Thus,
comorbid conditions of PTSD and musculoskeletal pain have been associated with a large
cost to individuals and to society.
Currently, three models have been proposed to account for the high comorbidity
rates between PTSD and chronic pain (i.e., mutual maintenance model, shared
vulnerability model, and triple vulnerability model). Given that the triple vulnerability
model (Otis et al., 2003) accounts for biological, psychological, and social aspects of
PTSD and chronic pain, it is thought to hold the most promise as a comprehensive
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theoretical model. This model was derived from Barlow’s (2000, 2002) original triple
vulnerability model that was developed to account for anxiety symptomatology.
According to this model, individuals must have a generalized biological vulnerability
(e.g., inherited personality traits that lead individuals to react to environmental stressors
in a defensive manner), a generalized psychological vulnerability (e.g., sense of
uncontrollability and perceived inability to cope), and a specific psychological
vulnerability (e.g., development of learned alarms) before PTSD and chronic pain can
develop (Barlow, 2000; Barlow, 2002; Keane & Barlow, 2002; Otis et al., 2003). A
learned alarm may elicit both symptoms of chronic pain and PTSD (Otis et al., 2006), and
the two diagnoses may work together to maintain or even worsen symptoms of both
conditions (Otis et al., 2003).
Human stress responses can be greatly accounted for by the role of the HPA axis
(Tanriverdi et al., 2007). Subsequently, the HPA axis has gained increasing attention in
accounting for PTSD and musculoskeletal pain symptomatology. Although some
research has provided conflicting results, previous research assessing HPA axis
functioning in PTSD and musculoskeletal pain populations have generally demonstrated
that both conditions tend to be associated with a blunted cortisol response when
compared to control groups (e.g., Crofford et al., 1994; Olff et al., 2006; Rasmusson &
Friedman, 2002; Wingenfeld et al., 2008; Yehuda, 2003). Thus, assessing for cortisol
and psychological reactivity following a stress induction task (i.e., TSST) within PTSD
and chronic pain samples may provide beneficial information regarding the generalized
biological and psychological vulnerabilities proposed within the triple vulnerability
model.
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The purpose of the current study was to test aspects of the triple vulnerability
model (Barlow, 2000; Barlow, 2002; Otis et al., 2003) in PTSD and chronic
musculoskeletal pain populations. Since limited research has tested aspects of this model
with a comorbid PTSD and chronic pain population, subsequent study results can
contribute to a greater understanding of the relationship between these two diagnoses.
These results may have important implications for future research and treatment of both
diagnoses.
In the current study, aspects of the triple vulnerability model were examined
within the following groups of women: women who have PTSD without chronic pain (n
= 11), women who have musculoskeletal pain without PTSD (n = 10), women with both
PTSD and musculoskeletal pain (n = 10), and women without PTSD and chronic pain (n
= 15). Cortisol reactivity and anxious mood were assessed before and after the Trier
Social Stress Task (TSST). Participants also completed questionnaires to assess for other
potential indicators of the triple vulnerability model.
Hypotheses: Experimental Stressor
1.

A general biological vulnerability was predicted to be evident in all three clinical
groups (i.e., PTSD and pain group, PTSD group, pain group), although this was
not predicted to be demonstrated in the control group. This would be
demonstrated by: a) lower baseline cortisol levels prior to the experimental
stressor, and b) blunted salivary cortisol levels following the experimental
stressor.

2.

Anxious mood was hypothesized to exist on a continuum across the measurement
occasions of the experimental stressor. Participants in the PTSD and pain group
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were anticipated to report the highest levels of anxious mood (both at baseline and
in response to the experimental stressor), followed by the PTSD and the pain only
groups. Participants in the control group were anticipated to report the lowest
levels of anxious mood.
3.

Participants in the three clinical groups were predicted to report greater use of
negative coping strategies (i.e., denial, behavioral disengagement, self-blame) in
response to the experimental stressor, while participants in the control group were
predicted to report greater use of positive coping strategies (i.e., active coping,
positive reframing, acceptance).
Hypotheses: Questionnaire Data

4.

It was hypothesized that depression levels would exist on a continuum. Women
in the PTSD and pain group were anticipated to report the highest levels of
depression symptoms, followed by women in the PTSD only and the pain only
groups. Women in the control group were anticipated to report the lowest level of
depression symptoms.

5.

A general psychological vulnerability will be evident in all three clinical groups,
although this is not hypothesized to be demonstrated in the control group. This
will be evident by higher levels of learned helplessness (e.g., greater levels of
internal, stable, and global attributions).

6.

Support for a general psychological vulnerability will also be evident in all three
clinical groups by increased mean impact ratings of negative life events and
general levels of self-perceived stress. Subsequently, these participants will also
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be more likely to view ambiguous situations as more threatening than participants
in the control group.
7.

Participants in the three clinical groups were predicted to report greater use of
negative coping strategies (i.e., denial, behavioral disengagement, self-blame) in
general, while participants in the control group were predicted to report greater
use of positive coping strategies (i.e., active coping, positive reframing,
acceptance) in general.

8.

Differential learned alarms will be evident for the three clinical groups. Due to
the nature of PTSD, it is expected that both the PTSD group and the PTSD and
pain group will demonstrate a learned alarm with respect to PTSD (self-report). It
is hypothesized that participants in the pain only group and PTSD and pain group
will report greater anxiety associated with pain than participants in the PTSD only
group or control group. All three clinical groups are hypothesized to report
greater levels of anxiety sensitivity than the control group.
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Chapter 2
METHOD
Participants
Participants were 46 females who were 18 years of age or older. All participants
were recruited from the local community and undergraduate psychology courses at the
University of Maine. Based on initial screening criteria (see below), participants were
categorized into the following four groups: (1) women who have PTSD without chronic
pain (hereafter referred to as the PTSD group; n = 11), (2) women who have
musculoskeletal pain without PTSD (hereafter referred to as the pain group; n = 10), (3)
women with both PTSD and musculoskeletal pain (hereafter referred to as the PTSD and
pain group; n = 10), and (4) women without PTSD and chronic pain (hereafter referred to
as the control group; n = 15). Power analyses were conducted using the GPower 3.0
program (Faul, Erdfelder, Lang, & Buchner, 2007). With an alpha level of .05, power
analyses revealed that a sample size of 48 would result in a power of .97 for cortisol
analyses. This calculation was based on a 4 (Group: PTSD, pain, PTSD and pain,
control) X 5 (Measurement collection point: baseline, 10 minute post-stress induction, 20
minute post-stress induction, 40 minute post-stress induction, and 60 minute post-stress
induction) mixed between-within-subjects ANOVA. Previous research has indicated that
there is a correlation of .76 between cortisol samples that are taken by the same
individual within 20 minutes of each other, with variance of .042 and an effect size of .20
(Hruschka, Kohrt, & Worthman, 2005).
Participants from the local community received $20 for participation in the study,
and participants from undergraduate psychology courses at the University of Maine
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received 4 research credits. Participants were also offered enrollment in a free treatment
study. All participants read and signed an informed consent form (Appendix A) prior to
their participation in the study. Individuals were notified that they could discontinue their
participation in the study at any time, and that they could choose to not answer any
questions that they did not feel comfortable answering. Once participation was
completed, all participants were debriefed regarding the study protocol.
Study Criteria
Participants were enrolled in the PTSD group if they: 1) met DSM-IV-TR
research criteria for PTSD, and 2) did not report experiencing chronic pain. Participants
in the PTSD and Pain group: 1) met diagnostic criteria for PTSD, and 2) had self-reported
symptoms of chronic musculoskeletal pain. The Pain group had: 1) self-reported
symptoms of chronic musculoskeletal pain, and 2) they did not meet criteria for PTSD.
In order for the musculoskeletal pain to be defined as chronic pain, it must have lasted for
at least the last three months (International Association for the Study of Pain, 1986). For
the purposes of this study, self-report of chronic pain symptoms was utilized to categorize
participants. To qualify for the control group: 1) participants did not meet criteria for
PTSD, and 2) they did not report experiencing any chronic pain conditions. Participants
in all groups were excluded if they reported having: 1) cardiovascular disorder, 2) current
alcohol or substance abuse disorders, 3) a history of psychotic disorder, 4) a history of
bipolar disorder, 5) daily use of opioid medications, or 6) were receiving hormone
replacement therapy.
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Recruitment
Participants were recruited from the local community, websites, and
undergraduate psychology courses at the University of Maine. Flyers were hung up
within approving local establishments and doctors’ offices. All potential participants
who contacted the principal investigator were given a brief description of the study and
completed a phone screening (Appendix B). All participants who met the initial
screening criteria were invited to participate in the study.
Experimenters
A fifth-year graduate student was the principal investigator and oversaw all
aspects of the study. Other graduate students in clinical psychology who were trained to
administer diagnostic interviews helped to interview participants. A graduate student
who was blind to the participants’ group status also reviewed each audiotape recording of
the SCID-I interview to establish interrater reliability for diagnostic status.
Undergraduate research assistants were trained on study procedures to assist in the
experimental task and with data entry. All personnel read the American Psychological
Association ethics code regarding research, were familiar with IRB procedures, and
completed the University of Maine IRB website training for human subjects.
Measures
Structured Clinical Interview for DSM-IV-TR Axis I Disorders, Research
Version, Patient Edition (SCID- I/P). The SCID-I/P was used to establish PTSD
diagnoses, establish comorbid diagnoses, and to rule out the existence of exclusionary
diagnoses. The SCID-I/P is a semi-structured interview designed to assess for both
current and lifetime Axis I diagnoses (First, Spitzer, Gibbon, & Williams, 2002). During
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the interview, individuals are asked questions regarding potential symptoms that they
may experience with regard to Axis I diagnoses such as depression (e.g., In the past
month, has there been a period of time when you were feeling depressed or down most of
the day nearly every day?), and anxiety (e.g., In the past six months, have you felt
particularly nervous or anxious?).
The SCID has been used extensively in studies to establish anxiety disorder
diagnoses, and to rule out the presence of other psychiatric disorders (e.g., Horsch,
McManus, Kennedy, & Edge, 2007; Mehner & Koch, 2007; Orr et al., 1998). Studies
that have assessed for the reliability of the SCID-I have demonstrated good interrater
reliability with kappa values of .57-1.00, and test-retest reliability with kappa values of
.35 -.78 (Zanarini & Frankenburg, 2001; Zanarini et al., 2000). The SCID-I has also
demonstrated superior validity when compared to routine clinical interviews (Basco et
al., 2000; Shear et al., 2000).
Short Screening Scale for PTSD. The Short Screening Scale for PTSD is a brief
clinician-administered interview to assess for a PTSD diagnosis (Appendix B; Breslau,
Peterson, Kessler, & Schultz, 1999). The Short Screening Scale for PTSD was used as a
prescreening measure to be administered over the phone since it can be administered in 3
minutes (Orsillo, Batten, & Hammond, 2001). The measure consists of 7 yes/no
questions to assess for various aspects of a DSM-IV diagnosis of PTSD (e.g. Did you
avoid being reminded of this experience by staying away from certain places, people, or
activities?). A score of 4 or higher has been shown to have the greatest sensitivity (.80 .85), specificity (.84 - .97), and predictive value (.71 positive predictive value, and .98
negative predictive value) when considering a DSM-IV diagnosis for PTSD (Breslau et
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al., 1999; Kimerling et al., 2006). Furthermore, the measure has good test-retest
reliability with a Spearman’s rank correlation of .84 (Kimerling et al., 2006).
McGill Pain Questionnaire (MPQ). The MPQ is a self-report questionnaire,
designed to assess for pain descriptors, the spatial distribution of pain, temporal
properties of pain, and an overall pain intensity rating (Melzack, 1975; Appendix C).
Pain descriptor words are grouped into four major subgroups: Sensory (e.g., pulsing,
pricking, pinching), Affective (e.g., tiring, sickening, blinding), Evaluative (e.g.,
annoying, troublesome), and Miscellaneous (e.g., tight, cold, nagging). Drawings of the
human body are provided to mark the location of both internal and external pain. Finally,
pain intensity levels are rated on a 6 point Likert scale (0 = “No Pain” to 5 =
“Excruciating”). The MPQ is a widely used questionnaire, and has been administered in
over 350 studies assessing various pain populations. For the purposes of this study, the
MPQ was used to confirm symptoms of musculoskeletal pain (i.e., location of pain), and
to determine the number of tender points reported by participants (Melzack & Katz,
2001).
The MPQ has demonstrated good test-retest reliability within a chronic low back
pain sample (Love, Leboeuf, & Crisp, 1989). Factor analyses have remained
inconsistent, with the factor loadings possibly being dependent of the type of pain that is
being assessed. The measure has been shown to be sensitive to treatment effects in
reducing pain levels, and has demonstrated discriminative ability between various forms
of chronic pain (Melzack & Katz, 2001).
Expanded Attributional Style Questionnaire (Expanded ASQ). The Expanded
ASQ is a 24-item self-report scale, designed to assess for attributional styles associated
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with the learned helplessness model of depression. In particular, the measure assesses for
three subscales: Internality, Stability, and Globality (Appendix D; Peterson & Villanova,
1988). Each of the 24 items involves reactions to a range of hypothetical negative events.
Individuals were asked to imagine themselves in each situation, and then to rate three 7point Likert scales with regards to internality (1 = “totally due to others,” and 7 = “totally
due to me”), stability (1 = the cause of the situation will be “never present” in the future,
and 7 = the cause of the situation will be “always present” in the future), and globality (1
= the cause is associated with “just this situation,” and 7 = the cause is associated with
“all situations”).
The Expanded ASQ was derived from the original Attributional Style
Questionnaire (ASQ; Peterson et al., 1982) to improve upon the measure’s reliability
(Peterson & Villanova, 1988). The Expanded ASQ demonstrated good reliability with
Cronbach’s coefficient alpha scores of .66 for the Internality subscale, .85 for the
Stability subscale, and .88 for the Globality subscale. The expanded version also
demonstrated good predictive validity, and greater internal consistency than the original
ASQ (Peterson & Villanova, 1988).
Life Experiences Survey (LES). The LES is a 57-item self-report measure
designed to assess individuals’ experiences with a wide range of situations in the past 6
and 12 months (Appendix E; Sarason, Johnson, & Siegel, 1978). Three additional blank
spaces were also included in the LES in the event that an individual experienced a
situation that was not listed in the questionnaire. Items were chosen to represent a wide
range of situations that are frequently experienced by the general population (e.g.,
marriage, new job, death of a close family member, serious illness or injury). Each item
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that an individual has experienced within the past year is rated on a 7-point Likert scale
from -3 (“extremely negative”) to +3 (“extremely positive”). The LES yields a positive
change score (sum of the positive impact ratings), a negative change score (sum of the
negative impact ratings), and a total change score (sum of all impact ratings). Research
indicates that the negative change scores have demonstrated the greatest test-retest
reliability across a 5-6 week time period (.56 - .88, p < .001), followed by the total
change scores (.63 - .64, p < .001) and positive change scores (.19 - .53, p < .001). When
compared to the other change scores, the negative change score was found to be most
predictive of health status. In addition, negative change scores demonstrated a positive
correlation with state (.29, p < .01) and trait (.46, p <.01) anxiety (Sarason et al., 1978).
Since the negative change score has demonstrated the greatest test-retest reliability, is
most predictive of health, and is positively correlated with trait anxiety symptomatology,
only the negative change score will be used for the purposes of this study. The LES was
also slightly modified to assess for experiences that each individual has experienced
within the past 12 months, and within their lifetime.
Brief Cope. The Brief Cope is a 28-item self-report scale, designed to assess for
the use of a variety of coping strategies. Fourteen subscale scores are obtained for
individual coping strategies including: Active Coping, Planning, Positive Reframing,
Acceptance, Humor, Religion, Using Emotional Support, Using Instrumental Support,
Self-Distraction, Denial, Venting, Substance Use, Behavioral Disengagement, and SelfBlame (Appendix F; Carver, 1997). The Brief Cope was derived from the longer original
version of the COPE, which consisted of 60-items (Carver, Scheier, & Weintraub, 1989).
The Brief Cope was designed to obtain similar reliability and validity ratings in a shorter
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amount of time (Carver, 1997). Each individual item ranges from 1 (“I haven’t been
doing this at all”) to 4 (“I’ve been doing this a lot”). Reliability analyses have yielded
acceptable coefficient alpha scores for the individual subscales, ranging from .50 to .90
(with most exceeding .60; Carver, 1997). For the purposes of this study, participants
completed the Brief Cope with regards to how they cope in general and in response to the
experimental stress task.
Impact of Event Scale – Revised (IES – Revised). The IES – Revised is a selfreport measure to assess PTSD symptomatology based upon DSM-IV diagnostic criteria
(Appendix G; Weiss & Marmar, 1997). The IES – Revised consists of 22 items, with
each item ranging from 0 (“Not at all”) to 4 (“Extremely”). The measure is broken down
into three subscales: Intrusion, Avoidance, and Hyperarousal (Weiss & Marmar, 1997).
The measure was derived from the original Impact of Event Scale (IES; Horowitz,
Wilner, & Alvarez, 1979), with some changes to add the Hyperarousal subscale and
update the diagnostic criteria from DSM-III criteria to DSM-IV criteria (Weiss &
Marmar, 1997). The IES – Revised has demonstrated high internal consistency within
various studies for the Intrusion subscale (coefficient alpha scores ranging from .87 .92), Avoidance subscale (alpha scores ranging from .84 - .84), and the Hyperarousal
subscale (alpha scores ranging from .79 - .90). Test-retest reliability was also assessed in
two samples, demonstrating acceptable reliability for all of the subscales (Weiss &
Marmar, 1997).
Pain Anxiety Symptom Scale-20 (PASS-20). The PASS-20 is a self-report
measure designed to assess anxiety and fear that is associated with pain conditions
(Appendix H; McCracken & Dhingra, 2002). The PASS-20 was derived from the
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original PASS (McCracken, et al., 1993) to decrease the amount of time and effort
needed to administer the questionnaire within clinical and research populations
(McCracken & Dhingra, 2002). The PASS-20 consists of 20 items that are rated on a 6point Likert scale, ranging from 0 (“Never”) to 5 (“Always”). Responses on the PASS20 are used to compute 4 subscales: Cognitive, Escape/Avoidance, Fear, and
Physiological Anxiety. A total score may also be computed by adding all items of the
questionnaire (McCracken & Dhingra, 2002).
The PASS-20 has demonstrated good reliability and validity within a chronic pain
sample. Subscale scores on the PASS-20 are highly correlated with the original subscale
scores of the PASS with 40 items (ranging from r = 0.93 to r = 0.97). The PASS-20
demonstrated good internal consistency (ranging from α = 0.75 to α = 0.91). Results also
supported the predictive and construct validity of the PASS-20 (McCracken & Dhingra,
2002). Research with fibromyalgia and chronic low back pain samples also supported the
one and four-factor structures of the PASS-20 (Roelofs et al., 2004).
Anxiety Sensitivity Index (ASI). The ASI (Reiss, Peterson, Gursky, & McNally
(1986); Appendix I) is a 16 item self-report questionnaire designed to measure fear of
symptoms related to anxiety. In particular, anxiety sensitivity is a functional diagnostic
dimension in which high levels may serve as a risk factor for anxiety disorders (Reiss,
1991). High levels of anxiety sensitivity are associated with catastrophic views regarding
consequences of anxiety related symptoms (Peterson & Reiss, 1992). Each item in the
ASI is rated using a 5-point Likert scale ranging from 0 (“very little”) to 4 (“very much”).
The total score is determined by adding up the scores for all 16 items.
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Numerous studies have been conducted looking at internal reliability scores
within the ASI, with Cronbach’s alpha coefficient scores ranging from .82 to .91
(Peterson & Heilbronner, 1987; Taylor et al., 1991; Taylor, Koch, McNally, & Crocket,
1992; Telch et al., 1989). The two-week test-retest reliability of the ASI, as computed by
Pearson product-moment correlations, was 0.74 for the women (Reiss et al., 1986).
Similarly, the ASI was found to have a three year test-retest reliability of .71 (Maller &
Reiss, 1992). There is also strong evidence supporting the construct validity of the ASI
(Peterson & Reiss, 1992).
Intolerance of Uncertainty Scale – Short Version (IUS-12). The IUS-12 is a
self-report measure designed to assess individual reactions to uncertainty, ambiguous
situations, and to the future (Appendix J; Carleton, Norton, & Asmundson, 2007). In
particular, intolerance to uncertainty may mean that an individual views that there is no
way to predict negative events, to the point that all ambiguous information is viewed as
being threatening (Heydayati, Dugas, Buhr, & Francis, 2003). The IUS-12 was derived
from the original IUS to decrease the number of questions and boost the measure’s factor
structure (Carleton et al., 2007). The IUS-12 consists of 12 items that are rated on a 5point Likert scale ranging from 1 (“not at all characteristic of me”) to 5 (“entirely
characteristic of me”). The sum of all items creates a total score for a general intolerance
of uncertainty. The IUS-12 has demonstrated very good internal consistency (α = .91),
and is highly correlated with the original 27-item IUS (r = .96). The IUS-12 also
demonstrated convergent validity with the Generalized Anxiety Disorder QuestionnaireIV (GADQ; r = .61), the Penn State Worry Questionnaire (PSWQ; r = .54), and the Beck
Anxiety Inventory (BAI; r = .57; Carleton et al., 2007).
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Profile of Mood States (POMS). The POMS is a self-report measure of transitory
mood states (e.g., nervous, irritated, bored, etc.; McNaire, Lorr, & Droppleman, 1971;
Appendix K). The POMS consists of six subscales that may be used individually or in
combination with each other as one measure. Items are rated on a 5-point Likert scale,
ranging from 0 (“not al all”) to 4 (“extremely”). For the purposes of this study, the
anxiety (POMS-A) subscale was administered prior to and following the experimental
task. This assisted in measuring participants’ anxiety levels before and after the stress
task. Research has demonstrated that the POMS has good reliability and validity, with
coefficient alpha levels ranging from .90 or greater (McNair et al., 1971).
Visual Analog Stress Scale (VASS). A 7-point Likert scale (Appendix L) was
constructed to assess for the level of stress that participants experienced during the
experimental task. Items on the scale range from 0 (“Not at all stressful”) to 7
(“Extremely stressful”). Since the Trier Social Stress Task is expected to induce
moderate levels of psychological and physiological stress (Kirschbaum, Pirke, &
Hellhammer, 1993), it is important to measure self perceptions of stress as a manipulation
check.
Perceived Stress Scale (PSS). The PSS is a 14-item self-report measure designed
to assess general self-perceptions of stress over the previous month (Cohen, Kamarck, &
Mermelstein, 1983; Appendix M). This is a measure of stress in general, and not a
measure of cumulative stressful events. Items are rated on a 5-point Likert scale ranging
from 0 (“never”) to 4 (“very often”). Research indicates that the PSS has good internal
consistency (r = 0.84 - 0.86) and test-retest reliability (r = 0.85; Cohen et al., 1983). In
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addition, scores on the PSS have been found to be positively correlated with negative
health outcomes (e.g., Cohen, Tyrell, & Smith, 1993).
Beck Depression Inventory-II (BDI-II). The BDI-II (Beck, Steer, & Brown,
1996; Appendix N) is a 21-item self-report measure used to assess the severity of
depressive symptomatology. Each item response ranges from 0 to 3 possible points (with
0 representing that the participant does not experience the individual symptom and 3
representing the most severe degree that the symptoms may be experienced). Total
scores may range from 0 to 63 points. For the purposes of this study, the BDI was used
to assess for comorbid depressive symptoms.
In a meta-analysis of studies that assessed for the psychometric properties of the
initial BDI (Beck, Steer, & Carbin, 1988), the average internal consistency found for the
measure demonstrated a Cronbach’s alpha coefficient of .86 for clinical samples and .81
for nonclinical samples. The BDI-II has demonstrated high levels of internal consistency
within a sample of clinical outpatients (α = 0.92; Beck et al., 1996). Statistical analyses
have demonstrated that the BDI-II has stronger factorial validity than the initial version
of the BDI (Dozois, Dobson, & Ahnberg, 1998). In a study that assessed psychometric
properties of the BDI-II within an older adult population, results supported the internal
reliability of the measure (α = .86). The convergent and discriminant validity of the BDIII was also supported within this population (Segal, Coolidge, Cahill, & O’Riley, 2008).
Experimental Task
Trier Social Stress Test (TSST). The TSST (Kirschbaum et al., 1993) has been
used within both the PTSD and chronic pain literature to induce moderate physiological
and psychological stress (e.g., Dorn et al., 2003; Jones, Rollman, & Brooke, 1997;
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McRae et al., 2006; Simeon et al., 2007; Wingenfeld et al., 2008). The TSST was
established to elicit HPA axis activation in a large proportion of participants, and has
been found to double or even quadruple salivary cortisol levels within numerous samples.
Within the TSST, participants are first given a ten minute anticipation time period, during
which they are instructed to prepare a five minute speech regarding why they are the
perfect applicant for a particular job. Participants are told that they will be giving the
speech in front of two “managers” that are trained to monitor nonverbal behavior (these
individuals are really research assistants trained in study protocol). Following the ten
minute anticipation period, participants are told that their speech is also being videotaped
(which is not true). Participants then begin their 5 minute speech. If their speech does
not last for the full five minute period, they are prompted to continue with a series of
previously prepared questions. Following the five minute speech, the participant is
instructed to serially subtract 13 from 1,022 as quickly and accurately as possible for a
five minute period. If a mathematical error is made during this time period, then they are
asked to start over from the beginning (Kirschbaum et al., 1993).
Psychophysiological Recording. Salivary cortisol samples were collected using a
Salimetrics drool tube. Participants were instructed to drool a small amount of saliva into
a plastic tube and then replace the lid on the tube. This method of collecting salivary
cortisol levels has been found to have better volume recovery of saliva than the
Salivette® (Jennifer Jewell, personal communication, November, 2008). Research has
demonstrated high correlations between salivary cortisol levels and blood-based samples
of cortisol (r > 0.90 in most reports; e.g., Kirschbaum & Hellhammer, 1989). Salivary
cortisol samples were utilized for this study because they are less invasive and could be
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sent for analysis through the mail. In an attempt to increase reliability and validity of
cortisol samples, participants were instructed to not eat anything, drink anything (other
than water), not exercise, or smoke cigarettes for up to 1.5 hours before coming in for
their research visit. Menstrual cycle phase was also controlled. All of these variables
have been found to alter salivary cortisol levels (Kirschbaum & Hellhammer, 1989).
Procedure
Participants who met screening criteria (see above) were invited to participate in
the study. Participants who expressed an interest in participating were scheduled to come
in to the laboratory in the Psychology Department for their research visit. Premenopausal
women were scheduled during the luteal phase of their menstrual cycle (1 to 7 days
before menstruation begins). All participants were scheduled between 2:00 to 6:00 p.m.
Previous research has demonstrated that there are diurnal rhythms to cortisol levels,
subsequently, similar time restrictions have been used in previous research that assessed
cortisol levels (e.g., Kirschbaum, Klauer, Filipp, & Hellhammer, 1995; Kirschbaum et al.,
1999; Rohleder, Wolf, Piel, & Kirschbaum, 2003).
Upon arriving for their scheduled appointment, participants were asked to read
and sign an informed consent form (Appendix A) before participating in the study. The
experimenter also reviewed the content of the consent form with each participant, and
answered any questions that participants had. Each participant completed the MPQ to
confirm self-report of chronic musculoskeletal pain. Participants were then interviewed
using the SCID-I/P to confirm diagnoses or rule out the specified exclusionary diagnoses.
Participants who met exclusionary criteria following administration of the MPQ and
SCID-I/P were debriefed regarding the study and received $5 for their participation.
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Participants who met criteria for any of the experimental groups (PTSD group,
pain group, or PTSD and pain group) or the control group were placed in a soundattenuated room to help minimize the effects of external stimuli during the study
protocol. Prior to receiving experimental instructions for the TSST, participants were
asked to sit quietly for a 10-minute baseline period while they adjusted to the laboratory
setting. Following the adaptation period, participants were asked to complete the POMS,
and a baseline salivary cortisol sample was collected. After baseline assessments,
participants began the experimental task using the TSST study protocol described above.
Following the completion of the TSST, participants were asked to remain in their chair
and rest quietly for 60 minutes. Ten minutes after the completion of the TSST,
participants completed measures assessing changes in their mood state (POMS) following
the experimental task. Participants also completed a Brief Cope as a measure of coping
strategies utilized during the experimental task, and the VASS as a measure of selfperceived stress during the TSST. A second salivary cortisol sample was collected at this
time, and at 20 minutes following the TSST, to assess for peak salivary cortisol levels.
Research has demonstrated that cortisol levels are at their highest during these time
points (e.g., Kirschbaum et al., 1993). The POMS was completed with each saliva
sample to measure changes in mood following the experimental task. A fourth cortisol
sample and POMS was collected at 40 minutes after the completion of the TSST to
measure changes in cortisol as the participant begins to relax again. To ensure that stress
levels have been lowered before leaving the lab, participants then listened to a 20 minute
relaxation exercise before leaving the lab. Following the relaxation exercise, participants
completed their fifth salivary cortisol sample and POMS.
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Participants were then debriefed regarding study procedures (Appendix P), and
were given instructions for completion of their counterbalanced packet of questionnaires
including: Expanded ASQ, LES, Brief Cope, IES-Revised, PASS-20, ASI, IUS-12, PSS,
BDI-II, and the POMS. Included in this packet of questionnaires was a demographics
information form (Appendix O) which included the date, age, race, education (in years),
current household income, current medications, weight, height, and menstrual cycle
status. Finally, participants were compensated for their participation.
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Chapter 3
RESULTS
The current study represents a quasi-experimental, four groups (PTSD, pain,
PTSD and pain, control), design. Data analyses were completed using PASW version
18.0 software for Windows. Participant characteristics and results for each hypothesis
are presented in this section. When possible, power and effect size (eta2) were
calculated. Cohen (1988) suggested guidelines with respect to interpreting effect size in
which .10 is small, .25 is medium, and .40 is large. Marginal results were reported with
alphas <.10 for omnibus tests. Chi-square analyses were used for frequency data. When
the test of sphericity was significant in a mixed design, degrees of freedom were adjusted
using the Greenhouse-Geisser correction (Brace, Kemp, & Snelgar, 2009). In general,
post-hoc comparisons were conducted using Tukey’s HSD test with alpha set at .05.
Given specific predictions in the hypotheses of this study, a priori planned comparisons
were completed when appropriate with independent samples t-tests by combining group
scores that were hypothesized to be similar. This was completed as part of the ANOVA
calculations.
Participant Characteristics
The total sample consisted of 46 females. Participants ranged in age from 18 to
66 (see Table 3.1.for group averages). The four groups of participants (PTSD and pain,
PTSD only, pain only, controls) differed significantly in age [F(3,43) = 6.15, p<.01].
Post-hoc analyses revealed that the pain only group was significantly older than the
PTSD only and control groups. Similarly, women in the PTSD and pain group were
significantly older than controls. There were no significant differences in age between
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the PTSD and pain and pain only groups, between the PTSD and pain and PTSD only
groups, or between the PTSD only and control groups. The four groups of participants
also differed significantly in body mass index; BMI [F(3,41) = 3.86, p = .02]. Post-hoc
analyses revealed that the pain only group had a significantly higher BMI rating than the
PTSD only and control groups.
Table 3.1. Group Averages in Age and BMI
PTSD and pain
(n = 10)

PTSD only
(n = 11)

Pain only
(n = 10)

Control
(n = 15)

Mean Age

42.80ab
(15.39)

27.44bc
(15.90)

45.90a
(15.62)

25.27c
(11.05)

BMI

28.19ab
(7.09)

23.75b
(3.89)

31.73a
(6.29)

24.59b
(5.29)

Note. Standard deviations are in parentheses. Means with different subscripts differ
significantly at p < .05.
Chi-square analyses indicated that there were significant group differences in
diagnoses of depression [χ2 (3, N = 45) = 17.22, p = .001]. In particular, the PTSD and
pain group had the highest prevalence of depression, followed by the PTSD only, control,
and pain only groups respectively. No significant group differences were found for social
phobia [χ2 (3, N = 45) = 0.14, ns], specific phobia [χ2 (3, N = 45) = 0.43, ns], obsessivecompulsive disorder [χ2 (3, N = 45) = 7.33, ns], panic disorder [χ2 (3, N = 45) = 3.15, ns],
agoraphobia [χ2 (3, N = 45) = 1.07, ns], or generalized anxiety disorder [χ2 (3, N = 45) =
.17, ns]. See Table 3.2 for specific percentages of these diagnoses.
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Table 3.2. DSM-IV Diagnoses
PTSD &
Pain
70%

PTSD Only

Pain Only

Control

40%

0%

7%

Social Phobia

30%

10%

10%

0%

Specific Phobia

40%

10%

30%

20%

OCD

20%

0%

0%

0%

Panic Disorder

20%

20%

0%

7%

Agoraphobia

0%

10%

10%

7%

Generalized
Anxiety Disorder

40%

20%

10%

7%

Depression

Advanced clinical graduate students reviewed audiotapes of the SCID-IV
interviews and rated whether or not the participants met criteria for PTSD. These ratings
were compared to diagnoses given to the participants during their laboratory session.
Unfortunately, inter-rater reliability could only be assessed for 17 out of 46 interviews
(37%). Many of the interviews could not be reviewed due to equipment failure during
the recording process. Several of the interviews were also missing from the laboratory
tapes.

Of the 17 interviews that were rated, the principal investigator and the advanced

clinical graduate students agreed 100% that women in the PTSD and pain and PTSD only
groups met DSM-IV criteria for PTSD, and that women in the pain only and control
groups did not meet criteria for PTSD.
Participant demographics are found in Table 3.3. Chi-square analyses indicated
that there were no significant group differences in race [χ2 (3, N=43) = 1.91, ns], income
[χ2 (24, N=41) = 23.32, ns], or education [χ2 (21, N=44) = 24.05, ns]. However, there
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were significant differences between groups regarding relationship status [χ2 (9, N=44) =
22.60, p < .007]. Women in the PTSD and pain and pain only groups were more likely to
be married or divorced, whereas women in the PTSD only and control groups were more
likely to be single.
Table 3.3. Participant demographics

Race
Caucasian
Asian
Unknown
Education
< High school
High school diploma
Associate’s degree
Partial undergraduate
Bachelor’s degree
Partial graduate
Master’s degree
Doctorate
Family Income
< 30,000
30,000 – 39,999
40,000 – 49,999
>50,000
Unknown
Relationship Status
Single
Living with partner
Married
Divorced

PTSD &
Pain

PTSD
Only

Pain Only

Control

100%
0%
0%

100%
0%
0%

90%
0%
10%

93%
7%
0%

10%
0%
30%
20%
30%
0%
10%
0%

0%
33%
0%
56%
0%
11%
0%
0%

0%
20%
10%
40%
20%
0%
10%
0%

0%
33%
7%
40%
0%
7%
7%
7%

60%
0%
20%
20%
0%

44%
22%
11%
11%
12%

20%
30%
0%
40%
10%

47%
0%
13%
33%
7%

0%
10%
60%
30%

78%
0%
11%
11%

20%
20%
50%
10%

73%
7%
20%
0%

There were no significant group differences regarding the use of birth control pills
[χ2 (3, N=44) = 5.38, ns]. Significant group differences in menstrual status were reported
[χ2 (3, N=44) = 8.15, p = .04]. Women in the PTSD only and control groups were more
likely to be premenstrual than women in the other two groups. Women in the PTSD and
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pain and pain only groups reported more postmenopausal status than women in the other
two groups (see Table 3.4. for specific percentages).
Table 3.4. Menstrual Cycle Demographics
PTSD &
Pain
20%

PTSD Only

Pain Only

Control

56%

20%

53%

Pre-menopausal

60%

89%

50%

93%

Post-menopausal

40%

11%

50%

7%

Birth Control

There were significant group differences regarding family history of PTSD [χ2 (3,
N=44) =8.15, p = .04]. Women with PTSD and chronic pain and PTSD only were more
likely to report a family history of PTSD than those without a diagnosis of PTSD ([pain
only and control groups). There were also significant group differences in family history
of chronic pain [χ2 (3, N=44) =13.02, p = .005]. Women who reported experiencing
chronic pain (PTSD and pain and pain only groups) were more likely to report a family
history of chronic pain than those without chronic pain (PTSD only and control groups
(see Figure 3.1 for specific percentages).
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Figure 3.1. Family History of PTSD and Chronic Pain
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Hypothesis Results: Experimental Stressor
Hypothesis One
According to hypothesis one, participants in the clinical group (for combination
hypotheses, the three clinical groups combined are referred to as the clinical group) were
predicted to demonstrate: a) lower baseline cortisol levels prior to the experimental
stressor, and b) blunted salivary cortisol levels following the experimental stressor as
compared to controls. Two participants were considered outliers (at least 2 standard
deviations above the mean) and were removed from statistical analyses for cortisol
related hypotheses. First, comparisons of baseline cortisol levels were assessed using a
one-way ANOVA with incorporated planned comparisons. Planned comparisons in
baseline cortisol levels between the clinical group and control group were not significant
(t = -.78, df = 38, ns). Post-hoc power analyses were completed for t-test results on
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baseline levels of cortisol between the clinical and control groups. Given the observed
effect size and variability within the current study, power analyses revealed that a sample
size of 40 would result in a power of .18. In addition, a one-way ANOVA did not reveal
a significant difference between the groups on baseline cortisol levels [F(3,41) = .36, ns].
Planned comparisons in cortisol levels across occasions for the clinical group and
control group were completed within a 2 (Group: clinical group, control) X 5 (Occasion:
baseline, 10 minutes post-stress induction, 20 minutes post-stress induction, 40 minutes
post-stress induction, and 60 minutes post-stress induction) repeated measures ANOVA.
Given that the test of sphericity was found to be significant, degrees of freedom were
adjusted using the Greenhouse-Geisser correction. The Group x Occasion interaction
effect was not significant [F(2.50, 99.91) = .66, ns]. The main effect for Group [F(1, 40)
= .67, ns] was not significant. The main effect for Occasion was significant [F(2.50,
99.91) = 5.89, p < .01, partial η2 = .13, power = .92].
Paired samples t-tests revealed that baseline levels of cortisol were higher than
those at 40 [t = 2.56, df = 41, p = .01] and 60 min [t = 2.96, df = 41, p = .01]. Cortisol
levels at 10 minutes following the TSST were greater than those at 40 minutes [t = 3.70,
df = 41, p = .01] and at 60 minutes [t = 3.62, df = 41, p = .01]. Finally, cortisol levels at
20 minutes were higher than those at 40 minutes [t = 3.82, df = 41, p = .01] and at 60
minutes [t = 3.38, df = 51, p = .01]. All other paired samples t-tests did not reveal any
significant differences in cortisol levels. Group averages are presented in Table 3.5 and
Figure 3.2.
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Table 3.5. Cortisol Means (nmol/L)Across Time Periods
Time Period

Control

Clinical Group

Total Sample

Baseline

6.62a
(3.94)

5.80a
(2.73)

6.09
(3.19)

10 Min Post TSST

6.19a
(3.16)

6.17a
(3.78)

6.18
(3.54)

20 Min Post TSST

6.16a
(3.04)

5.82a
(3.70)

5.94
(3.45)

40 Min Post TSST

4.93a
(2.88)

4.97a
(3.04)

4.96
(2.95)

60 Min Post TSST

5.46a
(3.08)

4.63a
(2.44)

4.93
(2.68)

Total Sample

5.87
(.74)

5.48
(.55)

Note. Standard deviations are in parentheses. Means with different subscripts differ
significantly at p < 05.
Figure 3.2 Cortisol Levels across Occasions
Cortisol Across Occasions
7
6.5

Cortisol Levels

6
5.5
Clinical Groups

5
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4.5
4
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3
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10 Min Post 20 Min Post 40 Min Post 60 Min Post
TSST
TSST
TSST
TSST
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To further assess for any group differences, a 4 (Group: PTSD, pain, PTSD and
pain, control) X 5 (Occasion: baseline, 10 minutes post-stress induction, 20 minutes poststress induction, 40 minutes post-stress induction, and 60 minutes post-stress induction)
repeated measures ANOVA was completed. Given that the test of sphericity was found to
be significant, degrees of freedom were adjusted using the Greenhouse-Geisser
correction. The Group x Occasion interaction effect was not significant [F(7.41, 93.84) =
.45, ns]. The main effect for Group [F(1, 38) = .63, ns] was not significant. The main
effect for Occasion was significant [F(2.47,93.84) = 5.97, p = .002, partial η2 = .14.
Please refer to planned comparisons for paired samples t-test analyses (see Figure 3.3 and
refer to table 3.6 for individual group averages). A logarithmic transformation of the
cortisol values yielded the same results. The interaction effect for Group x Occasion was
not significant when age was included as a covariate [F(7.47, 87.12) = .84, ns].
Similarly, the interaction effect for Group x Occasion was not significant when BMI was
used as a covariate [F(7.47, 84.58) = .87, ns].
Figure 3.3. Cortisol levels across occasions: Individual Groups
Cortisol Levels
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Table 3.6. Cortisol Means (nmol/L) Across Time Periods: Individual Groups
Time Period

PTSD &
Pain

PTSD Only

Pain Only

Control

Total
Sample

Baseline

5.31a
(2.07)

6.37a
(3.26)

5.70a
(2.94)

6.62a
(3.94)

6.09
(3.19)

10 Min Post
TSST

5.60a
(2.82)

7.16 a
(4.85)

5.77a
(3.63)

6.19a
(3.16)

6.18
(3.53)

20 Min Post
TSST

4.58a
(2.14)

6.98a
(4.13)

5.89a
(4.44)

6.16a
(3.04)

5.94
(3.45)

40 Min Post
TSST

3.89a
(1.79)

5.93a
(3.55)

5.09a
(3.42)

4.93a
(2.88)

4.96
(2.94)

60 Min Post
TSST

3.99a
(1.80)

5.37a
(2.80)

4.53a
(2.69)

5.46a
(3.08)

4.93
(2.68)

Total Sample

4.68
(.96)

6.36
(.96)

5.40
(.96)

5.87
(.74)

Note. Standard deviations are in parentheses. Means with different subscripts differ
significantly at p < 05.
Ancillary Findings
Cortisol Levels within Groups. Although not hypothesized, analyses were
conducted to determine within group differences in cortisol levels across the stress task.
As the test of sphericity was found to be significant across occasions in the PTSD and
pain group, degrees of freedom were adjusted using the Greenhouse-Geisser correction.
There was a significant Occasion effect for women in the PTSD and pain group [F(4, 32)
= 2.87, p = .04, partial η2 = .26]. Paired samples t-tests revealed that cortisol levels at 10
min were greater than those at 40 min [t = 2.65, df = 8, p = .03], 60 min [t = 2.27, df = 8,
p = .05]. Cortisol levels at 20 min were greater than those at 40 min [t = 2.39, df = 8, p =

84
.05] for women in the PTSD and pain group. There were no significant Occasion effects
for women in the PTSD only [F(4,32) = 1.89, ns] pain only [F(4,32) = 1.19, ns], and
control groups [F(4,32) = 1.19, ns].
Hypothesis Two
It was predicted that group means for anxious mood would exist on a continuum
across the measurement occasions of the experimental task (POMS anxiety subscale).
Participants in the PTSD and pain group were anticipated to report the highest levels of
anxious mood, followed by the PTSD and the pain only groups. Participants in the
control group were anticipated to report the lowest levels of anxious mood. Two
participants considered to be outliers for cortisol results were excluded from experimental
session analyses. To test this hypothesis, the PTSD only and pain only were combined to
form a PTSD only plus pain only group.
As the test of sphericity was found to be significant in the 2 (Groups: PTSD and
pain, PTSD only plus pain only) X 5 (Occasions) mixed-factor ANOVA, degrees of
freedom were adjusted using the Greenhouse-Geisser correction. The main effect for
Occasion [F(1.92,49.95) = 21.24, p <.0001, partial η2 = .45] and Group [F(1,26) = 13.18,
p <.001, partial η2 = .34] were significant. The test of the Group x Occasion interaction
effect was marginally significant [F(1.92, 49.95) = 2.65, p= .08, partial η2 = .09]. The
PTSD and pain group reported significantly higher levels of anxious mood than the
PTSD only and pain only group. Refer to Table 3.7 for group averages.
Paired samples t-tests indicated that baseline levels of anxious mood were
significantly higher than levels of anxious mood at 10 minutes [t = -.2.58, df = 27, p =
.02]. Levels of anxious mood were significantly lower from baseline at 20 minutes [t =
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2.95, df = 27, p = .007], 40 minutes [t = 4.00, df = 27, p = .001], and at 60 minutes [t =
4.82, df = 27, p = .0001]. Levels of anxious mood were significantly higher at 10
minutes following the TSST than at 20 [t = 4.98, df = 27, p = .0001], 40 [t = 5.29, df = 27,
p = .0001], and 60 [t = 5.79, df = 27, p = .0001] minutes. Levels of anxious mood at 20
minutes were significantly higher than anxious mood at 60 minutes [t = 3.75, df = 27, p =
.001]. Finally, levels of anxious mood at 40 minutes were significantly higher than those
at 60 minutes [t = 3.06, df = 27, p = .005].
As the test of sphericity was found to be significant in the 2 (Groups: PTSD only
plus pain only, control) X 5 (Occasions) mixed-factor ANOVA, degrees of freedom were
adjusted using the Greenhouse-Geisser correction. The main effect for Occasion [F(1.64,
52.59) = 16.98, p <.0001, partial η2 = .35] was significant. The Group [F(1,32) = .96, ns]
and Group x Occasion interaction [F(1.64, 52.59) = 1.16, ns] were not significant.
Paired samples t-tests indicated that baseline levels of anxious mood were
significantly higher than levels of anxious mood at 10 minutes [t = -.3.81, df = 33, p =
.001]. Levels of anxious mood were significantly lower from baseline at 20 minutes [t =
2.79, df = 33, p = .009], 40 minutes [t = 2.50, df = 33, p = .02], and at 60 minutes [t =
3.54, df = 33, p = .001]. Levels of anxious mood were significantly higher at 10 minutes
following the TSST than at 20 [t = 5.14, df = 33, p = .0001], 40 [t = 4.50, df = 33, p =
.0001], and 60 [t = 4.84, df = 33, p = .0001] minutes. Finally, levels of anxious mood at
40 minutes were significantly higher than those at 60 minutes [t = 2.03, df = 33, p = .05].
All other paired samples t-tests were not significant. Refer to Table 3.7 for group
averages.
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Table 3.7. POMS Anxiety Levels Across Time Points
Occasion

PTSD & Pain

Control

Total
Sample

13.33a
(4.80)

PTSD Only
&
Pain Only
6.26a
(2.83)

Baseline

5.67a
(3.39)

7.53
(4.56)

10 Min Post
TSST

13.11a
(5.65)

10.26a
(6.45)

7.93a
(5.68)

10.05
(6.19)

20 Min Post
TSST

8.67a
(3.50)

5.16a
(2.52)

4.07a
(1.28)

5.51
(2.93)

40 Min Post
TSST

7.56a
(3.28)

4.58a
(1.77)

4.73a
(1.53)

5.26
(2.37)

60 Min Post
TSST

6.11a
(2.15)

4.00a
(0.75)

4.27a
(1.03)

4.53
(1.47)

Total Sample

9.76
(.77)

6.05
(.53)

5.33
(.60)

Note. Standard deviations are in parentheses. Means with different subscripts differ
significantly at p< .05
As the test of sphericity was found to be significant in the 4 (Groups) X 5
(Occasions) mixed-factor ANOVA, degrees of freedom were adjusted using the
Greenhouse-Geisser correction. The main effect for Occasion [F(1.90, 74.09) = 28.42, p
= .0001, partial η2 = .42] and Group [F(3,39) = 7.82, p = .0001, partial η2 = .38] were
significant. The test of the Group x Occasion interaction effect was also significant
[F(5.70, 74.09) = 2.32, p=.05, partial η2 = .15]. Refer to Table 3.8 and Figure 3.4 for
group averages.
F tests for the significant Group x Occasion interaction effect revealed the
following: baseline [F(3, 42) = 10.47, p < .0001, partial η2 = .45, power = .99], 10 min
[F(3, 42) = 2.41, ns], 20 min [F(3, 42) = 6.81, p < .001, partial η2 = .34, power = .96], 40
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min[F(3, 42) = 4.48, p = .009, partial η2 = .26, power = .85], and 60 min [F(3, 42) = 6.07,
p < .002, partial η2 = .32, power = .94].
Tukey’s HSD indicated that participants in the PTSD and pain group reported
significantly higher baseline levels of anxious mood than the PTSD only (Mean
Difference = 6.56, SE = 1.66, p = .002), pain only (Mean Difference = 7.53, SE = 1.62, p
< .001), and control groups (Mean Difference = 7.67, SE = 1.49, p < .001). No
significant group differences were demonstrated at 10 minutes following the TSST. The
PTSD and pain group reported significantly higher levels of anxious mood at 20 minutes
following the TSST than the PTSD only (Mean Difference = 3.57, SE = 1.16, p = .02),
Pain only (Mean Difference = 3.47, SE = 1.13, p = .02), and control groups (Mean
Difference = 4.60, SE = 1.04, p < .001). The PTSD and pain group reported significantly
higher levels of anxious mood at 40 minutes following the TSST than the PTSD only
(Mean Difference = 2.89, SE = 1.00, p = .04), pain only (Mean Difference = 3.06, SE =
.98, p = .02) and control groups (Mean Difference = 2.82, SE = .90, p = .02). Finally, the
PTSD and pain group reported significantly higher levels of anxious mood at 60 minutes
following the TSST than the PTSD only (Mean Difference = 2.11, SE = .59, p = .01) and
pain only (Mean Difference = 2.11, SE = .58, p = .01) groups (Group averages are
presented in Table 3.6). Overall, the PTSD and pain group reported higher levels of
anxious mood across all time points except at 10 minutes following the TSST (see Figure
3.3).
Paired samples t-tests indicated that baseline levels of anxious mood were
significantly lower than levels of anxious mood at 10 minutes [t = -3.28, df = 42, p =
.002], and significantly greater than at 20 minutes [t = 3.63, df = 42, p = .001], 40 minutes
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[t = 3.75, df = 42, p = .001], and 60 minutes [t = 4.72, df = 42, p = .0001]. Levels of
anxious mood were significantly higher at 10 minutes following the TSST than at 20 [t =
5.74, df = 42, p = .001], 40 [t = 5.53, df = 42, p = .0001], and 60 [t = 5.60, df = 42, p =
.0001] minutes. Levels of anxious mood at 20 minutes were significantly higher than
anxious mood at 60 minutes [t = 2.90, df = 42, p = .006]. Finally, levels of anxious mood
at 40 minutes were significantly higher than those at 60 minutes [t = 2.30, df = 42, p =
.005].
There was a significant within-group effect for women in the PTSD and pain
group [F(2.04, 16.32) = 9.97, p = .001, partial η2 = .56, power = .96], PTSD only group
[F(1.59, 12.69) = 11.1, p = .003, partial η2 = .58, power = .94], pain only group [F(1.46,
13.11) = 4.58, p < .05, partial η2 = .34, power = .59], and control group [F(1.64, 22.97) =
4.78, p < .05, partial η2 = .25, power = .68].
For the simple main effect for Group, Tukey’s HSD indicated that women in the
PTSD and pain group reported significantly higher baseline levels of anxious mood than
at 60 minutes (Mean Difference = 7.22, SE = 1.71, p = .03) following the TSST. Anxious
mood at 10 minutes (Mean Difference = 7.00, SE = 1.84, p = .05) was also significantly
higher than levels of anxious mood at 60 minutes following the TSST. The PTSD only
group reported a significantly higher levels of anxious mood at 10 minutes following the
TSST than at 20 minutes (Mean Difference = 7.56, SE = 1.83, p = .03), 40 minutes (Mean
Difference = 8.00, SE = 2.11, p = .05), and 60 minutes (Mean Difference = 8.67, SE =
2.29, p = .05). No significant differences across occasions were demonstrated for the
pain only group. Finally, the control group reported a significant decrease in anxious
mood from 10 to 20 minutes follow-up (Mean Difference = 3.87, SE = 1.29, p < .05).
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Ancillary Analyses
Since the PTSD and pain group reported significantly higher levels of anxious
mood at baseline than the remaining three groups [F(3,44) = 14.16, p < .0001], a repeated
measures ANOVA with baseline levels of anxious mood entered as a covariate was
conducted on the remaining 4 occasions. The main effects for Occasion [F(1.40, 54.18)
= .61, ns] and Group [F(3, 38) = .55, ns] were not significant. The Group x Occasion
interaction effect was significant [F(4.20, 54.18) = 2.96, p = .03, partial η2 = .19, power =
.77]. A breakdown of the interaction revealed no significance differences between
groups regarding anxious mood. Results continue to indicate that women in the PTSD
and pain group reported the highest levels of anxious mood across most time points.
Table 3.8. POMS Anxiety Levels Across Time Points: Individual Groups
Occasion

PTSD &
Pain
13.33a
(4.80)

PTSD Only

Pain Only

Control

6.78b
(3.11)

5.80b
(2.62)

5.67b
(3.39)

Total
Sample
7.53
(4.56)

10 Min Post
TSST

13.11a
(5.65)

12.67a
(6.91)

8.10a
(5.47)

7.93a
(5.68)

10.05
(6.19)

20 Min Post
TSST

8.67a
(3.50)

5.11b
(1.83)

5.20b
(3.12)

4.07b
(1.28)

5.51
(2.92)

40 Min Post
TSST

7.56a
(3.28)

4.67b
(1.50)

4.50b
(2.07)

4.73b
(1.53)

5.26
(2.37)

60 Min Post
TSST

6.11a
(2.15)

4.00b
(0.50)

4.00b
(.94)

4.27b
(1.03)

4.53
(1.47)

Total Sample

9.76
(.77)

6.64
(.77)

5.52
(.73)

5.33
(.60)

Baseline

Note. Standard deviations are in parentheses. Means with different subscripts differ
significantly at p< .05
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Figure 3.4. Anxious Mood across Experimental Task: Individual Groups
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Visual Analog Stress Scale
Although not originally incorporated into the study hypotheses,
participants completed the Visual Analog Stress scale immediately after completing the
experimental stressor as a means of measuring their self-perceived stress levels during
this task. A one way ANOVA demonstrated that no significant group differences were
reported in self-reported stress levels in response to the TSST [F(3,40) = .93, ns]. In
general, all groups reported experiencing moderate levels of stress during the TSST.
Group averages are presented in Table 3.9.
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Table 3.9. Visual Analog Stress Scale
PTSD and pain

PTSD only

Pain only

Control

4.89a
(1.36)

4.78a
(2.22)

4.50a
(1.41)

4.00a
(.76)

Mean VASS
Score

Note. Standard deviations are in parentheses. Means with different subscripts are
significantly at p < 05.
Hypothesis Three
Participants in the three clinical groups were predicted to report greater use of
negative coping strategies (i.e., denial, behavioral disengagement, self-blame), while
participants in the control group were predicted to report greater use of positive coping
strategies (i.e., active coping, positive reframing, acceptance). This trend was
hypothesized to occur in both general use of coping strategies and coping strategies
utilized in response to the TSST (general use of coping strategies will be discussed with
questionnaire data).
Planned comparisons did not indicate any significant group differences between
the clinical group and the control group for levels of denial [t = .21, df = 38, ns],
behavioral disengagement [t = .62, df = 38, ns], self-blame [t = 1.57, df = 38, ns], active
coping [t = 1.33, df = 38, ns], positive reframing [t = .45, df = 38, ns], and acceptance [t =
.27, df = 38, ns]. Refer to Table 3.10 for group averages.
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Table 3.10. Brief COPE Scores in Response to TSST
Subscales

Control

Clinical Group

Active Coping

2.47a
(.58)

2.81a
(.91)

Positive Reframing

2.47a
(.95)

2.59a
(.81)

Acceptance

2.67a
(.98)

2.74a
(.74)

Denial

1.37a
(.61)

1.41a
(.61)

Behavioral Disengagement

1.30a
(.49)

1.41a
(.56)

Self-Blame

1.77a
(.62)

2.15a
(.86)

Note. Standard deviations are in parentheses. Means with different subscripts differ
significantly at p< .05.
A series of one-way ANOVAs were completed to assess for additional group
differences. These analyses indicated a near significant group difference in self-blame
[F(3,41) = 2.65, p = .06] in response to the TSST. No significant group differences were
demonstrated for denial [F(3,41) = .85, ns], behavioral disengagement [F(3,41) = .80,
ns], active coping [F(3,41) = 1.28, ns], positive reframing [F(3,41) = .32, ns], or
acceptance [F(3,41) = .14, ns]. Individual group averages are presented in Table 3.11.
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Table 3.11. Individual Group Brief COPE Scores in Response to TSST
Subscales

PTSD & Pain

PTSD Only

Pain Only

Control

Active Coping

2.50a
(.75)

2.94a
(.77)

3.00a
(1.17)

2.47a
(.58)

Positive Reframing

2.67a
(1.00)

2.72a
(.91)

2.39a
(.49)

2.47a
(.95)

Acceptance

2.61a
(.86)

2.83a
(.66)

2.78a
(.75)

2.67a
(.98)

Denial

1.67a
(.83)

1.28a
(.36)

1.28a
(.51)

1.37a
(.61)

Behavioral
Disengagement

1.61a
(.65)

1.28a
(.44)

1.33a
(.56)

1.30a
(.49)

Self-Blame

2.17a
(.61)

2.56a
(.85)

1.72a
(.97)

1.77a
(.62)

Note. Standard deviations are in parentheses. Means with different subscripts differ
significantly at p< .05.
Hypothesis Results: Questionnaire Data
Hypothesis Four
It was predicted that depression levels would exist on a continuum. Women in
the PTSD and pain group were anticipated to report the highest levels of depression
symptoms, followed by women in the PTSD only and the pain only groups. Women in
the control group were anticipated to report the lowest level of depression symptoms.
Planned comparisons between the PTSD and pain group and the combined PTSD only
and pain only groups did not indicate any significant group differences in levels of
depression [t = 1.82, df = 39, ns]. Similarly, planned comparisons between the combined
PTSD only and pain only groups and the control group did not demonstrate any
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significant group differences [t = 1.74, df = 39, ns]. Please refer to table 3.12 for group
averages.
Table 3.12. Depression Severity Scores
PTSD & Pain
BDI-II

PTSD Only &
Pain Only
13.58a
(11.08)

19.78a
(3.63)

Control
8.43a
(5.81)

Note. Standard deviations are in parentheses. Means with different subscripts differ
significantly at p< .05
To further assess for individual group differences, a one-way ANOVA indicated
significant group differences in levels of depression on the BDI-II [F(3,41) = 7.19, p<
.001]. Post-hoc analyses revealed that the PTSD and pain and PTSD only groups
reported significantly higher levels of depression than the pain only and control groups.
BDI-II scores reported by the PTSD and pain and PTSD only groups were indicative of
mild to moderate levels of depression, whereas scores reported by the pain only and
control groups were in line with minimal levels of depression. Group averages are
presented in Table 3.13.
Table 3.13. Depression Severity Scores: Individual Groups
PTSD and pain

PTSD only

Pain only

Control

19.78a
(3.63)

19.22a
(12.31)

8.5b
(7.10)

8.43b
(5.81)

BDI-II

Note. Standard deviations are in parentheses. Means with different subscripts differ
significantly at p< .05.
Hypothesis Five
It was predicted that all three clinical groups would report higher levels of learned
helplessness than the control group. Planned comparisons did not reveal significant
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group differences between the three clinical groups and the control group for Internality
(t = 1.26, df = 39, ns), Stability (t = 1.03, df = 39, ns), or Globality (t = .43, df = 39, ns)
subscales on the Expanded Attributional Style Questionnaire. Group averages are
presented in Table 3.14.
Table 3.14. Expanded Attributional Style Questionnaire Subscales
ASQ Subscales

Control

Clinical Group

Internality

4.28a
(.94)

4.58a
(.62)

Stability

4.28a
(1.21)

4.58a
(.68)

Globality

4.09a
(1.10)

4.19a
(.63)

Note. Standard deviations are in parentheses. Means with different subscripts differ
significantly at p< .05.
Individual group differences in learned helplessness were completed using a 4
(Group: PTSD, pain, PTSD and pain, control) X 3 MANOVA with the 3 ASQ subscales
(Internality, Stability, Globality) as criterion variables. Results did not indicate a
significant effect for Group on the combined dependent construct of learned helplessness
[F(9, 90.20) = .77, ns; Wilks’ Lambda = .86; partial η2 = .05]. Analysis of individual
dependent variables indicated no significant Group effects for Internality [F(3, 39) = .72,
ns, partial η2 = .05]; Stability [F(3, 39) = .89, ns, partial η2 = .06]; or Globality [F(3, 39)
= 1.13, ns, partial η2 = .08]. Individual group averages are presented in Table 3.15.
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Table 3.15. Expanded Attributional Style Questionnaire Subscales: Individual Groups
ASQ Subscales

PTSD & Pain

PTSD Only

Pain Only

Control

Internality

4.74a
(.73)

4.53a
(.25)

4.49a
(.53)

4.28a
(.94)

Stability

4.89a
(.68)

4.45a
(.30)

4.40a
(.52)

4.28a
(1.21)

Globality

4.55a
(.61)

4.17a
(.27)

3.88a
(.63)

4.09a
(1.10)

Note. Standard deviations are in parentheses. Means with different subscripts differ
significantly at p< .05.
Hypothesis Six
Participants in all three clinical groups were predicted to report greater levels of
negative life events and general stress than the control group. Participants in the three
clinical groups were also anticipated to report viewing ambiguous situations as being
more threatening. To test these hypotheses group differences on self-reported measures
(LES, IUS-12, PSS) were assessed in a series of one-way ANOVAs.
Life Experiences Survey. Planned comparisons revealed significant group
differences between the three clinical groups and the control group for the mean impact
of life experiences in the previous year [t = -3.41, df = 35, p < .01]. Overall, the three
clinical groups combined reported significantly more negative mean impacts of life
events than the control group. Refer to Table 3.16 for planned comparison group
averages. Similarly, a one-way ANOVA indicated that there was a significant effect for
mean impact levels of life experiences in the previous year [F(3, 38) = 4.22, p = .01,
partial η2 = .27]. Post-hoc analyses revealed that the PTSD and pain and PTSD only
groups reported significantly more negative impact levels of life experiences in the past
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year than the control group (see Figure 3.5). Refer to Table 3.17 for individual group
averages.
Figure 3.5. Mean Impact of Life Experiences in past Year

Life Experiences
2.5
2
1.5

Mean Impact Level

1
0.5
PTSD and Pain
0

PTSD Only
Pain Only

-0.5

Control

-1
-1.5
-2
-2.5
-3

Perceived Stress Scale. Planned comparisons indicated significant group
differences between the three clinical groups and the control group on general levels of
perceived stress in the past month [t = 2.15, df = 39, p < .05]. Refer to Table 3.16 for
planned comparison group averages. A one-way ANOVA also indicated that there was a
significant effect for overall ratings of stress [F(3, 42) = 4.79, p < .01, partial η2 = .23].
Post-hoc analyses demonstrated that the PTSD and pain group reported significantly
higher levels of stress than the pain only and control groups in the past month (see Figure
3.6). Refer to Table 3.17 for individual group averages.
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Figure 3.6. General Levels of Stress
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Intolerance of Uncertainty Scale – Short Version. Planned comparisons between
the three clinical groups and the control group did not reveal significant group differences
for intolerance of uncertainty [t = .94, df = 39, ns]. Refer to Table 3.16 for planned
comparison group averages. Similarly, a one-way ANOVA did not indicate significant
group differences in levels of intolerance of uncertainty [F(3, 42) = 1.43, ns, partial η2 =
.03]. Refer to Table 3.17 for individual group averages.
Table 3.16. Stress Levels and Negative Life Experiences
Control
LES: Mean Impact

.69a
(1.15)

Combined Clinical
Groups
-.69b
(1.26)

PSS

23.20a
(5.70)

27.71b
(8.31)

IUS-12

29.47a
(8.39)

32.39a
(11.29)

Note. Standard deviations are in parentheses. Means with different subscripts differ
significantly at p< .05.
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Table 3.17. Stress Levels and Negative Life Experiences: Individual Groups
PTSD & Pain

PTSD Only

Pain Only

Control

LES: Mean
Impact

-1.09a
(1.23)

-.72a
(1.53)

-.34ab
(1.01)

.69b
(1.15)

PSS

31.22a
(5.48)

30.22ab
(8.58)

22.20b
(7.86)

23.20b
(5.70)

IUS-12

37.33a
(12.93)

31.55a
(11.39)

28.70a
(8.83)

29.47a
(8.39)

Note. Standard deviations are in parentheses. Means with different subscripts differ
significantly at p< .05.
Ancillary Findings
Frequency of Life Events. Although not originally included in hypotheses, group
differences on self-reported frequencies of negative and positive life events (i.e. LES)
were assessed in a series of one-way between subjects ANOVAs. Since the assumption
of homogeneity of variance was violated when assessing for group differences in total
frequency of positive and negative life events in the previous year, two Kruskal-Wallis
one-way between-subjects analyses were completed. There was not a significant effect
for frequency of positive life events [X2(3, N=39) = 2.34, ns] or frequency of negative life
events [X2(3, N=39) = 4.68, ns]. Please refer to Table 3.18 for group averages.
Table 3.18. Frequency of negative and positive life events in past year
PTSD & Pain

PTSD Only

Pain Only

Control

LES: Freq of
Negative Life Events

9.14a
(6.59)

6.33a
(3.94)

4.44a
(2.70)

4.36a
(5.05)

LES: Freq of
Positive Life Events

3.00a
(2.58)

2.33a
(1.58)

2.33a
(1.32)

4.43a
(3.63)
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Note. Standard deviations are in parentheses. Means with different subscripts differ
significantly at p< .05.
Hypothesis Seven
As mentioned earlier, participants in the three clinical groups were predicted to
report greater use of general negative coping strategies (i.e., denial, behavioral
disengagement, self-blame), while participants in the control group were predicted to
report greater use of general positive coping strategies (i.e., active coping, positive
reframing, acceptance).
Planned comparisons between the clinical group and the control group with
regards to general use of coping strategies indicated significant group differences in
levels of self-blame [t = 2.01, df = 38, p = .05]. In particular, the three clinical groups
combined reported higher levels of self-blame than the control group. Planned
comparisons did not indicate any significant group differences in denial [t = -.20, df = 38,
ns], behavioral disengagement [t = .15, df = 38, ns], active coping [t = -.10, df = 38, ns],
positive reframing [t = -.97, df = 38, ns], or acceptance [t = -.85, df = 38, ns]. Refer to
Table 3.19 for planned comparison group averages.
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Table 3.19. General Brief COPE
Subscales

Control

Clinical Group

Active Coping

2.75a
(.85)

2.73a
(.92)

Positive Reframing

2.68a
(.97)

2.39a
(.86)

Acceptance

2.96a
(.89)

2.71a
(.89)

Denial

1.21a
(.47)

1.18a
(.46)

Behavioral Disengagement

1.39a
(.71)

1.41a
(.51)

Self-Blame

1.50ab
(.71)

1.89a
(.72)

Note. Standard deviations are in parentheses. Means with different subscripts differ
significantly at p< .05.
A series of one-way ANOVAs were completed to further assess for group
differences. There were significant group differences in self-blame [F(3,41) = 5.82,
p<.01]. Post-hoc analyses revealed that the PTSD only group reported significantly
higher levels of self-blame than the pain only and control groups. The PTSD and pain
group also reported significantly higher levels of self-blame than the pain only group. No
significant group differences were demonstrated for denial [F(3,41) = 1.19, ns],
behavioral disengagement [F(3,41) = 1.32, ns], active coping [F(3,41) = .87, ns], positive
reframing [F(3,41) = .74, ns], or acceptance [F(3,41) = .40, ns]. Individual group
averages are presented in Table 3.20.
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Table 3.20. General Brief COPE: Individual Groups
Subscales

PTSD & Pain

PTSD Only

Pain Only

Control

Active Coping

2.72a
(.67)

2.39a
(.99)

3.05a
(1.01)

2.75a
(.85)

Positive Reframing

2.56a
(.85)

2.11a
(.93)

2.50a
(.85)

2.68a
(.97)

Acceptance

2.72a
(.83)

2.56a
(.95)

2.85a
(.97)

2.96a
(.89)

Denial

1.39a
(.70)

1.17a
(.35)

1.0a
(.00)

1.21a
(.47)

Behavioral
Disengagement

1.67a
(.50)

1.44a
(.58)

1.15a
(.34)

1.39a
(.71)

Self-Blame

2.17bc
(.66)

2.28c
(.67)

1.30a
(.42)

1.50ab
(.71)

Note. Standard deviations are in parentheses. Means with different subscripts differ
significantly at p< .05.
Hypothesis Eight
It was predicted that only participants in the PTSD group and PTSD and pain
group would report evidence of a PTSD specific learned alarm. Similarly, it was
predicted that only participants in the pain group and PTSD and pain group would report
evidence of a pain specific learned alarm. All three clinical groups were predicted to
report higher levels of anxiety sensitivity than the control group. Self-report measures
(i.e., IES-Revised, PASS-20, ASI) associated with evidence of a learned alarm were
assessed in a series of one-way between subjects ANOVAs.
Pain Anxiety Symptom Scale. No significant group differences between the two
chronic pain groups and the PTSD only and control groups were demonstrated with
planned comparisons for pain related avoidance [t = 1.44, df = 37, ns], cognitions [t =
1.23, df = 37, ns], physiological symptoms [t = 1.08, df = 37, ns], or total PASS scores [t
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= 1.59, df = 37, ns]; however, a marginal significant difference was found for pain
related fear [t = 1.90, df = 37, p = .06]. Refer to Table 3.21 for planned comparison group
averages.
Table 3.21. Pain Related Anxiety
Control
&
PTSD Only
31.59a
(21.55)

PTSD & Pain
&
Pain Only
41.63a
(17.73)

PASS: Fear

5.91a
(4.33)

8.89a
(5.50)

PASS: Avoidance

9.05a
(5.67)

11.47a
(4.67)

PASS: Cognitive

10.73a
(6.95)

13.53a
(5.36)

PASS: Physiological

5.91a
(4.51)

7.74a
(5.26)

PASS: Total

Note. Standard deviations are in parentheses. Means with different subscripts differ
significantly at p< .05.
A one-way ANOVA did not indicate any significant group differences in the total
score for pain related anxiety [F(3,40) = 1.40, ns]. Similarly, no significant group
differences were found on the avoidance [F(3,40) = .85, ns], cognitive [F(3,40) = 1.07,
ns], or physiological [F(3,40) = 1.90, ns] subscales of the PASS; however, a marginal
significant group difference was found for pain related fear [F(3,40) = 2.36, p = .09]. In
particular, the PTSD and pain group reported the highest levels of pain related fear,
followed by the pain only group, PTSD only group, and control groups respectively.
Please refer to Table 3.24 for individual group averages.
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Impact of Event Scale – Revised. Planned contrasts between the two PTSD
groups and the pain only and control groups indicated significant group differences for
total PTSD related symptoms on the IES-R [t = 2.14, df = 39, p < .05] and symptoms of
hyperarousal [t = 3.21, df = 39, p < .01]. Inspection of the data suggested that
participants with PTSD reported significantly higher levels of total PTSD symptoms and
symptoms of hyperarousal than those without PTSD. Planned contrasts did not indicate
significant group differences for levels of avoidance [t = 1.70, df = 39, ns] or intrusion [t
= .94, df = 39, ns]. Refer to Table 3.22 for planned comparison group averages.
Table 3.22. PTSD Related Anxiety
Control
&
Pain Only
1.03a
(.84)

PTSD & Pain
&
PTSD Only
1.45a
(.80)

IES:
Intrusion

1.25a
(.80)

1.51a
(.95)

IES: Hyperarousal

.87a
(.73)

1.69b
(.86)

23.40a
(14.28)

33.89b
(16.67)

IES: Avoidance

IES:
Total

Note. Standard deviations are in parentheses. Means with different subscripts differ
significantly at p< .05.
A series of one-way between subjects ANOVAs indicated significant group
differences for symptoms of hyperarousal [F(3,42) = 2.59, p = .01]. Post-hoc analyses
revealed that the PTSD and pain group reported significantly higher levels of
hyperarousal than the control group. No significant group differences were found for
total scores on the IES-R [F(3,42) = 1.69, ns] or for the avoidance [F(3,42) = 1.50, ns]
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and intrusion subscales [F(3,42) = .46, ns]. Please refer to Table 3.23 for individual
group averages.
Anxiety Sensitivity Index. Planned contrasts between the three clinical groups and
the control group did not reveal significant group differences [t = 1.11, df = 38, ns]. Refer
to Table 3.21 for planned comparison group averages. However, results of a one-way
between subjects ANOVA indicated significant group differences in levels of anxiety
sensitivity on the ASI, [F(3,41) = 3.62, p < .02]. Post-hoc analyses revealed that the
PTSD and pain group reported significantly higher levels of anxiety sensitivity than the
pain only group. Please refer to Table 3.24 for individual group averages.
Table 3.23. Anxiety Sensitivity
Control
ASI

17.64a
(11.24)

Combined Clinical
Groups
21.82a
(14.59)

Note. Standard deviations are in parentheses. Means with different subscripts differ
significantly at p< .05.
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Table 3.24. Measures of a Learned Alarm: Individual Groups
PTSD & Pain

PTSD Only

Pain Only

Control

ASI

30.22a
(14.66)

23.67ab
(15.22)

12.60b
(8.55)

17.64ab
(11.24)

PASS:
Total

45.78a
(21.30)

35.00a
(14.80)

37.90a
(13.88)

29.64a
(21.55)

PASS:
Fear

10.89a
(5.90)

6.62a
(3.02)

7.10a
(4.70)

5.50a
(4.99)

PASS:
Avoidance

10.67a
(5.31)

8.75a
(5.85)

12.20a
(4.16)

9.21a
(5.78)

PASS:
Cognitive

14.44a
(5.29)

12.37a
(6.02)

12.70a
(5.56)

9.78a
(7.48)

PASS:
Physiological

9.78a
(6.65)

7.25a
(3.49)

5.90a
(2.85)

5.14a
(4.96)

IES: Avoidance

1.21a
(.86)

1.69a
(.69)

.94a
(.81)

1.09a
(.88)

IES:
Intrusion

1.37a
(.73)

1.65a
(1.16)

1.27a
(.98)

1.23a
(.68)

IES:
Hyperarousal

1.83a
(.87)

1.55ab
(.88)

1.01ab
(.98)

.78b
(.53)

31.67a
(16.60)

36.11a
(17.44)

23.60a
(18.66)

23.27a
(11.22)

IES:
Total

Note. Standard deviations are in parentheses. Means with different subscripts differ
significantly at p< .05.
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Chapter 4
DISCUSSION
The purpose of the current study was to test aspects of the triple vulnerability
model (Barlow, 2000; Barlow, 2002; Otis et al., 2003) in PTSD and chronic
musculoskeletal pain populations. According to this model, individuals have a
generalized biological vulnerability (e.g., inherited personality traits that lead individuals
to react to environmental stressors in a defensive manner), generalized psychological
vulnerability (e.g., sense of uncontrollability and perceived inability to cope), and a
specific psychological vulnerability (e.g., development of learned alarms) that lead
individuals to develop both PTSD and chronic pain (Barlow, 2000; Barlow, 2002; Keane
& Barlow, 2002; Otis et al., 2003). Furthermore, PTSD and chronic pain may serve as a
reminder of each other, and may therefore maintain and worsen symptomatology of each
condition (Otis et al., 2003). Results of the current study are assessed within the context
of the vulnerability (i.e., generalized biological, generalized psychological, & specific
psychological) that they were hypothesized to represent.
Generalized Biological Vulnerability
According to Barlow (2000, 2002), a generalized biological vulnerability is
thought to be characterized by a genetic tendency to demonstrate emotional instability
and reactivity in response to changes and stressors in one's environment. Inherited
personality traits that are indicative of this vulnerability may consist of being high-strung,
nervousness, emotionality, negative affectivity, or neuroticism (Barlow, 2002; Clark et
al., 1994). Furthermore, neuroticism is characterized as experiencing emotions
associated with the fight or flight response (e.g., fear, anxiety, distress), which may lead
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to increased experience of negative moods (Eysenck, 1967, 1981). In assessing for a
generalized biological vulnerability for PTSD and chronic pain, three different
hypotheses were assessed.
Salivary Cortisol. If a biological vulnerability to demonstrate stress reactivity to
stressful events is similar for PTSD and chronic pain, then baseline levels of
physiological hyperarousal and physiological reactivity to environmental stressors were
predicted to be similar in the three clinical groups as opposed to the control group. In
particular, participants in the three clinical groups were hypothesized to demonstrate
lower baseline levels of cortisol prior to the experimental stressor and blunted cortisol
levels following the experimental stressor. Contrary to this hypothesis, results of the
current study did not demonstrate significant group differences in baseline levels of
cortisol between the three clinical groups and the control group. This finding is similar to
previous research comparing baseline levels of cortisol among fibromyalgia and control
group samples (Wingenfeld et al., 2008). Previous research studies assessing for basal
cortisol levels among participants with PTSD have also generally demonstrated
conflicting results (Meewisse, Reitsma, De Vries, Gersons, & Olff, 2007).
Visual inspection of the data suggested that the PTSD only group reported the
greatest increase in cortisol following the TSST; however, no significant group
differences were demonstrated between groups across all time points. Limited research
has assessed for the role of cortisol reactivity in response to the TSST among individuals
with PTSD or chronic pain, although McRae and colleagues (2006) reported that
participants with PTSD demonstrated higher cortisol reactivity in response to the TSST
than to a cold pressor task. The PTSD and pain and pain only groups appeared to
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demonstrate a blunted cortisol response following the TSST; however, this trend was also
unexpectedly demonstrated by the control group. Previous research has demonstrated
similar blunted cortisol reactivity in response to the TSST among participants with
fibromyalgia (Wingenfeld et al., 2008), although no previous studies have been found
that demonstrated a blunted response by a control group. It is possible that this may be a
result of publication biases in which researchers are less likely to publish non-significant
or atypical results (Meewisse et al., 2007). Levels of cortisol declined in all groups from
20 minutes to 40 minutes following the experimental stressor, although they began to
increase again in the control group from 40 to 60 minutes as participants were listening to
the relaxation soundtrack. It is possible that participants in this group began to feel
restless toward the end of their participation in the study.
As expected on the visual analog stress scale, all groups reported that the TSST
was perceived as a moderately stressful experience. Taking this into consideration, it
appears as though the TSST was successful in eliciting the level of stress reactivity that
was intended. Although several variables were controlled for in the current study (e.g.,
food intake, exercise, smoking, menstrual cycle), it is possible that cortisol levels may
have been influenced by the difficulty of controlling for other external variables (e.g.,
comorbid diagnoses, type of trauma). In a meta-analysis that assessed for basal cortisol
levels in participants with PTSD and control groups across 37 studies, results
demonstrated that basal levels of cortisol tend to be highly variable across studies
(Meewisse et al., 2007). Results also indicated that PTSD tends to be associated with
lower basal cortisol levels when participants experienced physical or sexual abuse;
however, no significant group differences were demonstrated between participants in the
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PTSD groups and control groups when other forms of trauma were assessed (Meewisse et
al., 2007). Controlling for type of trauma was beyond the scope of the current study,
although it is possible that type of trauma may have influenced study results.
Anxiety. It was hypothesized that self-reports of anxious mood during the lab visit
would exist on a continuum. Participants in the PTSD and pain group were predicted to
report the highest levels of anxiety across each occasion, followed by the PTSD only and
pain only groups, and then by the control group. This hypothesis was partially supported.
The PTSD and pain group reported significantly higher levels of anxiety across most time
points; however, no significant group differences were demonstrated between the PTSD
only, pain only, and control groups. No significant group differences were demonstrated
at 10 minutes following the TSST, although, trends indicate that the PTSD and pain and
PTSD only groups reported the highest levels of anxiety. The pain only and control
groups reported similar increases in anxiety at 10 minutes following the TSST. Although
not significantly different, the PTSD only group reported the second highest levels of
anxiety at 10 minutes following the TSST, while the pain only and control groups
continued to report similar levels of anxiety. After listening to the relaxation track in the
final 20 minutes of follow-up, the PTSD only, pain only, and control groups reported
minimal levels of anxiety, while the PTSD and pain group continued to report
significantly higher levels of anxiety. Given that the TSST is supposed to induce
moderate physiological and psychological stress (e.g., Dorn et al., 2003; Jones, Rollman,
& Brooke, 1997; McRae et al., 2006; Simeon et al., 2007; Wingenfeld et al., 2008),
results of the current study are in line with previous research demonstrating that
individuals with PTSD tend to report high levels of anxiety in response to everyday
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stressful life events than those without PTSD (Koopman, Gore-Felton, Classen, Kim,
Spiegel, 2001).
Overall, these findings support the hypothesis that comorbid diagnoses of PTSD
and pain are associated with increased anxiety both prior to and following the
experimental stressor; however, this trend was not the same for the PTSD only and pain
only groups. Although not significantly different, the PTSD only group reported higher
levels of anxiety than the pain only and control groups immediately following the
experimental stressor, although this trend was not demonstrated at other time points.
Finally, the pain only and control groups reported similar levels of anxiety at all time
points. As a result, it appears as though the combined influence of PTSD and pain may
lead to increased self-reports of anxious mood for individuals with these diagnoses.
Although it does not appear that the PTSD only and pain only groups are linked to a
similar vulnerability to respond to stressful situations with similar increases in selfreported anxious mood.
Depression. It was predicted that self-reported symptoms of depression would
also exist on a continuum. Participants in the PTSD and pain group were predicted to
report the highest levels of depression during the previous two weeks, followed by the
PTSD only and pain only groups. Participants in the control group were predicted to
report the lowest symptoms of depression. Contrary to this hypothesis, the PTSD and
pain and PTSD only groups reported similar and significantly higher levels of depression
than the pain only and control groups. These findings are similar to that of previous
research that has assessed for the high comorbidity rates between PTSD and depression
(Taft, Resick, Watkins, & Panuzio, 2009); however it is surprising that participants in the
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pain only group did not report higher levels of depression because high comorbidities
between these diagnoses have been reported in previous research (e.g., Gormsen,
Rosenberg, Bach, & Jensen, 2010). Findings in the current study suggest that symptoms
of depression may be associated with having a diagnosis of PTSD and not necessarily
chronic pain. When considering depression as a component of negative affectivity and
negative mood (Watson, Clark, & Carey, 1988), it does not appear as though PTSD and
chronic pain have the same vulnerability for these personality traits.
Family History of PTSD and Chronic Pain. Finally, self-report data indicated
that participants in the PTSD and pain and PTSD only groups were significantly more
likely to report a family history of PTSD than the pain only and control groups. This
finding is similar to that of previous research reporting that individuals with PTSD are
more likely to report a family history of PTSD than those without PTSD (Davidson et al.,
1985; McFarlane, 1988). Similarly, participants in the PTSD and pain and pain only
groups were significantly more likely to report a family history of chronic pain than
participants in the PTSD only and control groups. This finding also supports previous
research assessing for a family history of chronic pain among individuals with
generalized chronic widespread pain or a specific diagnosis of fibromyalgia (Bergman,
2005). Overall, these findings support the notion that there may be a genetic
vulnerability toward developing PTSD and/or chronic pain due to the high family history
rates of each diagnosis. Given that participants in the chronic pain only group did not
report significant frequencies of a family history of PTSD, and participants in the PTSD
only group did not report significant frequencies of a family history of chronic pain,
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results suggest that genetic vulnerabilities toward developing each diagnosis may be
independent of one another.
In summary, results of the current study do not provide support for the hypothesis
that PTSD and chronic pain have a similar biological vulnerability to respond to stressful
situations with an alarm reaction. Results do provide initial support for the potential role
of a biological vulnerability for individuals with PTSD to respond to stressful situations
with an alarm reaction. This was evident with regards to anxiety reactivity, heightened
symptoms of depression, and self-reported family histories of PTSD; however, it is
unclear as to whether several of these factors represent an actual vulnerability or a
reaction to having the diagnosis. Participants with chronic pain also reported
significantly higher family history rates of chronic pain, although participants in the pain
only group did not report heightened levels of anxiety in response to the experimental
stressor or general levels of depression. As such, evidence for this vulnerability was not
readily evident among participants with chronic pain without PTSD.
Given that no significant results were demonstrated with cortisol analyses,
additional research will be needed to determine the role of cortisol reactivity in both
populations. As hypothesized, participants with comorbid PTSD and chronic pain
reported the highest levels of anxiety reactivity. This group also reported similarly high
levels of depression to that of the PTSD only group. As a result, it may be possible that
several of these factors served as an initial vulnerability for PTSD, although it is also
possible that having both conditions may serve to worsen symptoms experienced by this
population. This hypothesis would be in line with Otis and colleagues proposal that

114
PTSD and chronic pain may work together to maintain and worsen symptomatology of
each condition (Otis et al., 2003).
Generalized Psychological Vulnerability
A generalized psychological vulnerability is thought to refer to a general sense of
uncontrollability and perceived inability to cope with unpredictable negative life events
(Barlow, 2000, 2002). Barlow (2002) also highlighted the importance of inducing a stress
response to measure changes in coping strategies. Otis and colleagues (2003, 2006)
notion that a generalized psychological vulnerability may be applied to both PTSD and
chronic pain was assessed within three hypotheses.
Learned Helplessness. According to the fourth hypothesis, all three clinical
groups were predicted to report higher levels of learned helplessness than the control
group. Results of the current study indicate that there were no significant group
differences for learned helplessness factors of internality, stability, or globality.
Consequently, results suggest that the construct of learned helplessness may not serve as
a psychological vulnerability for PTSD or chronic pain. This lack of significant group
differences conflicts with limited research that has found PTSD to be associated with a
helpless attributional style (Casella & Motta, 1990; Gibb, 2002), although results are
similar to those previously found within the chronic pain literature that did not
demonstrate an increase in learned helplessness among participants with chronic pain
(Ingram et al., 1990). As the Attributional Style Questionnaire (ASQ; Peterson &
Villanova, 1988) does not specifically target symptoms associated with PTSD and
chronic pain populations, it is possible that responses to the ASQ scenarios do not
generalize to real life experiences.
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Life experiences. If individuals with PTSD and chronic pain experience a general
sense of uncontrollability and perceived inability to cope with negative life events, then it
was hypothesized that the three clinical groups would report greater levels of negative
life events, perception of stress over the past month, and intolerance of uncertainty.
Results of the current study support the hypothesis that having a diagnosis of PTSD
and/or chronic pain is associated with greater impact of negative life events than the
control group. When considering all four groups independently, results revealed that the
PTSD and pain and PTSD only groups, in particular, reported significantly more negative
impact ratings of stressful events than the control group. Of particular interest, is that the
control group was the only group that rated the average impact of their life events as
being in the positive range.
Previous research has demonstrated that PTSD or chronic pain populations are
more likely to experience negative life events than individuals without these diagnoses
(e.g., Naidoo & Pillay, 1994; Solomon, Zur-Noah, Horesh, Zerach, & Keinan, 2008).
When assessing for the frequency of negative life events reported by participants in the
current study, no significant group differences were demonstrated; however, participants
in the PTSD and pain group did report the highest frequencies of negative life events,
followed by the PTSD only, pain only, and control groups respectively. These findings
also provide preliminary support for the hypothesis that individuals with PTSD and
chronic pain tend to report life events more negatively, which may suggest that they may
experience greater difficulty in coping with these events for them to rate the impact of
these events in this way.

116
Stress. As mentioned above, it was hypothesized that participants in the three
clinical groups would report greater perceptions of stress over the past month than the
control group. Planned comparisons indicated that the three clinical groups combined
reported significantly greater perceptions of stress than the control group. When
considering the four groups independently, results revealed that the PTSD and pain group
reported significantly higher perceptions of stress than the pain only and control groups.
Although not significantly different from the pain only and control groups, the PTSD
only group also reportedly similar levels of stress as the PTSD and pain group. The high
rates of general stress reported by participants with PTSD provides further support for
previous research that has also indicated that individuals with PTSD tend to report high
levels of stress (Fincham, Altes, Stein, & Seedat, 2009). As a result, it appears as though
having a co-morbid diagnosis of PTSD and pain is associated with the highest
perceptions of stress over the past month, followed by the PTSD only, control, and pain
only groups respectively.
Intolerance of Uncertainty. It was also predicted that the three clinical groups
would report higher levels of intolerance of uncertainty than the control group. Planned
comparisons between the three clinical groups and the control group did not indicate
significant group differences in levels of this construct. Similarly, analysis of the four
groups independently did not demonstrate any significant group differences for
intolerance of uncertainty. As a result, it does not appear that intolerance of uncertainty
plays a major role as a psychological vulnerability for either PTSD or chronic pain.
These findings conflict with previous research that has demonstrated a relationship
between intolerance of uncertainty and symptoms of anxiety (Kirby & Yardly, 2009).
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Previous research has also demonstrated that uncertainty regarding illness within a
fibromyalgia population was associated with increased difficulty in coping with
symptoms of fibromyalgia (Johnson, Zautra, & Davis, 2006). No known research studies
have been found that directly assessed for the relationship between intolerance of
uncertainty within PTSD or chronic pain populations.
Coping Strategies. Finally, it was predicted that the clinical groups would report
greater use of negative coping strategies than the control group. Conversely, it was
predicted that the control group would report greater use of positive coping strategies
than the three clinical groups. Coping strategies were assessed as both general use of
coping strategies and coping strategies utilized in response to the experimental stressor.
Planned comparisons of general coping strategies indicated that the three clinical
groups combined reported significantly higher levels of self-blame than the control
group. However, planned comparisons did not indicate significant group differences in
levels of denial, behavioral disengagement, active coping, positive reframing, or
acceptance. When each group was considered independently, results further indicated
that the PTSD only group reported using significantly higher levels of self-blame coping
than the pain only and control groups. Although not significantly different from the
control and pain only groups, the PTSD and pain group reported similar levels of selfblame to that of the PTSD only group. The pain only group actually reported the lowest
levels of self-blame. These results are similar to that of previous research that has not
found an increase in self-blame within a chronic pain population that reported comorbid
symptoms of depression (Lopez-Lopez, Montorio, Izal, & Velasco, 2008). With regards
to symptoms of PTSD, the current results support previous research that has found
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symptoms of PTSD to be positively correlated with self-blame (e.g., Najdowski, &
Ullman, 2009).
When considering coping strategies in response to the experimental stressor,
planned comparisons did not suggest any significant group differences in self-blame,
behavioral disengagement, denial, acceptance, positive reframing, or active coping.
Similar to that of general coping strategies that were reported, analysis of individual
group differences demonstrated that participants in the PTSD only group reported higher
levels of self-blame coping in response to the TSST than the pain only group, although
this was only a marginal result. The pain only group continued to report the lowest levels
of self-blame when compared to the other three groups. No other significant group
differences in coping strategies were demonstrated in response to the experimental
stressor.
Overall, these findings suggest that individuals with PTSD are significantly more
likely to utilize negative coping strategies such as self-blame than individuals who have
chronic pain without PTSD. No significant group differences were reported with regards
to the use of positive coping strategies. Furthermore, this trend held true when assessing
for both general use of coping strategies and coping strategies utilized in response to the
experimental stressor. Thus, the current results support the potential role of negative
coping strategies among individuals with chronic pain, although this trend was not
supported for individuals with chronic pain without PTSD. It is possible that analyses of
group coping strategies were limited by the small sample size.
In summary, results of the current study suggest that PTSD may be associated
with a generalized psychological vulnerability. This was evident by greater perceptions
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of stress over the past month, negative impact ratings of significant life events over the
past year, and greater report of negative coping strategies (i.e., self-blame) than the pain
only group. The only indicator of a psychological vulnerability that was supported for
the clinical group was the negative mean impact ratings of life events. However, having
a comorbid diagnosis of both PTSD and chronic pain appears to be associated with the
greatest levels of stress and negative impact ratings of life events. Similar to findings
focusing on a generalized biological vulnerability, results of the current study suggest
that having both diagnoses may maintain and even worsen symptoms experienced by
these individuals. The findings among the PTSD and pain group are not surprising as
previous research has also demonstrated that comorbid diagnoses of PTSD and pain are
associated with greater psychological distress and disability (Sherman et al., 2000).
Specific Psychological Vulnerability
According to Barlow (2002), a specific psychological vulnerability refers to the
development of a learned alarm, which may occur after the experience of a traumatic
event. With regards to chronic pain, activities and sensations that are associated with the
experience of pain may also serve as learned alarms (Asmundson et al., 1999;
McCracken et al., 1993; Otis et al., 2003). To assess for this vulnerability, the current
study predicted that PTSD and chronic pain would be associated with learned alarms that
are specific to the particular diagnosis. It was hypothesized that participants in the PTSD
and pain and PTSD only groups would report specific learned alarms associated with
PTSD, while participants with chronic pain would report evidence of a learned alarm
associated with chronic pain. All three clinical groups were predicted to report higher
levels of anxiety sensitivity than the control group.
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PTSD Related Anxiety. As expected, results of the current study suggested
evidence of a related learned alarm among participants with PTSD. This was indicated
by higher levels of total PTSD related symptoms and symptoms of hyperarousal among
participants with PTSD. No significant group differences were reported for the intrusion
and avoidance subscales of the IES-R. All participants in the current study met DSM-IV
diagnostic criteria for PTSD on a structured clinical interview, so it is likely that results
of the current study were limited due to the small number of participants. Despite this
limitation, evidence for a PTSD specific learned alarm was still evident among
participants with PTSD as opposed to those without PTSD.
Pain Related Anxiety. No significant group differences were demonstrated for
total scores for pain-related anxiety. Similarly, no significant group differences were
demonstrated for the avoidance, cognitive, and physiological subscales of the PASS;
however, near significant group differences were demonstrated for pain- related fear. In
particular, the PTSD and pain group reported the highest levels of pain- related fear,
followed by the pain only group, PTSD only group, and control groups respectively.
This suggests that significant group differences in pain- related fear would likely be
evident with a larger sample size. Given that participants in the PTSD and pain group
reported the highest levels of pain- related fear, results of the current study provide
preliminary support for the role of a learned alarm among individuals with chronic pain.
Furthermore, it appears as though having a comorbid diagnosis of PTSD and chronic pain
contributes to increased pain-related fear among this population. It is possible that pain
related fear is elevated within this group because symptoms of chronic pain may serve as
a reminder of an individual’s traumatic event (Straub & Straub, 2009).
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Anxiety Sensitivity. With regards to anxiety sensitivity, planned comparisons
between the three clinical groups and the control group did not demonstrate any
significant group differences. Analyses of individual group differences demonstrated that
the PTSD and pain group reported significantly higher levels of anxiety sensitivity than
the pain only group. Although not significantly different, the PTSD only group reported
the second highest levels of anxiety sensitivity, followed by the control and pain only
groups respectively. These results are in line with results of the current study given that
participants with PTSD and chronic pain reported the highest levels of pain related fear.
Previous research has also demonstrated that pain anxiety may be accounted for by
anxiety sensitivity (Greenburg & Burns, 2003). The relationship between anxiety
sensitivity and PTSD has also been well established within the extant literature (Kilic et
al., 2008; Taylor, 2004). Overall, results of the current study support the potential role of
anxiety sensitivity as a vulnerability for PTSD; however, results do not support the
hypothesis that anxiety sensitivity serves as a vulnerability for chronic pain without
PTSD. Having comorbid diagnoses of PTSD and chronic pain appears to lead to greater
self-reports of anxiety sensitivity for individuals with these diagnoses.
In summary, preliminary evidence for a specific learned alarm associated with
PTSD was demonstrated. This was evidenced by total PTSD related symptoms and
symptoms of hyperarousal. Similarly, preliminary evidence for a specific learned alarm
among participants with chronic pain was also demonstrated. Although there was only a
marginal significant difference, the PTSD and pain group reported the highest levels of
pain related fear, followed by the pain only, PTSD only, and control groups respectively.
Finally, results did not support the role of anxiety sensitivity in all three clinical groups;
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however, the PTSD and pain group reported significantly higher levels of anxiety
sensitivity than the pain only group.
Summary of Findings
The purpose of the current study was to test aspects of the triple vulnerability
model (Barlow, 2000; Barlow, 2002; Otis et al., 2003) in PTSD and chronic
musculoskeletal pain populations. This model proposed that individuals have a
generalized biological vulnerability (e.g., inherited personality traits that lead individuals
to react to environmental stressors in a defensive manner), generalized psychological
vulnerability (e.g., sense of uncontrollability and perceived inability to cope), and a
specific psychological vulnerability (e.g., development of learned alarms) to develop both
PTSD and chronic pain (Barlow, 2000; Barlow, 2002; Keane & Barlow, 2002; Otis et al.,
2003). PTSD and chronic pain may also serve as a reminder of each other, which may
maintain and worsen symptoms of each condition (Otis et al., 2003).
Results of the current study do not provide support for the hypothesis that PTSD
and chronic pain have a similar biological vulnerability to respond to stressful situations
with an alarm reaction; however, initial support for the role of a biological vulnerability
for individuals with PTSD to respond to stressful situations with an alarm reaction was
demonstrated. This was evident by participants’ anxiety reactivity, heightened symptoms
of depression, and self-reported family histories of PTSD. Participants with chronic pain
also reported significantly higher family history rates of chronic pain, although measures
of anxiety and depression were not heightened in the pain only group. No significant
results were demonstrated with cortisol analyses, so additional research is needed to
assess for cortisol reactivity in both populations. As hypothesized, participants with

123

comorbid PTSD and chronic pain reported the highest levels of anxiety in response to the
experimental stressor. This group also reported high levels of depression. As a result, it
may be possible certain vulnerabilities may exist for PTSD to initially develop, and that
having both diagnoses may serve to worsen and maintain symptoms experienced by this
population. This result also supports, Otis and colleagues’ contention that PTSD and
chronic pain may maintain and worsen symptoms of each condition (Otis et al., 2003).
Preliminary support for a generalized psychological vulnerability among
participants with PTSD was demonstrated. This was evident by greater perceptions of
stress over the past month, negative impact ratings of significant life events over the past
year, and greater report of negative coping strategies (i.e., self-blame) than the pain only
group. Having a diagnosis of chronic pain was only associated with negative mean
impact ratings of life events when combined with the other clinical groups. Having both
PTSD and chronic pain is associated with the greatest levels of stress and negative impact
ratings of life events. As such, results of the current study further suggest that having
both conditions may maintain and potentially worsen psychological symptoms
experienced by these individuals.
Preliminary evidence for a specific learned alarm associated with PTSD was
demonstrated. Participants with PTSD reported higher total PTSD related symptoms and
symptoms of hyperarousal. Preliminary evidence for a specific learned alarm among
participants with chronic pain was also demonstrated. Although there was only a
marginal significant difference, the PTSD and pain group reported the highest levels of
pain related fear, followed by the pain only, PTSD only, and control groups respectively.
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Finally, the PTSD and pain group reported significantly higher levels of anxiety
sensitivity than the pain only group.
Overall, results of the current study support the role of a generalized biological,
generalized psychological, and specific psychological vulnerabilities toward developing
PTSD. Limited findings have supported the potential role of these vulnerabilities toward
developing chronic pain; however, results of these measures were not similar to that of
PTSD (e.g., family history of chronic pain). As such, it is not thought that PTSD and
chronic pain are associated with the same vulnerabilities. Across many measures, having
PTSD and chronic pain was associated with an increase in symptoms. At this point in
time, it is thought that having both diagnoses may serve to maintain and possibly worsen
symptoms experienced by this population.
Study Limitations
There are several limitations associated with the current study. Small sample
sizes may have limited the ability to find significant group differences. Due to
difficulties with recruiting participants, women were recruited from both community and
student populations. As a result, participants in the PTSD only and control groups were
significantly younger than those in the pain only group. Conflicting results have been
found regarding whether or not there are differences in cortisol reactivity across the
lifespan (Gotthardt et al., 1995; Kudielka et al., 1999; Kudielka et al., 2000; Kudielka et
al., 2004). This may have increased variability in both cortisol levels and self-report
measures, although no significant group differences in cortisol were demonstrated when
age was utilized as a covariate. It is also possible that undergraduate students may
respond differently to stressful situations than the general population.
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Due to financial constraints, salivary cortisol was the only indicator of stress
reactivity in the HPA axis that was measured. The current results may have been limited
by not assessing for other changes in the HPA axis (e.g., CRH, ACTH, DHEA).
Variability in stress reactivity may also have been increased by including participants
who were both premenopausal and postmenopausal. In an attempt to control for this,
participants who were premenopausal were scheduled during the premenstrual phase of
their menstrual cycle; however, this may not have eliminated all variability (Kudielka et
al., 2004). Similarly, an inability to control for use of oral contraceptives may have
influenced cortisol analyses (Kirschbaum et al., 1999).
Significant group differences were also demonstrated with regards to body mass
index. In particular, the pain only group had significantly higher BMI ratings than the
PTSD only and control groups. It is possible that BMI may have influenced cortisol
reactivity, although this is unlikely given that previous research has not demonstrated
significant group differences between obese and non-obese women with regards to
cortisol reactivity in response to the TSST (Therrien et al., 2010).
Participants in the current study were primary Caucasian females. This may limit
generalizability of study results to other racial and ethnic groups. Ability to generalize
results to male populations may be limited as well.
The use of the TSST as a stress inducing event may not have been stressful
enough to induce levels of cortisol across all populations. Although all groups reportedly
perceived the TSST as being a moderately stressful event on the VASS, it is concerning
that the control group did not demonstrate an increase in cortisol levels following the
TSST as has been reported in previous research (e.g., Kirschbaum et al., 1993). It is also
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possible that levels of cortisol in the control group were influenced by other axis I
diagnoses that were not ruled out (Young, Abelson, & Cameron, 2004). Individual
differences in raters for the TSST may have also influenced cortisol levels for the control
group. Male and female raters were used but approximately 10 different sets of raters
were used in the current study. In addition, college students may be less reactive to a
stress task given IRB requirements regarding harm and previous experience with
psychological experiments.
Due to the constraints of the current study, no formal medical chart review was
conducted to confirm chronic pain diagnoses. Although the current study attempted to
limit variability within the chronic pain groups by only including participants with
chronic musculoskeletal pain, it is possible that including participants with different types
of musculoskeletal pain could have influenced cortisol reactivity. Similarly, the current
study was unable to account for type of traumatic events among participants with PTSD.
It is possible that this may have also influenced cortisol reactivity among these
participants (Meewisse et al., 2007). Participants with differential conditions of PTSD
and or chronic pain may also have varying sleep-wake schedules. Although time of day
was controlled for in the current study, it is possible that variations in sleep-wake cycles
may have influenced cortisol reactivity (e.g., Neylan, Otte, Yehuda, Marmar, 2006).
Finally, participants in the current study appeared to be relatively high functioning
when demographic information was examined (e.g., education, family income).
Individuals who experience more severe levels of PTSD and chronic pain may have been
less likely to respond to recruitment efforts. Approximately 50% - 60% of participants
who completed the initial phone screening did not show up for their laboratory visit.
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Several efforts were made to reschedule these participants, however many of them never
participated. It is unknown if severity in symptoms of PTSD, chronic pain, or disability
may have played a role in these individuals not showing up for their research
appointment.
Future Directions
Additional research will be needed to further assess for the role of biological and
psychological factors that may influence the high comorbidity rates of PTSD and chronic
pain. It is likely that study analyses were limited due to the small number of participants
and high variability among several of the factors. As such, a larger sample size would
likely be beneficial. Furthermore, future research will be needed to generalize study
findings to other populations (e.g., male, racial/ethnic minorities).
The current study was only able to assess for salivary cortisol reactivity due to
financial constraints. It will be helpful for future research to assess for the role of other
hormones in the HPA axis in attempt to obtain a complete picture of HPA axis
functioning. Although it would be extremely difficult, longitudinal data is needed to
determine the temporal course of cortisol reactivity, in addition to other biological and
psychological markers, before and after experiencing a traumatic event. Changes in pain
sensitivity before and after experiencing a stressful event would also provide interesting
information regarding the effects of daily stressors on chronic pain.
Finally, the current study provides preliminary support for several indicators of
biological and psychological vulnerabilities toward developing PTSD and/or chronic
pain. Results also indicate that having comorbid diagnoses of PTSD and chronic pain is
associated with increased symptoms on many of the measures utilized in this study. As
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such, it will be imperative for future research to consider treatment implications for
individuals with both diagnoses. It would be interesting to investigate if symptoms of
chronic pain lessen when symptoms of PTSD are treated. Furthermore, preventative
efforts should be developed that address the potential vulnerabilities demonstrated in the
current study.
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APPENDICES
Appendix A
CONSENT FORMS
Traumatic Events and Chronic Pain
Informed Consent Form – Community Participants
Because you are a female 18 years of age or older, and you responded to recruitment
efforts, you are invited to participate in a research project investigating the relationship
between posttraumatic stress disorder (PTSD) and chronic musculoskeletal pain. This
study is being conducted by Anna Cassel, a graduate student in the Psychology
department at the University of Maine, and is being supervised by Dr. Sandy Sigmon, a
professor in the Psychology department at the University of Maine.
How do I qualify for this study?
• You have already responded to some brief questions over the phone.
• Next, you will be asked to come into the lab to answer some questions from a
diagnostic interview (e.g., In the past six months, have you felt particularly nervous or
anxious?).
• You will also be asked to draw the location of your pain on a human figure and answer
a few brief questions regarding your pain condition.
• There are four ways that you may qualify for this study:
• Meet diagnostic criteria for PTSD without a chronic pain condition (PTSD group)
• Meet diagnostic criteria for PTSD and chronic musculoskeletal pain (PTSD and pain
group)
• Meet diagnostic criteria for chronic musculoskeletal pain without PTSD (pain group)
• Never had a diagnosis of either PTSD or chronic pain
What does this study involve?
• If you qualify based on information that you have given regarding the initial phone
screening criteria, you will be scheduled to come into the lab at the University of Maine.
During this visit, you will be asked to answer further questions (discussed above) to
confirm your eligibility for this study. It is estimated that it will take approximately 60
minutes for this portion of the study. Next, you will complete two mentally challenging
tasks. Following the challenging tasks, you will be asked to stay for an additional hour.
During the last 20 minutes of this hour, you will listen to some relaxing music. Saliva
samples and pain sensitivity will be assessed at various points throughout a 90 minute
period. Overall, it is estimated that the laboratory visit will take approximately 2 to 2.5
hours.
• Levels of pain sensitivity will be measured using a device that will apply a small
amount of pressure on to your thumb. You will be asked to report when you first
perceive symptoms of pain.

154
• Salivary cortisol samples will be collected using a plastic tube. You will be
asked to drool into the plastic tube.
• Following the completion of your laboratory visit, you will be asked to complete a
packet of questionnaires. Questionnaires may be completed on surveymonkey.com, or
you may be given a packet of questionnaires with a return envelope. It is estimated that it
will take approximately 45 minutes to complete the packet of questionnaires. You will
be asked questions about:
• Your reactions to various situations and life events (e.g., “You confront a
serious conflict in your values”)
• Life experiences (e.g., “Serious injury or Illness”)
• Coping strategies (e.g., “I've been expressing my negative feelings”)
• Symptoms associated with a stressful experience (“Pictures about it popped into
my mind”)
• Symptoms associated with the experience of pain (e.g., “I think that if my pain
gets too severe, it will never decrease”)
• Symptoms of anxiety (e.g., “It is important to me not to appear nervous”)
• Feelings of uncertainty (e.g., “I can’t stand being taken by surprise”)
• Feelings of stress (e.g., “In the past month, how often have you felt that you
were unable to control the important things in your life?”)
• Symptoms of depression (e.g., “I am so sad or unhappy that I can’t stand it.”)
• Basic demographic questions (e.g., “Current household income”)
Voluntary
Your participation in this research project is voluntary. You have the right to withdraw
from this study at any point. You may also choose to not answer any question that you
do not feel comfortable answering. If you do withdraw from the study, then you will be
compensated for the parts of the study that you participated in.
Are there any potential risks?
In previous research, any risk associated with participating in the mentally challenging
tasks has not been any greater than what you would normally encounter in your daily life.
While measuring pain sensitivity, you may temporarily experience a minimal level of
pain. This method of measuring pain sensitivity has been used in previous research
studies with no other adverse side effects being reported. There are no known risks
associated with collecting and analyzing the saliva samples. No identifying information
is sent with the samples when they are analyzed. In addition, there have been no long
lasting effects of completing questionnaires included in this study. All questionnaires
and tasks utilized in this study have been used in previous research with no reported
negative effects. You may, however, experience some discomfort when answering
questions that involve stressful events or situations. Anna Cassel (the principal
investigator) and Dr. Sandy Sigmon (her supervisor) will be available to talk with you if
you would like to discuss this discomfort. You may also request referral information for
psychological services at any time.
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Potential risks associated with completing online questionnaires on SurveyMonkey.com
are thought to be no greater than those encountered during routine access of the internet.
SurveyMonkey.com has taken precautions to secure the website and protect its users
from fraud or compromised confidentiality. In addition, they will not utilize customers’
data for their own purposes
What are the benefits of participating in this study?
Your responses may help us to gain a better understanding of the relationship between
chronic pain and PTSD. You will receive $20 for completing participation in this study.
If you do not qualify for participation, then you will receive $5 for the diagnostic
interview. You may also be eligible to participate in a free treatment study. This
treatment study will involve treatment for individuals who are still bothered by traumatic
events that have happened to them. You will have the option of participating or not in this
treatment study. The treatment consists of learning new skills in how to deal with
recurring thoughts and images that you may be bothered with.
Will my answers be confidential?
Your participation and all of your answers will be confidential. All study materials will
be stored in Dr. Sigmon’s locked laboratory. You will be assigned a participant number
for the study that will be written on all information that you give us. A list that contains
your identifying information will be stored in a separate location. This list will be
destroyed after the study is completed. Your answers will only be used for research
purposes. If any data becomes published or presented at a conference, then all of your
answers will remain anonymous and be compiled in a group format. The data will be kept
in Dr. Sigmon’s lab for an indefinite period of time.
Who do I contact if I have any questions?
In the event that you have any questions regarding this study, you may contact Anna
Cassel (581-2030, 301 Little Hall, Orono, ME, 04469 or by email:
anna.cassel@umit.maine.edu) or her advisor, Dr. Sandy Sigmon (581-2049, 376 Little
Hall, Orono, ME, 04469 or by email: sandra.Sigmon@umit.maine.edu). In the event that
you have questions regarding your right as a research participant, you may contact Gayle
Anderson who is the Assistant to the Protection of Human Subjects Review Board (5811498, 114 Alumni Hall, Orono, ME, 04469, or by email:
gayle.anderson@umit.maine.edu).
If you would like a copy of the results of this study when it is completed, please indicate
below. Also, please indicate if you would like to be contacted regarding the free
treatment study.
You will receive a copy of this consent form.
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Participant Signature: ______________________________ Date: ________________
Print Name Here: _________________________________ Phone: _______________
Please indicate if you would like a summary of study results: _____ yes _____ no
Would you like to be contacted regarding the free treatment study? _____ yes _____ no
If you would like the results of this study, please write down your permanent address:
________________________________________________________________________
________________________________________________________________________
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Traumatic Events and Chronic Pain
Informed Consent Form – Student Version
Because you are a female 18 years of age or older, and you responded to recruitment
efforts, you are invited to participate in a research project investigating the relationship
between posttraumatic stress disorder (PTSD) and chronic musculoskeletal pain. This
study is being conducted by Anna Cassel, a graduate student in the Psychology
department at the University of Maine, and is being supervised by Dr. Sandy Sigmon, a
professor in the Psychology department at the University of Maine.
How do I qualify for this study?
• You have already responded to some brief questions over the phone.
• Next, you will be asked to come into the lab to answer some questions from a
diagnostic interview (e.g., In the past six months, have you felt particularly nervous or
anxious?).
• You will also be asked to draw the location of your pain on a human figure and answer
a few brief questions regarding your pain condition.
• There are four ways that you may qualify for this study:
• Meet diagnostic criteria for PTSD without a chronic pain condition (PTSD
group)
• Meet diagnostic criteria for PTSD and chronic musculoskeletal pain (PTSD and
pain group)
• Meet diagnostic criteria for chronic musculoskeletal pain without PTSD (pain
group)
• Never had a diagnosis of either PTSD or chronic pain
What does this study involve?
• If you qualify based on information that you have given regarding the initial phone
screening criteria, you will be scheduled to come into the lab at the University of Maine.
During this visit, you will be asked to answer further questions (discussed above) to
confirm your eligibility for this study. It is estimated that it will take approximately 60
minutes for this portion of the study. Next, you will complete two mentally challenging
tasks. Following the challenging tasks, you will be asked to stay for an additional hour.
During the last 20 minutes of this hour, you will listen to some relaxing music. Saliva
samples and pain sensitivity will be assessed at various points throughout a 90 minute
period. Overall, it is estimated that the laboratory visit will take approximately 2 to 2.5
hours.
• Levels of pain sensitivity will be measured using a device that will apply a small
amount of pressure on to your thumb. You will be asked to report when you first
perceive symptoms of pain.
• Salivary cortisol samples will be collected using a plastic tube. You will be
asked to drool into the plastic tube.
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• Following the completion of your laboratory visit, you will be asked to complete a
packet of questionnaires. Questionnaires may be completed on surveymonkey.com, or
you may be given a packet of questionnaires with a return envelope. It is estimated that it
will take approximately 45 minutes to complete the packet of questionnaires. You will
be asked questions about:
• Your reactions to various situations and life events (e.g., “You confront a
serious conflict in your values”)
• Life experiences (e.g., “Serious injury or Illness”)
• Coping strategies (e.g., “I've been expressing my negative feelings”)
• Symptoms associated with a stressful experience (“Pictures about it popped into
my mind”)
• Symptoms associated with the experience of pain (e.g., “I think that if my pain
gets too severe, it will never decrease”)
• Symptoms of anxiety (e.g., “It is important to me not to appear nervous”)
• Feelings of uncertainty (e.g., “I can’t stand being taken by surprise”)
• Feelings of stress (e.g., “In the past month, how often have you felt that you
were unable to control the important things in your life?”)
• Symptoms of depression (e.g., “I am so sad or unhappy that I can’t stand it.”)
• Basic demographic questions (e.g., “Current household income”)
Voluntary
Participation in this research project is voluntary. You have the right to withdraw from
this study at any point. You may also choose to not answer any question that you do not
feel comfortable answering. If you do withdraw from the study, then you will be
compensated for the parts of the study that you participated in. You will receive 1 credit
for completing the initial interview, 1 credit for participation in the mentally challenging
tasks, 1 credit for remaining in the lab for an additional hour while saliva samples are
collected, and then 1 credit for completing the questionnaires.
Are there any potential risks?
In previous research, any risk associated with participating in the mentally challenging
tasks has not been any greater than what you would normally encounter in your daily life.
While measuring pain sensitivity, you may temporarily experience a minimal level of
pain. This method of measuring pain sensitivity has been used in previous research
studies with no other adverse side effects being reported. There are no known risks
associated with collecting and analyzing the saliva samples. No identifying information
is sent with the samples when they are analyzed. In addition, there have been no long
lasting effects of completing questionnaires included in this study. All questionnaires
and tasks utilized in this study have been used in previous research with no reported
negative effects. You may, however, experience some discomfort when answering
questions that involve stressful events or situations. Anna Cassel (the principal
investigator) and Dr. Sandy Sigmon (her supervisor) will be available to talk with you if
you would like to discuss this discomfort. You may also request referral information for
psychological services at any time.
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Potential risks associated with completing online questionnaires on SurveyMonkey.com
are thought to be no greater than those encountered during routine access of the internet.
SurveyMonkey.com has taken precautions to secure the website and protect its users
from fraud or compromised confidentiality. In addition, they will not utilize customers’
data for their own purpose.
What are the benefits of participating in this study?
Your responses may help us to gain a better understanding of the relationship between
chronic pain and PTSD. You will receive 5 credits for completing participation in this
study. If you do not qualify for participation, then you will receive 1 credit for the
diagnostic interview. If you do qualify for the study, you will receive 1 credit for
completing the diagnostic interview, 1 credit for participation in the mentally challenging
tasks, 1 credit for remaining in the lab for an additional hour while saliva samples are
collected, and then 1 credit for completing the questionnaires. You may also be eligible
to participate in a free treatment study. This treatment study will involve treatment for
individuals who are still bothered by traumatic events that have happened to them. You
will have the option of participating or not in this treatment study. The treatment consists
of learning new skills in how to deal with recurring thoughts and images that you may be
bothered with.
Will my answers be confidential?
Your participation and all of your answers will be confidential. All study materials will
be stored in Dr. Sigmon’s locked laboratory. You will be assigned a participant number
for the study that will be written on all information that you give us. A list that contains
your identifying information will be stored in a separate location. This list will be
destroyed after the study is completed. Your answers will only be used for research
purposes. If any data becomes published or presented at a conference, then all of your
answers will remain anonymous and be compiled in a group format. The data will be kept
in Dr. Sigmon’s lab for an indefinite period of time.
Who do I contact if I have any questions?
In the event that you have any questions regarding this study, you may contact Anna
Cassel (581-2030, 301 Little Hall, Orono, ME, 04469 or by email:
anna.cassel@umit.maine.edu) or her advisor, Dr. Sandy Sigmon (581-2049, 376 Little
Hall, Orono, ME, 04469 or by email: sandra.Sigmon@umit.maine.edu). In the event that
you have questions regarding your right as a research participant, you may contact Gayle
Anderson who is the Assistant to the Protection of Human Subjects Review Board (5811498, 114 Alumni Hall, Orono, ME, 04469, or by email:
gayle.anderson@umit.maine.edu).
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If you would like a copy of the results of this study when it is completed, please indicate
below. Also, please indicate if you would like to be contacted regarding the free
treatment study.
You will receive a copy of this consent form.
Participant Signature: ______________________________ Date: ________________
Print Name Here: __________________________________Phone: ______________
Please indicate if you would like a summary of study results: _____ yes _____ no
Would you like to be contacted regarding the free treatment study? _____ yes _____ no
If you would like the results of this study, please write down your permanent address:
________________________________________________________________________
________________________________________________________________________
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Appendix B
SHORT SCREENING SCALE FOR DSM-IV PTSD
1. Did you avoid being reminded of this experience by staying away from certain places,
people, or activities? (REMIND RESPONDENT OF LIFE EVENT IF NECESSARY.)
1. YES
2. NO
2. Did you lose interest in activities that were once important or enjoyable? (REMIND
RESPONDENT OF LIFE EVENT IF NECESSARY.)
1. YES
2. NO
3. Did you begin to feel more isolated or distant from other people? (REMIND
RESPONDENT OF LIFE EVENT IF NECESSARY.)
1. YES
2. NO
4. Did you find it hard to have love or affection for other people? (REMIND
RESPONDENT OF LIFE EVENT IF NECESSARY.)
1. YES
2. NO
5. Did you begin to feel that there was no point in planning for the future? (REMIND
RESPONDENT OF LIFE EVENT IF NECESSARY.)
1. YES
2. NO
6. After this experience, were you having more trouble than usual falling asleep or
staying asleep? (REMIND RESPONDENT OF LIFE EVENT IF NECESSARY.)
1. YES
2. NO
7. Did you become jumpy or get easily startled by ordinary noises or movements?
(REMIND RESPONDENT OF LIFE EVENT IF NECESSARY.)
1. YES
2. NO
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Appendix C
MPQ
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Appendix D
EXPANDED ASQ
Interpretations of Events
Please try to imagine yourself in the situations that follow. If such a situation happened
to you, what would you feel would have caused it? While events may have many causes,
we want you to pick only one—The MAJOR CAUSE IF THIS EVENT HAPPENED TO
YOU.
Please write the cause in the blank provided after each event. Next we want you to
answer three questions about the cause you provided. First, is the cause of this event
something about you or something about other people or circumstances? Second, is the
cause of this event something that will persist across time or something that will never
again be present? Third, is the cause of this event something that affects all situations in
your life or something that just affects this type of event?
To summarize, we want you to:
1. Read each situation and vividly imagine it happening to you.
2. Decide what you feel would be the one major cause of the situation if it
happened to you.
3. Write the cause in the blank provided.
4. Answer three questions about the cause.
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1. You have been looking for a job unsuccessfully for some time.
A. Write down one major cause:

B. Is the cause of this due to something about you or something about other
people or circumstances? (circle one number)
totally due
to others

1

2

3

4

5

6

7

totally due
to me

C. In the future, will this cause be present again? (circle one number)
never
present

1

2

3

4

5

6

7

always
present

D. Is this cause something that affects just this type of situation, or does it also
influence other areas of your life? (circle one number)
just this
situation

1

2

3

4

5

6

7

all
situations

2. A friend comes to you with a problem, and you don’t try to help.
A. Write down one major cause:

B. Is the cause of this due to something about you or something about other
people or circumstances? (circle one number)
totally due
to others

1

2

3

4

5

6

7

totally due
to me

C. In the future, will this cause be present again? (circle one number)
never
present

1

2

3

4

5

6

7

always
present

D. Is this cause something that affects just this type of situation, or does it also
influence other areas of your life? (circle one number)
just this
situation

1

2

3

4

5

6

7

all
situations
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3. You give an important talk in front of a group, and the audience reacts negatively.
A. Write down one major cause:

B. Is the cause of this due to something about you or something about other
people or circumstances? (circle one number)
totally due
to others

1

2

3

4

5

6

7

totally due
to me

C. In the future, will this cause be present again? (circle one number)
never
present

1

2

3

4

5

6

7

always
present

D. Is this cause something that affects just this type of situation, or does it also
influence other areas of your life? (circle one number)
just this
situation

1

2

3

4

5

6

7

all
situations

4. You meet a friend who acts hostilely to you.
A. Write down one major cause:

B. Is the cause of this due to something about you or something about other
people or circumstances? (circle one number)
totally due
to others

1

2

3

4

5

6

7

totally due
to me

C. In the future, will this cause be present again? (circle one number)
never
present

1

2

3

4

5

6

7

always
present

D. Is this cause something that affects just this type of situation, or does it also
influence other areas of your life? (circle one number)
just this
situation

1

2

3

4

5

6

7

all
situations
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5. You can’t get all the work done that others expect of you.
A. Write down one major cause:

B. Is the cause of this due to something about you or something about other
people or circumstances? (circle one number)
totally due
to others

1

2

3

4

5

6

7

totally due
to me

C. In the future, will this cause be present again? (circle one number)
never
present

1

2

3

4

5

6

7

always
present

D. Is this cause something that affects just this type of situation, or does it also
influence other areas of your life? (circle one number)
just this
situation

1

2

3

4

5

6

7

all
situations

6. You go out on a date, and it goes badly.
A. Write down one major cause:

B. Is the cause of this due to something about you or something about other
people or circumstances? (circle one number)
totally due
to others

1

2

3

4

5

6

7

totally due
to me

C. In the future, will this cause be present again? (circle one number)
never
present

1

2

3

4

5

6

7

always
present

D. Is this cause something that affects just this type of situation, or does it also
influence other areas of your life? (circle one number)
just this
situation

1

2

3

4

5

6

7

all
situations
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7. Your stead romantic relationship ends.
A. Write down one major cause:

B. Is the cause of this due to something about you or something about other
people or
circumstances? (circle one number)
totally due
to others

1

2

3

4

5

6

7

totally due
to me

C. In the future, will this cause be present again? (circle one number)
never
present

1

2

3

4

5

6

7

always
present

D. Is this cause something that affects just this type of situation, or does it also
influence other areas of your life? (circle one number)
just this
situation

1

2

3

4

5

6

7

all
situations

8. You experience a major personal injury.
A. Write down one major cause:

B. Is the cause of this due to something about you or something about other
people or
circumstances? (circle one number)
totally due
to others

1

2

3

4

5

6

7

totally due
to me

C. In the future, will this cause be present again? (circle one number)
never
present

1

2

3

4

5

6

7

always
present

D. Is this cause something that affects just this type of situation, or does it also
influence other areas of your life? (circle one number)
just this
situation

1

2

3

4

5

6

7

all
situations
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9. You are found guilty of a minor violation of the law.
A. Write down one major cause:

B. Is the cause of this due to something about you or something about other
people or circumstances? (circle one number)
totally due
to others

1

2

3

4

5

6

7

totally due
to me

C. In the future, will this cause be present again? (circle one number)
never
present

1

2

3

4

5

6

7

always
present

D. Is this cause something that affects just this type of situation, or does it also
influence other areas of your life? (circle one number)
just this
situation

1

2

3

4

5

6

7

all
situations

10. You and your family have a serious argument.
A. Write down one major cause:

B. Is the cause of this due to something about you or something about other
people or circumstances? (circle one number)
totally due
to others

1

2

3

4

5

6

7

totally due
to me

C. In the future, will this cause be present again? (circle one number)
never
present

1

2

3

4

5

6

7

always
present

D. Is this cause something that affects just this type of situation, or does it also
influence other areas of your life? (circle one number)
just this
situation

1

2

3

4

5

6

7

all
situations
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11. You are fired from your job.
A. Write down one major cause:

B. Is the cause of this due to something about you or something about other
people or circumstances? (circle one number)
totally due
to others

1

2

3

4

5

6

7

totally due
to me

C. In the future, will this cause be present again? (circle one number)
never
present

1

2

3

4

5

6

7

always
present

D. Is this cause something that affects just this type of situation, or does it also
influence other areas of your life? (circle one number)
just this
situation

1

2

3

4

5

6

7

all
situations

12. After your first term at school, you are on academic probation.
A. Write down one major cause:

B. Is the cause of this due to something about you or something about other
people or circumstances? (circle one number)
totally due
to others

1

2

3

4

5

6

7

totally due
to me

C. In the future, will this cause be present again? (circle one number)
never
present

1

2

3

4

5

6

7

always
present

D. Is this cause something that affects just this type of situation, or does it also
influence other areas of your life? (circle one number)
just this
situation

1

2

3

4

5

6

7

all
situations
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13. Your best friend tells you that you are not to be trusted.
A. Write down one major cause:

B. Is the cause of this due to something about you or something about other
people or circumstances? (circle one number)
totally due
to others

1

2

3

4

5

6

7

totally due
to me

C. In the future, will this cause be present again? (circle one number)
never
present

1

2

3

4

5

6

7

always
present

D. Is this cause something that affects just this type of situation, or does it also
influence other areas of your life? (circle one number)
just this
situation

1

2

3

4

5

6

7

all
situations

14. You have a lot of trouble understanding what your new employer requires of you.
A. Write down one major cause:

B. Is the cause of this due to something about you or something about other
people or circumstances? (circle one number)
totally due
to others

1

2

3

4

5

6

7

totally due
to me

C. In the future, will this cause be present again? (circle one number)
never
present

1

2

3

4

5

6

7

always
present

D. Is this cause something that affects just this type of situation, or does it also
influence other areas of your life? (circle one number)
just this
situation

1

2

3

4

5

6

7

all
situations
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15. You cannot sleep soundly.
A. Write down one major cause:

B. Is the cause of this due to something about you or something about other
people or circumstances? (circle one number)
totally due
to others

1

2

3

4

5

6

7

totally due
to me

C. In the future, will this cause be present again? (circle one number)
never
present

1

2

3

4

5

6

7

always
present

D. Is this cause something that affects just this type of situation, or does it also
influence other areas of your life? (circle one number)
just this
situation

1

2

3

4

5

6

7

all
situations

16. You experience sexual difficulties.
A. Write down one major cause:

B. Is the cause of this due to something about you or something about other
people or circumstances? (circle one number)
totally due
to others

1

2

3

4

5

6

7

totally due
to me

C. In the future, will this cause be present again? (circle one number)
never
present

1

2

3

4

5

6

7

always
present

D. Is this cause something that affects just this type of situation, or does it also
influence other areas of your life? (circle one number)
just this
situation

1

2

3

4

5

6

7

all
situations
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17. You confront a serious conflict in your values.
A. Write down one major cause:

B. Is the cause of this due to something about you or something about other
people or circumstances? (circle one number)
totally due
to others

1

2

3

4

5

6

7

totally due
to me

C. In the future, will this cause be present again? (circle one number)
never
present

1

2

3

4

5

6

7

always
present

D. Is this cause something that affects just this type of situation, or does it also
influence other areas of your life? (circle one number)
just this
situation

1

2

3

4

5

6

7

all
situations

18. Your roommate tells you he/she is switching to a room down the hall.
A. Write down one major cause:

B. Is the cause of this due to something about you or something about other
people or circumstances? (circle one number)
totally due
to others

1

2

3

4

5

6

7

totally due
to me

C. In the future, will this cause be present again? (circle one number)
never
present

1

2

3

4

5

6

7

always
present

D. Is this cause something that affects just this type of situation, or does it also
influence other areas of your life? (circle one number)
just this
situation

1

2

3

4

5

6

7

all
situations
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19. There are few recreational activities in which you are interested.
A. Write down one major cause:

B. Is the cause of this due to something about you or something about other
people or circumstances? (circle one number)
totally due
to others

1

2

3

4

5

6

7

totally due
to me

C. In the future, will this cause be present again? (circle one number)
never
present

1

2

3

4

5

6

7

always
present

D. Is this cause something that affects just this type of situation, or does it also
influence other areas of your life? (circle one number)
just this
situation

1

2

3

4

5

6

7

all
situations

20. Your holiday vacation plans are cancelled.
A. Write down one major cause:

B. Is the cause of this due to something about you or something about other
people or circumstances? (circle one number)
totally due
to others

1

2

3

4

5

6

7

totally due
to me

C. In the future, will this cause be present again? (circle one number)
never
present

1

2

3

4

5

6

7

always
present

D. Is this cause something that affects just this type of situation, or does it also
influence other areas of your life? (circle one number)
just this
situation

1

2

3

4

5

6

7

all
situations

174
21. You have trouble with one of your instructors.
A. Write down one major cause:

B. Is the cause of this due to something about you or something about other
people or circumstances? (circle one number)
totally due
to others

1

2

3

4

5

6

7

totally due
to me

C. In the future, will this cause be present again? (circle one number)
never
present

1

2

3

4

5

6

7

always
present

D. Is this cause something that affects just this type of situation, or does it also
influence other areas of your life? (circle one number)
just this
situation

1

2

3

4

5

6

7

all
situations

22. You experience financial difficulties.
A. Write down one major cause:

B. Is the cause of this due to something about you or something about other
people or circumstances? (circle one number)
totally due
to others

1

2

3

4

5

6

7

totally due
to me

C. In the future, will this cause be present again? (circle one number)
never
present

1

2

3

4

5

6

7

always
present

D. Is this cause something that affects just this type of situation, or does it also
influence other areas of your life? (circle one number)
just this
situation

1

2

3

4

5

6

7

all
situations
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23. Your attempt to capture the interest of a specific person of the opposite sex is a
failure.
A. Write down one major cause:

B. Is the cause of this due to something about you or something about other
people or circumstances? (circle one number)
totally due
to others

1

2

3

4

5

6

7

totally due
to me

C. In the future, will this cause be present again? (circle one number)
never
present

1

2

3

4

5

6

7

always
present

D. Is this cause something that affects just this type of situation, or does it also
influence other areas of your life? (circle one number)
just this
situation

1

2

3

4

5

6

7

all
situations

24. You feel sick and tired all of the time.
A. Write down one major cause:

B. Is the cause of this due to something about you or something about other
people or circumstances? (circle one number)
totally due
to others

1

2

3

4

5

6

7

totally due
to me

C. In the future, will this cause be present again? (circle one number)
never
present

1

2

3

4

5

6

7

always
present

D. Is this cause something that affects just this type of situation, or does it also
influence other areas of your life? (circle one number)
just this
situation

1

2

3

4

5

6

7

all
situations
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Appendix E
LIFE EXPERIENCES SURVEY
Listed below are a number of events which sometimes bring about change in the lives of those
who experience them and which necessitate social readjustment. For events that have happened
to you in the past year, please indicate the extent to which you viewed the event as having either
a positive or negative impact on your life (by putting a number from -3 to +3 in the blank
space). That is, indicate the type and extent of impact that the event had. A rating of -3 would
indicate an extremely negative impact. A rating of 0 suggests no impact either positive or
negative. A rating of +3 would indicate an extremely positive impact. Then put a checkmark (√)
to indicate when in your lifetime that the event occurred (either in the past year, or in your
lifetime)
-3
-2
-1
0
+1
+2
+3
Extremely Moderately Somewhat
No
Slightly
Moderately
Extremely
negative
negative
negative
impact
positive
positive
positive
Past
Impact Event
year Lifetime
1. Marriage
____ ____
2. Detention in jail or
Comparable institution ____ ____
3. Death of Spouse
____ ____
4. Major change in
sleeping habits (much
more or much less
sleep)
____ ____
5. Death of close family ____ ____
a. mother
____ ____
b. father
____ ____
c. brother
____ ____
d. sister
____ ____
e. grandmother
____ ____
f. grandfather
____ ____
g. other (specify)
____ ____
6. Major change in eating
Habits (much more or
less food intake)
____ ____
7. Foreclosure on
Mortgage or loan
____ ____
8. Death of close friend ____ ____
9. Outstanding personal
achievement
____ ____
10. Minor law violations
(traffic tickets,
disturbing the peace,
etc.)
____ ____
11. Male: Wife/girlfriend’s
pregnancy
____ ____
12. Female: Pregnancy ____ ____

Past
Impact Event
year Lifetime
13. Changed work
situation (different work
responsibility, major change
in working conditions,
working hours, etc.)
____ ____
14. New Job
____ ____
15. Serious illness or injury
of close family member:
____ ____
a. father
____ ____
b. mother
____ ____
c. sister
____ ____
d. brother
____ ____
e. grandfather
____ ____
f. grandmother
____ ____
g. spouse
____ ____
h. other (specify)
____ ____
16. Sexual difficulties
____ ____
17. Trouble with employer
(in danger of losing job,
being suspended, demoted, etc.) ____ ____
18. Trouble with in-laws
____ ____
19. Major change in
financial status (a lot better
or a lot worse off)
____ ____
20. Major change in closeness
of family members
(increased or decreased)
____ ____
21. Gaining a new family member
(through birth, adoption, family
member moving in, etc.)
____ ____
22. Change in residence
____ ____
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-3
-2
Extremely Moderately
negative
negative
Impact Event

-1
0
+1
Somewhat
No
Slightly
negative
impact
positive
Past
year Lifetime
Impact Event

+2
+3
Moderately Extremely
positive
positive
Past
year Lifetime

23. Marital separation
38. Divorce
____ ____
mate (due from to conflict) ____ ____
39. Serious injury or illness
24. Major change in church
(you or to a close friend)
____ ____
activities (increased or
40. Retirement from work
____ ____
decreased attendance)
____ ____
41. Son or daughter leaving
25. Martial reconciliation
home
____ ____
with mate
____ ____
42. Ending of formal schooling ____ ____
26. Major change in number
43. Separation from spouse
of arguments with
(due to work, travel, etc.)
____ ____
spouse (a lot more or a
44. Engagement
____ ____
lot less arguments)
____
____
45. Breaking up with boyfriend
27. Married male: Change
or girlfriend
____ ____
in wife’s work outside
46. Leaving home for the
the home (beginning work,
first time
____ ____
ceasing work, change to a
47. Reconciliation with
new job, etc.)
____
____
boyfriend/girlfriend
____ ____
28. Married female: Change
48. Beginning a new school
in husband’s work, (loss
experience at a higher academic
of job, beginning a new job,
level (college, graduate school,
retirement, etc.)
____
____
professional school, etc.)
____ ____
29. Major change in usual
49. Changing to a new school
type and/or amount of
at same academic level
recreation
____
____
(undergraduate, graduate, etc.) ____ ____
30. Borrowing more than
50. Academic probation
____ ____
$10,000 (buying car, TV,
51. Being dismissed from dormitory
getting school loan, etc.) ____
____
or other residence
____ ____
31. Borrowing less than
52. Failing an important exam ____ ____
$10,000 (buying car, TV,
53. Changing a major
____ ____
getting school loan, etc.)
____
____
54. Failing a course
____ ____
32. Being fired from a job ____
____
55. Dropping a course
____ ____
33. Male: Wife/girlfriend
56. Joining a fraternity/ sorority ____ ____
having an abortion
____
____
57. Financial problems concerning
34. Female: having an
school (in danger of not having
abortion
____
____
sufficient money to continue) ____ ____
35. Major personal
illness or injury
____
____
Other recent experiences which have had an impact
36. Major change in social
on your life. List and rate.
activities, e.g. parties,
58. _____________________ ____ ____
movies, visiting
59. _____________________ ____ ____
(increased or decreased)
____
____
60. _____________________ ____ ____
37. Major change in living
conditions of family (building new home, remodeling,

deterioration of home, neighborhood, etc.)

____

_____
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Appendix F
BRIEF COPE
These items deal with ways you've been coping with the stress in your life. There are
many ways to try to deal with problems. These items ask what you've been doing to cope
with this one. Each item says something about a particular way of coping. I want to
know to what extent you've been doing what the item says – How much or how
frequently. Don't answer on the basis of whether it seems to be working or not—just
whether or not you're doing it. Use these response choices. Try to rate each item
separately in your mind from the others. Make your answers as true FOR YOU as you
can.
1
I haven’t been
doing this at all

2
I’ve been doing
this a little bit

3
I’ve been doing
this a medium amount

4
I’ve been doing
this a lot

1. _____ I've been turning to work or other activities to take my mind off things.
2. _____ I've been concentrating my efforts on doing something about the situation I'm
in.
3. _____ I've been saying to myself "this isn't real.
4. _____ I've been using alcohol or other drugs to make myself feel better.
5. _____ I've been getting emotional support from others.

6. _____ I've been giving up trying to deal with it.
7. _____ I've been taking action to try to make the situation better.
8. _____ I've been refusing to believe that it has happened.
9. _____ I've been saying things to let my unpleasant feelings escape.
10. _____ I’ve been getting help and advice from other people.

11.
12.
13.
14.
15.

_____ I've been using alcohol or other drugs to help me get through it.
_____ I've been trying to see it in a different light, to make it seem more positive.
_____ I’ve been criticizing myself.
_____ I've been trying to come up with a strategy about what to do.
_____ I've been getting comfort and understanding from someone.

16.
17.
18.
19.

_____ I've been giving up the attempt to cope.
_____ I've been looking for something good in what is happening.
_____ I've been making jokes about it.
_____ I've been doing something to think about it less, such as going to movies,
watching TV, reading, daydreaming, sleeping, or shopping.

179

20.
21.
22.
23.
24.

_____ I've been accepting the reality of the fact that it has happened.
_____ I've been expressing my negative feelings.
_____ I've been trying to find comfort in my religion or spiritual beliefs.
_____ I’ve been trying to get advice or help from other people about what to do.
_____ I've been learning to live with it.

25.
26.
27.
28.

_____ I've been thinking hard about what steps to take.
_____ I’ve been blaming myself for things that happened.
_____ I've been praying or meditating.
_____ I've been making fun of the situation.
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Appendix G
IES – REVISED
Instructions: The following is a list of difficulties people sometimes have after stressful
life events. Please read each item, and then indicate how distressing each difficulty has
been for you during the past 7 days with respect to __________. How much were you
distressed or bothered by these difficulties?

1. Any reminder brought back
feelings about it.

Not at
All
0

A little
bit
1

Moderately

Extremely

2

Quite
a bit
3

4

2. I had trouble staying asleep.

0

1

2

3

4

3. Other things kept making me
think about it.

0

1

2

3

4

4. I felt irritable and angry.

0

1

2

3

4

5. I avoided letting myself get
upset when I thought about it
or was reminded of it.

0

1

2

3

4

6. I thought about it when
I didn’t mean to.

0

1

2

3

4

7. I felt as if it hadn’t happened
or wasn’t real.

0

1

2

3

4

8. I stayed away from reminders
about it.

0

1

2

3

4

9. Pictures about it popped
into my mind.

0

1

2

3

4

10. I was jumpy and easily startled. 0

1

2

3

4

11. I tried not to think about it.

0

1

2

3

4

12. I was aware that I had
a lot of feelings about it,
but I didn’t deal with them.
13. My feelings about it were
kind of numb.

0

1

2

3

4

0

1

2

3

4
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Not at
All
14. I found myself acting or
0
feeling like I was back at that time.

A little
bit
1

Moderately

Extremely

2

Quite
a bit
3

4

15. I had trouble falling asleep.

0

1

2

3

4

16. I had waves of strong
feelings about it.

0

1

2

3

4

17. I tried to remove it from
my memory.

0

1

2

3

4

18. I had trouble concentrating.

0

1

2

3

4

19. Reminders of it caused me
0
to have physical reactions,
such as sweating, trouble breathing,
nausea, or pounding heart.

1

2

3

4

20. I had dreams about it.

0

1

2

3

4

21. I felt watchful and on guard.

0

1

2

3

4

22. I tried not to talk about it.

0

1

2

3

4
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Appendix H
PAIN ANXIETY SYMPTOM SCALE
Individuals who experience pain develop different ways to respond to that pain. We would like
to know what you do and what you think about when in pain. Please use the rating scale
below to indicate how often you engage in each of the following thoughts or activities. Circle
any number from 0 (NEVER) to 5 (ALWAYS) for each item.

PASS-20
NEVER

1.

2.

3.

4.

5.

6.

7.

8.

9.

I think that if my pain gets too severe,
it will never decrease
When I feel pain I am afraid that something
terrible will happen
I go immediately to bed when I feel severe pain

I begin trembling when engaged in activity that
increases pain
I can’t think straight when I am in pain

I will stop any activity as soon as I sense pain
coming on
Pain seems to cause my heart to pound or race

As soon as pain comes on I take medication to
reduce it
When I feel pain I think that I may be seriously ill

ALWAYS

0

1

2

3

4

5

0

1

2

3

4

5

0

1

2

3

4

5

0

1

2

3

4

5

0

1

2

3

4

5

0

1

2

3

4

5

0

1

2

3

4

5

0

1

2

3

4

5

0

1

2

3

4

5
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During painful episodes it is difficult for me to
10.

11.

12.

13.

14.

15.

16.

17.

think of anything else besides the pain

I avoid important activities when I hurt

When I sense pain I feel dizzy or faint

Pain sensations are terrifying

When I hurt I think about the pain constantly

Pain makes me nauseous (feel sick)

When pain comes on strong I think I might become
paralyzed or more disable
I find it hard to concentrate when I hurt

0

1

2

3

4

5

0

1

2

3

4

5

0

1

2

3

4

5

0

1

2

3

4

5

0

1

2

3

4

5

0

1

2

3

4

5

0

1

2

3

4

5

0

1

2

3

4

5

0

1

2

3

4

5

0

1

2

3

4

5

0

1

2

3

4

5

I find it difficult to calm my body down after periods of
18.

19.

20.

pain
I worry when I am in pain

I try to avoid activities that cause pain
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Appendix I
ASI
Respond to each item by indicating the number of the phrase which best represents the
extent to which you agree with the item. If any of the items address something that is not
part of your experience (i.e., "it scares me when I feel shaky" for someone who has never
trembled or had the "shakes"), answer on the basis of how you think you might feel if you
had such an experience. Otherwise answer all items on the basis of your own experience.
Be careful to make only one choice for each item and please answer all items.
0
Very Little

1
A Little

2
Some

3
Much

4
Very Much

______ 1.

It is important to me not to appear nervous.

______ 2.
______ 3.

When I cannot keep my mind on a task, I worry that I might be going
crazy.
It scares me when I feel "shaky" (trembling).

______ 4.

It scares me when I feel faint.

______ 5.

It is important to me to stay in control of my emotions.

______ 6.

It scares me when my heart beats rapidly.

______ 7.

It embarrasses me when my stomach growls.

______ 8.

It scares me when I am nauseous.

______ 9.
______ 10.

When I notice that my heart is beating rapidly, I worry that I might have a
heart attack.
It scares me when I am short of breath.

______ 11.

When my stomach is upset, I worry that I might be seriously ill.

______ 12.

It scares me when I am unable to keep my mind on a task.

______ 13.

Other people notice when I feel shaky.

______ 14.

Unusual body sensations scare me.

______ 15.

When I am nervous, I worry that I might be mentally ill.

______ 16.

It scares me when I am nervous.
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Appendix J
IUS-12
Please rate each item based on the following scale.
Not at all
characteristic of me
1

Entirely
characteristic of me
2

3

4

5

____ 1. Unforeseen events upset me greatly.
____ 2. It frustrates me not having all the information I need.
____ 3. One should always look ahead so as to avoid surprises.
____ 4. A small, unforeseen event can spoil everything, even with the best of planning.
____ 5. I always want to know what the future has in store for me.
____ 6. I can’t stand being taken by surprise.
____ 7. I should be able to organize everything in advance.
____ 8. Uncertainty keeps me from living a full life.
____ 9. When it’s time to act, uncertainty paralyses me.
____ 10. When I am uncertain I can’t function very well.
____ 11. The smallest doubt can stop me from acting.
____ 12. I must get away from all uncertain situations.
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Appendix K
POMS SCALE
Directions: Below is a list of words that describe feelings that people have. Please read
each one carefully. Then select the number that best describes HOW YOU FEEL
RIGHT NOW. Place that number on the small line to the left of each word. Do not skip
any items, and print your numbers clearly.
0
1
2
3
4

=
=
=
=
=

Not at all
A little
Moderately
Quite a bit
Extremely

_____ 1. Tense

_____ 13. Restless

_____ 2. Unhappy

_____ 14. Discouraged

_____ 3. Sorry for things done

_____ 15. Nervous

_____ 4. Shaky

_____ 16. Lonely

_____ 5. Sad

_____ 17. Miserable

_____ 6. On edge

_____ 18. Anxious

_____ 7. Blue

_____ 19. Gloomy

_____ 8. Panicky

_____ 20. Desperate

_____ 9. Hopeless

_____ 21. Helpless

_____ 10. Relaxed

_____ 22. Worthless

_____ 11. Unworthy

_____ 23. Terrified

_____ 12. Uneasy

_____ 24. Guilty
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Appendix L
VISUAL ANALOG STRESS SCALE
Please rate the level of stress you felt during the task.
1-------------2-------------3-------------4-------------5-------------6--------------7
Not at all
Moderately
Extremely
stressed
stressed
stressed
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Appendix M
PERCEIVED STRESS SCALE
The questions in this scale ask you about your feelings and thoughts during the last
month. In each case, you will be asked to indicate how often you felt or thought a certain
way. Although some of the questions are similar, there are differences between them and
you should treat each one as a separate question. The best approach is to answer each
question fairly quickly. That is, don’t try to count up the number of times you felt a
particular way, but rather indicate the alternative that seems like a reasonable estimate.
For each question, choose from the following alternatives:
0------------------1------------------2----------------3------------------4
Never
Almost Never
Sometimes
Fairly Often
Very Often

____ 1. In the very last month, how often have you been upset because of something that
happened unexpectedly?
____ 2. In the last month, how often have you felt that you were unable to control the
important things in your life?
____ 3. In the last month, how often have you felt nervous and “stressed”?
____ 4. In the last month, how often have you dealt successfully with irritating life
hassles?
____ 5. In the last month, how often have you felt that you were effectively coping with
important changes that were occurring in your life?
____ 6. In the last month, how often have you felt confident about your ability to handle
your personal problems?
____ 7. In the last moth, how often have you felt that things were going your way?
____ 8. In the last month, how often have you found that you could not cope with all the
things that you had to do?
____ 9. In the last month, how often have you been able to control irritations in your life?
____ 10. In the last month, how often have you felt that you were on top of things?
____ 11. In the last month, how often have you been angered because of things that
happened that were outside of your control?
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____ 12. In the last month, how often have you found yourself thinking about things that
you have to accomplish?
____ 13. In the last month, how often have you been able to control the way you spend
your time?
____ 14. In the last month, how often have you felt difficulties were piling up so high
that you could not overcome them?
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Appendix N
BDI-II
Instructions: This questionnaire consists of 21 groups of statements. Please read each
group of statements carefully, and then pick out the one statement in each group that
best describes the way you have been feeling during the past two weeks, including
today. Circle the number beside the statement you have picked. If several statements in
the group seem to apply equally well, circle the highest number for that group. Be sure
that you do not choose more than one statement for any group, including Item 16
(Changes in Sleeping Pattern) or Item 18 (Changes in Appetite).
1. Sadness
0

I do not feel sad.

1

I feel sad much of the time.

2

I am sad all the time.

3

I am so sad or unhappy that I can't stand it.

2. Pessimism
0

I am not discouraged about my future.

1

I feel more discouraged about my future than I used to be.

2

I do not expect things to work out for me.

3

I feel my future is hopeless and will only get worse.

3. Past Failure
0

I do not feel like a failure.

1

I have failed more than I should have.

2

As I look back, I see a lot of failures.

3

I feel I am a total failure as a person.

4. Loss of Pleasure
0

I get as much pleasure as I ever did from the things I
enjoy.

1

I don't enjoy things as much as I used to.

2

I get very little pleasure from the things I used to enjoy.

3

I can't get any pleasure from the things I used to enjoy.

5. Guilty Feelings
0

I don't feel particularly guilty.

1

I feel guilty over many things I have done or should
have done.

191

8. Self-Criticalness
0

I don't criticize or blame myself more than usual

1

I am more critical of myself than I used to be.

2

I criticize myself for all of my faults.

3

I blame myself for everything bad that happens.

9. Suicidal Thoughts or Wishes
0

I don't have any thoughts of killing myself.

1

I have thoughts of killing myself, but I would not carry
them out.

2

I would like to kill myself.

3

I would kill myself if I had the chance.

10. Crying
0

I don't cry anymore than I used to.

1

I cry more than I used to.

2

I cry over every little thing.

3

I feel like crying, but I can't.

11. Agitation
0

I am no more restless or would upAppendix
than usual.K

1

I feel more restless or wound up than usual.

2

I am so restless or agitated that it's hard to stay still.

3

I am so restless or agitated that I have to keep moving

Debriefing Statement

or doing something.
12. Loss of Interest
0

I have not lost interest in other people or activities.

1

I am less interested in other people or things than
before.
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15. Loss of Energy
0

I have as much energy as ever.

1

I have less energy than I used to have.

2

I don't have enough energy to do very much.

3

I don't have enough energy to do anything.

16. Changes in Sleeping Pattern
0

I have not experienced any change in my sleeping pattern.

1a I sleep somewhat more than usual.
1b I sleep somewhat less than usual.
2a I sleep a lot more than usual.
2b I sleep a lot less than usual
3a I sleep most of the day.
3b I wake up 1-2 hours early and can't get back to sleep.
17. Irritability
0

I am no more irritable than usual.

1

I am more irritable than usual.

2

I am much more irritable than usual.

3

I am irritable all the time.

18. Changes in Appetite
0

I have not experienced any change in my appetite.

1a My appetite is somewhat less than usual.
1b My appetite is somewhat greater than usual.
2a My appetite is much less than before.
2b My appetite is much greater than usual.
3a I have no appetite at all.
3b I crave food all the time.
19
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Appendix O
DEMOGRAPHICS PAGE
Date: __________________
Age:

__________________

Race: __________________
Highest Educational Attainment: _______________
Current Household Income (circle one):
Under 10,000

10,000-19,999

20,000-29,999

30,000-39,999

40,000-49,999

50,000-59,999

Greater than 60,000
Relationship Status (circle one):
Single

Living with partner

Divorced

Widowed

Married

Separated

Current medications: _____________________________________________________
Are you currently taking any form of birth control medications? _____ yes _____no
If so, which one? _________________________________
Weight: ____________
Height: ____________
Please indicate the actual date of your last menstrual cycle, in other words, what
was the date when you began blood flow (e.g., April 15, 2006).
________________________
Do you have a family history of posttraumatic stress disorder? _____ yes _____ no
Do you have a family history of chronic pain? _____ yes _____ no
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Appendix P
DEBRIEFING STATEMENT
Assessing a Biopsychosocial Model for PTSD and Chronic Pain
Debriefing Statement
The purpose of this study was to look at aspects of a biopsychosocial model that
has been proposed to account for the relationship between PTSD and chronic pain. Four
groups of women were assessed in this study: women with posttraumatic stress disorder
(PTSD) without chronic pain, women with musculoskeletal pain without PTSD, women
with both musculoskeletal pain and PTSD, and women who no not have a diagnosis of
either PTSD or chronic pain.
During the course of this study, participants were asked to prepare and give a
speech about a dream job, and why they would be the perfect applicant for this job.
Participants were told that they would be giving the speech in front of two “managers”
that are trained to monitor nonverbal behavior. These “managers” were actually research
assistants who did not have any training in monitoring nonverbal behavior. In addition,
the videotape was not recording during the speech. Participants then began a 5 minute
mental arithmetic task, where they were instructed to serially subtract 13 from 1,022 as
quickly and accurately as possible for a five minute period. The purpose of these tasks
was to induce stress. Participants were also asked to complete questionnaires regarding
their thoughts and feelings. In addition, salivary cortisol samples were collected.
Cortisol is a hormone in your body that is released in response to stress. These samples
were taken to see how participants in each group responded to the stressful event, and to
see how long it will take their body to return to their original level of cortisol following
the stress event. Below is a list of hypotheses that are being assessed in this study:
Study hypotheses:
1.

Individuals who have either PTSD, chronic pain, or both conditions will have
lower initial levels of cortisol levels before the experimental stressor, and
blunted (i.e. lower) salivary cortisol levels following the experimental stressor.

2.

Individuals in all groups will experience symptoms of depression and anxiety on a
continuum. Individuals with PTSD and pain group are anticipated to report the
highest depressive and anxiety symptomatology (both at baseline and in response
to the experimental stressor), followed by individuals with only PTSD or chronic
pain. Participants in the control group are anticipated to report to least depressive
and anxiety symptomatology.

3.

Individuals who have either PTSD, chronic pain, or both conditions will be more
likely to make to internal, stabile, and global attributions about events than
individuals in the control group.
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4.

Individuals who have either PTSD, chronic pain, or both conditions will be more
likely to report negative life events and general levels of self-perceived stress.
Subsequently, these individuals will also be more likely to view ambiguous
situations as more threatening than individuals in the control group.

5.

Individuals who have either PTSD, chronic pain, or both conditions will be more
likely to use negative coping strategies (i.e., denial, behavioral disengagement,
self-blame) than individuals in the control group.

6.

Individuals who have PTSD or chronic pain and PTSD will be more likely to
report symptoms of PTSD. Similarly, individuals with chronic pain or PTSD
and chronic pain will be more likely to report anxiety associated with their pain
condition.
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